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Depression and anxiety are highly prevalent psychiatric disorders (1). More than 
300 million people are affected by depression and nearly the same number of people 
suffer from a range of anxiety disorders. Depression is ranked by the World Health 
Organization (WHO) as the single largest contributor to global disability, and anx-
iety disorders are ranked 6th. 
To successfully diagnose, treat and monitor depressive and anxiety disorders, wear-
ables/mobile technologies have become promising ambulatory assessment tools in 
psychiatry. Ambulatory assessment tools including wrist-worn actigraphy devices 
and smartphones have become widely used in psychiatric research to measure core 
features and symptoms of psychiatric disorders: disturbances in sleep and circadian 
rhythm and, physical activity alterations. However, more research is needed to un-
derstand the added value of these tools in psychiatric clinical practice. This thesis 
focuses on examining sleep, circadian rhythm and physical activity assessed with 
wrist-worn actigraphy devices in depressive and anxiety disorders.
In this general introduction, depressive and anxiety disorders will be described. This 
will be followed by a brief introduction of epidemiological studies on the relation-
ship between sleep, circadian rhythm and physical activity and depressive and anx-
iety disorders. After that, an introduction of ambulatory assessment and literature 
on this topic will be described. Finally the aim and outline of the thesis will be 
discussed.      
What are depressive and anxiety disorders?
This thesis focuses on depressive and anxiety disorders. Approximately 6% of the 
adult population is diagnosed with depressive disorders every year (2) and one in ten 
adults experience anxiety disorders every year (3).
Depressive disorders
Depressive disorders can be subdivided into Major Depressive Disorder (MDD) 
and dysthymia. According to the Diagnostic and Statistical Manual of Mental 
Disorders (DSM, version 5) of the American Psychiatric Association, the two core 
symptoms of MDD are: 1) the presence of depressed mood, and 2) loss of interest 
or pleasure (anhedonia). Additional symptoms may be insomnia and hypersomnia, 
psychomotor agitation or retardation, fatigue or loss of energy, significant weight 
loss or weight gain (or a decreased or increased appetite), feelings of worthlessness 
and excessive or inappropriate guilt, loss of concentration or indecisiveness, and a 
death- or suicide wish attempt. To fulfill a DSM-V diagnosis of depression, five or 
more symptoms should be present, including at least one core symptom, for at least 
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two consequent weeks, almost every day and for most part of the day, resulting in 
marked distress or impairment. In short, a diagnosis of dysthymia is given when 
there is mildly depressed mood for most of the day, for more days than not, for at 
least 2 years. 
Anxiety disorders 
Anxiety disorders included in this thesis are social phobia, generalized anxiety dis-
order (GAD), panic disorder (with or without agoraphobia) and pure agoraphobia. 
Social phobia is defined as the persistent fear of one or more social situations in 
which one is exposed to possible scrutiny by others or in which one could display 
anxiety symptoms, that will be humiliating or embarrassing. 
GAD is defined as excessive anxiety and worry, occurring more days that not for 
at least six consecutive months, about a number of events or activities (i.e., work or 
school performance). Additionally, at least three or more of the following symptoms 
must be present: restlessness or feeling on edge, fatigue, loss of concentration, irrita-
bility, muscle tension and sleep disturbances. 
The core symptom of panic disorder is recurrent panic attacks, an overwhelming 
combination of physical and psychological distress. During an attack several of these 
symptoms occur in combination: palpitations, sweating, trembling and shaking, feel-
ing of shortness of breath, chest pain, numbness or tingling, feeling detached, fear of 
losing control, fear of dying. 
Panic disorders may occur with agoraphobia: fear of being in situations where escape 
may be difficult or embarrassing, or help might not be available in the event of panic 
symptoms. Situations in which agoraphobia is expressed are for instance being in 
public transportation, standing in line or being in a crowd, being outside the home 
alone.
Sleep, circadian rhythm and physical activity 
in depressive and anxiety disorders
Epidemiological studies using traditional self-reported questionnaires 
Epidemiological research on depressive and anxiety disorders has confirmed their 
association with a cluster of biopsychosocial and lifestyle factors (4,5). In particular, 
disturbances in sleep and circadian rhythm and altered physical activity have long 
been recognized as core features of depression and anxiety. Sleep problems, such as 
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experiencing insomnia or hypersomnia nearly every day is also one of the DSM‐V 
diagnostic criteria of depressive disorders. Disturbances in sleep and circadian 
rhythm and altered physical activity are traditionally assessed using self-reported 
questionnaires; studies are summarized in this section. 
Several studies reported that mental disorders are consistently associated with sleep 
difficulties. This seems to be especially true for depression (6,7) but it has been 
showed in anxiety as well (7). Sleep disturbances are characterized most frequently 
by insomnia, but also by hypersomnia in some individuals. Overall, sleep disturbanc-
es include reduced sleep duration, longer time to fall asleep and more awakenings 
during the night and lower sleep quality.  
Circadian rhythm disturbances often occur in patients with depression and anxiety 
(8). Circadian rhythms include a range of cyclical physiological rhythms across the 
24-hour period such as the sleep-wake cycle, the core body temperature and the se-
cretion of hormones (e.g., cortisol). Studies have shown that those cyclical rhythms 
appear to be dampened and shifted towards later time of the day in persons with 
mood disorders compared to controls. Chronotype or the individual’s time-of-day 
preference for morningness or eveningness is especially studied in persons with de-
pression and anxiety and it is related to circadian rhythms. Evening chronotype has 
been linked to depressive (9) and anxiety disorders (10), depressive symptoms as 
reported in the meta-analysis by Au & Reece, (2017) and to comorbid depressive 
and anxiety disorders (9). 
Depression and anxiety have also been found to be associated with altered physical 
activity. Altered forms of physical activity are not only limited to sedentary behavior 
and low daily activity levels, but psychomotor retardation, agitation and withdrawal 
from normal activities of daily living as well (12). Reduced physical activity level has 
been reported in patients with depression as shown in the meta‐analysis by Schuch 
et al., 2018, in patients with anxiety and in patients with comorbid depressive and 
anxiety disorders (14). Previous studies reported more frequent sedentary behavior 
in mental disorders (15) and longitudinal association of low sport participation with 
chronicity of depression (14). 
Limitations of traditional self-reported questionnaires 
Sleep, circadian rhythm and physical activity are often assessed infrequently during 
clinical interviews with the use of static retrospective self-reported questionnaires. 
Although traditional self-reported questionnaires have high validity and reliability 
(16–18), they are often limited in detecting sudden changes in patient’s symptoms. 
Additionally, most patients have negative and recall bias while completing assess-
ment questionnaires and may recall their symptoms as worse than they actually pres-
Chapter One: General introduction 
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ent (19). As most symptoms are not continuously tracked outside the clinical setting 
or between treatment sessions, there has been a recent and significant increase in 
research to identify novel methods to measure depressive and anxiety disorders.
Ambulatory assessment tools in psychiatry
Definition and characteristics
Ambulatory assessment covers a wide range of assessment methods to study peo-
ple in their living environment, including (electronic) daily diaries, sensors to mea-
sure physiological or biological data and behavioural information (20). Mostly used 
ambulatory assessment tools in mental health research are actigraphy devices and 
Ecological Momentary Assessment methods. Actigraphy is a tool to measure ob-
jectively sleep, circadian rhythm and physical activity with the use of a wrist-worn 
device (21). Data are gathered continuously with the use of integrated accelerometer 
sensors and some algorithms are used to extract information about a person’s sleep, 
circadian rhythm and physical activity daily measurements. Ecological Momentary 
Assessment measures individual’s current behaviors, clinical symptoms and moods 
as they occur in real time and in their real-world settings (22). Persons are often 
asked to fill-out an electronic diary with the use of their smartphone multiple times 
per day for a defined time period. Studies employing actigraphy and Ecological Mo-
mentary Assessment methods have become more common in recent years in mental 
health research, partially spurred by the ubiquitous availability of mobile devices and 
wearable sensors that provide access to individuals in their living environment. 
Figure 1: actigraphy and ecological momentary assessment
Many features distinctly characterized ambulatory assessment from traditional as-









lection of data in real-world environments, gathering data that are ecologically valid 
and therefore results are more generalizable to real-world settings. Second, it can 
provide continuous measurements or individuals’ current or very recent states or 
behaviors and collects multiple assessments of each individual over time, typically 
several times per day. This allows to capture fluctuations and changes over the time 
in patient’s mental health. Third, it allows for the examination of multiple individual 
processes such as emotional, behavioral and psychophysiological at the same time. 
As a consequence the short-term, daily-life dynamics of different systems can be 
studied almost instantaneously.   
Although more research is needed to demonstrate the clinical utility of these tools, 
ambulatory assessment may provide new opportunities for diagnosis, treatment and 
monitoring of depression and anxiety. As ambulatory assessment tools can provide 
a real-time and real-world measurements, they may be used to refine the diagnostic 
process, tailor treatment, improve the monitoring for actionable outcomes, such as 
identify early signs of relapse and give feedback to patients about their condition.   
Actigraphy and Ecological Momentary Assessment in the study of 
depressive and anxiety disorders
Actigraphy has become widely available in epidemiological research to objectively 
study sleep, circadian rhythms and physical activity (23). Sleep quantity and quality 
are often assessed as sleep duration and sleep efficiency. Circadian rhythms measures 
can be described as circadian rhythm amplitude (i.e., the daily rhythm has a cosin 
shape and the difference between the min and max of the cosin function is the 
amplitude) and sleep midpoint which is a proxy of chronotype. Physical activity is 
measured as daily activity level as well as minutes spent in different levels of activity 
such as light and moderate-to-vigorous physical activity level. 
Ecological Momentary Assessment is often used in mental health research to study 
affect or the underlying experience of feelings and emotions. Persons self-rate their 
current emotions (e.g., ‘I am feeling down’) on a 7-point Likert scale ranging from 
‘1 = not at all’ to ‘7 = very much’. Positive Affect and Negative Affect subscales are 
created by averaging the single scores of positive and negative emotions respectively. 
Ecological Momentary Assessment can also measure depressive and anxiety symp-
toms and, sleep quantity and quality rated by the individuals.
Several studies using actigraphy, including the systematic review of Burton (12) have 
shown that depressive disorders and symptoms are associated with lower daily activ-
ity (24–26) and circadian rhythm amplitude (27). The association between sleep dis-
turbances and depression has been less confirmed when using actigraphy. Although 
night-time activity level appears to be higher in patients with depression (12), this 
Chapter One: General introduction 
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is not always reflected in actigraphy measures of sleep duration and sleep efficiency. 
Research has also focused on the association of actigraphy-assessed sleep, circadi-
an rhythm and physical activity and affect and emotions. However, only few stud-
ies have focused on the dynamics between different systems such as sleep, physical 
activity and their association with affect when using ambulatory assessment. Low 
physical activity levels assessed with actigraphy have been found longitudinally as-
sociated with subsequent sad mood assessed with Ecological Momentary Assess-
ment (EMA) (28). EMA-based, but not actigraphy-based, sleep quality has been 
found bi-directionally associated with affect; better sleep quality was associated with 
improved subsequent affect (29–31) and improved affect was associated with subse-
quent better sleep quality (29).   
Although several studies in mental health research have been using actigraphy and 
EMA, several questions on the association with psychopathology, its heterogeneity 
and temporal dynamics in different homeostatic systems are still open and will be 
addressed in this thesis. 
Thesis aim
This thesis has a general aim:
To examine the associations between sleep, circadian rhythms and physical ac-
tivity with depressive and anxiety disorders using ambulatory assessment tools. 
Methods
The Netherlands Study of Depression and Anxiety
To address the above mentioned research aim, this thesis is mainly using data from 
the Netherlands Study of Depression and Anxiety (NESDA). NESDA was de-
signed to investigate the course of depressive and anxiety disorders over a period of 
several years and the factors that influence the development and prognosis of such 
disorders. 2981 Participants were initially included at the baseline assessment in 
2004-2007, and seen for the fifth time at the nine-year follow-up assessment wave 
(2014-2017) for a regular follow-up interview, including a psychiatric diagnostic 
interview. Three hundred sixty-seven siblings of a subsample of NESDA partici-
pants were (also) included by asking NESDA participants at the regular nine-year 
follow-up interview for their consent to approach their siblings. A sub sample from 
NESDA, consisting of 384 people, was selected to participate in the Ecological Mo-
mentary Assessment & Actigraphy sub-study (NESDA-EMAA). Among demo-
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graphic, psychiatric and lifestyle characteristics, data from ambulatory assessment 
tools measuring negative and positive affect as well as actigraphy simultaneously 
during 2 weeks were collected at the nine-year follow-up assessment.
Thesis outline
This thesis addresses the relationship between sleep, circadian rhythms and physical 
activity with depressive and anxiety disorders using ambulatory assessment tools in 
different chapters. Figure 2 displays an overview of the chapters.
Figure 2: chapter overview of this thesis
Chapter 2 examines sleep, circadian rhythm and physical activity assessed with 
actigraphy and self-reported questionnaires in persons without and with depres-
sive and anxiety disorders; it also examines the association between sleep, circadi-
an rhythm and physical activity assessed with actigraphy and psychiatric clinical 
characteristics (i.e., depressive and anxiety symptom severity, number of psychiatric 
diagnoses, duration of depressive and/or anxiety episodes and antidepressant use). 
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Chapter 3 examines actigraphy-assessed daily activity patterns extracted with a da-
ta-driven technique and their association with sociodemographic, lifestyle, sampling 
and, mental health determinants. 
Chapter 4 examines the association between sleep, circadian rhythm and physical 
activity assessed with actigraphy and depressive symptom dimensions (i.e., mood/
cognition dimension, somatic dimension, sleep dimension). 
Chapter 5 examines the daily dynamics between sleep and affect assessed with ac-
tigraphy and EMA.      
Chapter 6 examines the within-person dynamics between within-day physical ac-
tivity assessed with actigraphy and affect assessed with EMA every 3 hour each day. 
Chapter 7 integrates findings of this thesis and discuss clinical implications as well 
as future research directions.
11
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Background: Actigraphy may provide more valid assessment of sleep, circadian 
rhythm (CR) and physical activity (PA) than self-reported questionnaires, but has 
not been used widely to study the association with depression/anxiety and their 
clinical characteristics. 
Methods: 14-day actigraphy data of 359 participants with current (n=93), remit-
ted (n=176) or no (n=90) CIDI depression/anxiety diagnoses was obtained from 
the Netherlands Study of Depression and Anxiety. Objective estimates included 
sleep duration (SD), sleep efficiency, relative amplitude between daytime and night-
time activity (RA), Mid Sleep on Free Days (MSF), gross motor activity (GMA) 
and moderate-to-vigorous PA (MVPA). Self-reported measures included Insomnia 
Rating Scale, SD, MSF, Metabolic Equivalent Total and MVPA. 
Results: Compared to controls, individuals with current depression/anxiety had sig-
nificantly different objective, but not self-reported, PA and CR: lower GMA (23.83 
versus 27.4 milli-gravity/day, p=0.022), lower MVPA (35.32 versus 47.64 min/day, 
p=0.023), lower RA (0.82 versus 0.83, p=0.033). In contrast, self-reported, but not 
objective, sleep differed between people with current depression/anxiety compared 
to those without current disorders; people with current depression/anxiety reported 
both shorter and longer SD and more insomnia. More depressive/anxiety symptoms 
and number of depressive/anxiety diagnoses were associated with larger disturbanc-
es of the actigraphy measures. 
Conclusion: Actigraphy provides ecologically-valid information on sleep, CR and 
PA that enhances data from self-reported questionnaires. As those with more severe 
or comorbid forms showed the lowest PA and most CR disruptions, the potential 
for adjunctive behavioural and chronotherapy interventions should be explored, as 
well as the potential of actigraphy  to monitor treatment response to such interven-
tions.
Keywords: Actigraphy; Anxiety Disorders; Depressive Disorder; Dysthymic Dis-
order; Sleep; Circadian rhythm; Exercise; Comorbidity
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Introduction
Depression and anxiety are highly prevalent psychiatric disorders, with largely 
overlapping pathophysiology (Zorn et al., 2017), high genetic correlation (Wray et 
al., 2018), both causing high disability (Vos et al., 2016), and sharing high degree of 
comorbidity (Lamers et al., 2011; Rodney et al., 1997). Sleep and circadian rhythm 
disturbances and altered physical activity have long been recognized as core features 
of depression and anxiety. 
Studies have shown that insomnia and hypersomnia are more frequent among those 
with a diagnosis of depression (Nutt, Wilson, & Paterson, 2008; van Mill, Hoo-
gendijk, Vogelzangs, van Dyck, & Penninx, 2010), and comorbid depression and 
anxiety (van Mill et al., 2010), which is not surprising as experiencing insomnia or 
hypersomnia nearly every day is one of the DSM-5 diagnostic criteria of depressive 
disorders. But more insomnia and hypersomnia have also been reported in anxiety 
disorders (Staner, 2003; van Mill et al., 2010). Evening chronotype has been linked 
to depressive (Antypa, Vogelzangs, Meesters, Schoevers, & Penninx, 2016; Norbury, 
2019) and anxiety disorders (Kivelä, Papadopoulos, & Antypa, 2018), depressive 
symptoms as reported in the meta-analysis by Au (Au & Reece, 2017)  and to co-
morbid depressive and anxiety disorders (Antypa et al., 2016). Reduced physical 
activity has been reported in patients with depression as shown in the meta-analysis 
by Schuch and colleagues (Schuch et al., 2017), in patients with anxiety (Hiles et al., 
2017; Ströhle, 2009) and in patients with comorbid depressive and anxiety disorders 
(Hiles et al., 2017). These findings are mainly based on retrospective self-reported 
questionnaires, that summarize static estimates which are potentially biased by pa-
tient’s cognitive impairments and negative perception (Sallis & Saelens, 2000). 
Wrist-worn actigraphy devices can objectively assess (disturbances in) sleep, cir-
cadian rhythm and physical activity. The ecological measurement with actigraphy 
in patients’ natural environments continuously over time may translate much more 
readily to potentially effective intervention (Shiffman, Stone, & Hufford, 2008). 
For instance, actigraphy may be used for clinical assessment to monitor treatment 
outcomes. Although actigraphy has become widely available in epidemiological re-
search (Doherty et al., 2017), only few large cohort studies have studied the relation-
ship of sleep, circadian rhythm and physical activity with depression and anxiety in 
a psychiatric sample using actigraphy. In addition, there is limited research studying 
the association of objective estimates with clinical characteristics, such as psychiatric 
comorbidity and chronicity of psychiatric disorders. Thus, a better understanding 
on the association of sleep, circadian rhythm and physical activity with psychopa-
thology that may have important clinical implications, in particular for the clinical 
assessment, monitoring, and treatment of depression and anxiety. 
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In this study we investigate whether: (1) objective and/or self-reported estimates 
of sleep, circadian rhythm, and physical activity differ in persons without and with 
remitted or current depressive and/or anxiety disorders; and (2) objective estimates 
of physical activity, sleep and circadian rhythm are associated with clinical charac-
teristics (i.e., severity of symptoms, number of psychiatric disorders, duration of psy-
chiatric disorders, age of onset, and antidepressant use). As part of objective (1) we 
also explore the correlations between objective and self-reported estimates of sleep, 
circadian rhythm, and physical activity. This may give us insight whether the – more 
objective - actigraphy collection is truly providing novel information. 
Method
Sample 
Participants from the Netherlands Study of Depression and Anxiety (NESDA) were 
selected to participate in the Ecological Momentary Assessment (EMA) & Actig-
raphy sub-study (NESDA-EMAA). NESDA is one of the sites that is member of 
the Motor Activity Research Consortium for Health (m-MARCH)(Scott et al., 
2017), a collaborative network on the application of objective assessment of motor 
activity, sleep and mood in population and clinical samples. Details about NESDA 
have been provided extensively before (Penninx et al., 2008). NESDA was designed 
to investigate the course of depressive and anxiety disorders over a period of several 
years and the factors that influence the development and prognosis of such disor-
ders. Participants were initially included at the baseline assessment in 2004-2007, 
and seen for the fifth time at the nine-year follow-up assessment wave (2014-2017) 
for a regular follow-up interview, including a psychiatric diagnostic interview. Sib-
lings of a subsample of NESDA participants were (also) included by asking NES-
DA participants at the regular nine-year follow-up interview for their consent to 
approach their siblings. Eligibility criteria were that the NESDA respondent had to 
meet diagnostic criteria for a depression or anxiety disorder either in the year prior 
to baseline or during the follow-up, participated in at least two of the four previous 
waves and the current regular interview, and had the same biological parents as their 
sibling(s). The NESDA study, including the EMAA component, was approved by 
the VUmc ethical committee (reference number 2003/183) and all respondents gave 
informed consent for both the regular interview and the EMAA component. 
A flowchart of the NESDA-EMAA is provided in Figure 1. After the face-to-
face nine-year interview, participants of NESDA who were eligible and willing to 
participate in the NESDA-EMAA sub-study were invited to one of our research 
facilities within one month. All participants were fully informed and given time 
to ask questions prior to participation. They received an instruction on the EMA 
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Figure 1: Flow-chart  NESDA-EMAA study
Newly enrolled NESDA 
siblings participated in 





- Did not give permission (n=128)
- Not eligible, presence of a 
lifetime depressive and/or anxiety 
disorder (n=120)






- Did not give permission (n=541)
- Not eligible, did not participate in at least 2 
waves (n=1)
- Not approached because EMAA study had 
not started yet (n=336)
Not included N=633
Reasons:
- Could not be contacted/no response (n=48)
- Could not be included within 30 days (n=132)
- Travelling abroad during test period (n=41)
- Not interested, no time (n=172)
- Not interested, too intensive (n=117)
- Not interested, unspecified (n=27)
- Won’t/can’t use smartphone or actigraphy 
device (n=37)
- Other reasons (n=59)
No actigraphy data available N=14
Reasons:
- technical failure (n=6)
- unknown reason (n=4)
- dropped out (n=2)
- watch lost in mail (n=1)
- watch not correctly set-up (n=1)
Not included in analyses N=11
- Less than 10 days with minimally 16hrs 
recording
- due to drop-out (n=2)
- due to technical failure (n=6)
- unknown/nonwear (n=1)
- Calibration error (n=1)
- Data processing did not work (n=1)
Approached for the 
NESDA-EMAA study 
N=1017
Included in the 
NESDA-EMAA study 
N=384
Actigraphy data available 
N=370
Included in analyses 
N=359
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and GENEActiv, and were provided with a GENEActiv device (Activinsights Ltd, 
Kimbolton, UK) as well as a pre-paid envelope or box to send the GENEActiv back 
by mail after the two-week period. Participants wore the wrist-worn GENEActiv 
actigraphy device and took part in the EMA assessment on a smartphone for two 
weeks during which they filled out questions on current mood states. If they did not 
have a smartphone with internet access, they could borrow one from the study. Of 
the 384 participants included in the NESDA-EMAA study, 14 had no available 
actigraphy data for several reasons, such as technical failure (see Figure 1), resulting 
in 370 (96.4%) participants with available data. According to previously published 
criteria (da Silva et al., 2014), participant’s actigraphy data were included in the 
analyses if at least one week day and one weekend day of usable data was available, 
with at least 16 hours recorded per day and per night (see Supplemental material 
‘Raw data processing’ for further details about the actigraphy data pipeline). The 
final sample was composed of 359 (93.5%) participants with 13.68 ± 1.26 valid days, 
of which 90% completed the protocol for 14 days. 
Diagnosis of depression and/or anxiety disorders
As in the previous waves, at the 9-year follow-up, DSM-IV based diagnoses of 
depressive disorders (dysthymia and major depressive disorder) and anxiety (social 
anxiety disorder, panic disorder with and without agoraphobia, agoraphobia and 
generalized anxiety disorder) were established with the Composite International 
Diagnostic Interview (CIDI, version 2.1)(Wittchen, 1994). The interviews were 
conducted by specially trained clinical research staff. For this study, participants were 
divided into three groups: 1) a group with no lifetime depressive and/or anxiety dis-
orders, 2) a group with remitted depressive and/or anxiety disorders (having a life-
time, but not current (6-month) diagnosis), and 3) a group with current depressive 
or anxiety disorder in the past 6 months.  
Clinical characteristics
Studied clinical characteristics were: severity of depressive symptoms and severity 
of anxiety symptoms, number of comorbid psychiatric disorders, duration of de-
pressive or anxiety disorders, age of onset and, medication use (i.e., antidepressant 
and benzodiazepines use). Severity of depressive symptoms and severity of anxiety 
symptoms were estimated using the 30-item Inventory of Depressive Symptom-
atology, self-report (IDS)(Rush, Gullion, Basco, Jarrett, & Trivedi, 1996) and the 
Beck Anxiety Inventory (BAI)(Beck, Epstein, Brown, & Steer, 1988), respectively. 
Number of psychiatric disorders was determined as a count of current depressive 
and anxiety diagnoses at nine-year follow-up. Duration of depressive or anxiety 
disorder was calculated as a count of the number of waves at which the patient 
reported a depression and/or anxiety diagnosis during the in-between follow-up 
periods (ranging from 1 waves to 5 waves). Age of onset was derived from the CIDI. 
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Antidepressant use and benzodiazepine use was based on drug container inspection, 
and medications were coded according to the World Health Organization Ana-
tomical Therapeutic Chemical (ATC) classification. Antidepressant and benzodiaz-
epines use was considered present if participants reported using it more than 50% 
of the time. Antidepressants included were selective serotonin reuptake inhibitors 
(SSRIs, ATC code N06AB), tricyclic antidepressant (TCA, ATC code N06AA) 
and other antidepressants (ATC codes N06AF, N06AG, N06AX); benzodiazepines 
included ATC codes N03AE, N05BA, N05CD and N05CF. 
Actigraphy estimates of sleep, circadian rhythm and physical activity
Participants wore the GENEActiv watch on their non-dominant wrist for two 
weeks. They were instructed to wear the watch day and night and only taking it 
off when going to the sauna or when playing a contact sport in which wearing a 
wristband is unsafe. They were also instructed to press the button on the device 
when going to sleep and when getting up. In this study, the accelerometer was set 
to sample at 30 Hz and raw actigraphy data was analysed using an open source R 
package, GGIR (version 1.5-18, see Supplement material for further details on the 
raw actigraphy data cleaning processing pipeline). Sleep was assessed as total sleep 
duration per night [in hh:mm] and sleep efficiency per night [%]. Circadian rhythm 
was assessed by Mid Sleep on Free Days (MSF) [clock time] and the relative am-
plitude (RA) between daytime and night-time activity per day. Physical activity was 
assessed as gross motor activity per day [milli-gravity (mg), 1g = 9.81m/s2] and min-
utes in moderate-to-vigorous physical activity per day (objective minutes in moder-
ate-to-vigorous physical activity per day were defined as the sum of 1-min epochs in 
which gross motor activity was larger than 125mg, which has recently been used by 
others (Kim et al., 2017)). Average weekly estimates were derived for each partici-
pant. Actigraphy variables were chosen based on several reasons. First, the selected 
actigraphy variables are among the ones reported frequently in adult studies and 
have been previously linked to psychopathology (Burton et al., 2013; Hori et al., 
2016; Luik et al., 2015; Lyall et al., 2018). Second, these measures cover the concepts 
often  collected with self-reported questionnaires allowing for a comparison on their 
association with depressive and anxiety disorders.
Self-reported sleep, circadian rhythm and physical activity 
Self-reported sleep was evaluated using the following questionnaires. Insomnia was 
assessed with the Women’s Health Initiative Insomnia Rating Scale (IRS)(Levine 
et al., 2003) which consists of 5 questions on difficulties in falling asleep, disruption 
and quality of sleep in the past month with a total score ranging from 0 (no insom-
nia) to 20 (severe insomnia). Sleep duration was also assessed (i.e., ≤6 hours, 7-9 
hours and ≥10 hours). 
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Self-reported chronotype was assessed with the Munich Chronotype Questionnaire 
(MCTQ)(Roenneberg, Wirz-Justice, & Merrow, 2003). The MCTQ contains 29 
questions about time of waking up and falling asleep on workdays and on free days, 
at this moment. Chronotype was defined as the midpoint in time between falling 
asleep and waking up on free days (Mid Sleep on Free Days (MSF)), since it is most 
likely to be accurate when one’s natural circadian rhythm can be observed, without 
the interference of work schedules and alarm clocks. 
Self-reported physical activity was assessed with the International Physical Activ-
ity Questionnaire – Short Form (IPAQ)(Ainsworth et al., 2000). This seven-item 
questionnaire provides information on the respondent’s time spent on walking and 
on vigorous and moderate physical activity during the last 7 days. Minutes spent 
in moderate to vigorous physical activity and general physical activity, expressed as 
metabolic equivalent total (MET, 1 MET = 1 kcal·kg−1·h−1) minutes per week were 
derived from the IPAQ. MET minutes per week were calculated as level×minutes of 
activity×events per week. 
The reliability and validity of the used self-reported questionnaires have been shown 
before in large-cohort studies(IRS, Levine et al., 2003; MCTQ, Zavada, Gordijn, 
Beersma, Daan, & Roenneberg, 2005; IPAQ, Craig et al., 2003).  
Covariates
Covariates were age at nine-year follow-up, sex and education level expressed in 
years. These covariates were selected as they have an established theoretical asso-
ciation with psychopathology and with sleep, circadian rhythm and physical activ-
ity levels, and have been regularly used in similar studies (Droomers, Schrijvers, & 
Mackenbach, 2001; Stamatakis, Kaplan, & Roberts, 2007).
Statistical analyses
Distributions of all variables were checked on normality with QQ plots. For de-
scriptive statistics, participant demographics, clinical characteristics, actigraphy and 
self-reported estimates of sleep, circadian rhythm and physical activity were com-
pared between the three groups (i.e., no, remitted and current depressive and/or anx-
iety disorders). For normally distributed continuous data ANOVA tests were used 
and for data that with a non-normal distribution Kruskall-wallis tests were used. 
Chi-squared tests were used to test differences in frequencies in the three groups. 
We calculated correlations between actigraphy and self-reported estimates of sleep, 
circadian rhythm and physical activity. Correlations were tested with Pearson’s cor-
relation or with polyserial correlation tests when the variables were continuous or 
nominal-continuous, respectively. This was done for the entire sample as well as 
stratified by the main grouping variable.
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The association between actigraphy estimates and clinical characteristics (i.e., sever-
ity of depressive symptoms and severity of anxiety symptoms, number of psychiatric 
diagnoses, duration of psychiatric diagnoses, age of onset and antidepressant use) 
was tested in separate models using linear regression model corrected for covariates 
and with each actigraphy estimate as outcome. Analyses to study the association 
with number of psychiatric diagnoses, duration of psychiatric diagnoses, age of on-
set and antidepressant use were performed only including participants with current 
depressive and/or anxiety disorders. Non-normally distributed outcomes were trans-
formed with Log-transformation or with Box-Cox transformation.
All analyses were performed with the statistical software R (version 1.0.143), a 
p-value < 0.05 was considered statistically significant. Post-hoc tests were performed 
to allow multiple comparison for actigraphy estimates with Dunn’s test when the 
differences between the three groups, i.e. no, remitted and current depressive and/
or anxiety disorders were significant.  To get a more comprehensive picture, we also 
performed post-hoc analyses to check whether day-to-day variability in actigraphy 
estimates (calculated as the SD across 14 days)  was associated with depressive and/
or anxiety disorders.
The potential clustering of NESDA participants with their siblings was ignored, as 
of the 27 siblings included in the analyses, only 7 were linked to NESDA partici-
pants in this sample. Analyses were rerun without the siblings that were linked to 
NESDA participants, but this did not alter results (data not shown).
Results
The sample demographics and clinical characteristics are described in Table 1. Of 
the total sample (n = 359), 93 had current and 176 had remitted depressive and/or 
anxiety disorders, 90 had no current depressive and/or anxiety disorders. The current 
depressive/anxiety disorder group was heterogeneous: in that 38.3% had anxiety dis-
orders only, 33.0% had depressive and anxiety disorders and 28.7% had depressive 
disorders only. As expected, persons with current depressive and/or anxiety disorders 
scored significantly higher on depressive and anxiety symptoms (both p< 0.001) 
and more frequently used antidepressant than both other groups, but no significant 
differences were found for benzodiazepine use. 
When using actigraphy, persons with current depressive and/or anxiety disorders 
were significantly less active and had significantly lower relative amplitude between 
daytime and night-time activity compared to controls (p<0.05, Table 2). We did 












































































































































































































































































































































































































































































































































































Table 1: Demographic, psychiatric, psychological characteristics and medication use in our NESDA sample (n = 359).
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Self-reported sleep, but not self-reported physical activity or circadian rhythm 
measures, differed significantly across groups (p<0.001, Table 2). Low to moderate 
correlations were observed between self-reported and objective estimates of sleep, 
circadian rhythm and physical activity (Table 3); objective and self-reported sleep 
estimates were not significantly correlated,  low but statistically significant, correla-
tions were found between objective and self-reported physical activity estimates 
w, and moderate and significant correlations between objective and self-reported 
circadian rhythm estimates were observed. When stratifying by diagnostic status 
(i.e., no, remitted and current depressive and/or anxiety disorders), we observed that 








or anxiety disorders p
Sleep
Sleep duration [clock time], mean (SD) b 6:59 (1:08) 7:02 (0:59) 6:53 (0:58) 0.478
Sleep duration  c 0.333
< 7 h, % 33.3 27.8 25.6
7 ≤ h ≤ 9, % 64.5 71.6 74.4
> 9 h, % 2.2 0.6 0.0
Sleep efficiency [ %], median (IQR) a 87.0 (8.0) 88.0 (7.0) 88.0 (6.0) 0.170
Self-reported sleep duration c <0.001 d e
≤ 6 h, % 40.9 19.9 13.3
7 ≤ h ≤ 9, % 53.8 76.7 86.7
≥ 10 h, % 5.4 3.4 0.0
Insomnia rating scale, mean (SD) b 8.95 (4.74) 6.87 (4.46) 5.4 (3.52) <0.001 d e
Circadian rhythm
Relative amplitude between daytime and night-time activity level, median (IQR) a 0.81 (0.08) 0.83 (0.06) 0.83 (0.06) 0.028 d
Mid Sleep on Free Days [clock time], median (IQR) a 04:10 (01:31) 04:11 (01:17) 04:14 (01:07) 0.883
Self-reported Mid Sleep on Free Days [clock time], mean (SD) b 04:03 (01:10) 03:55 (01:06) 04:00 (00:52) 0.628
Physical activity
Gross motor activity [milli-gravity], median (IQR) a 23.80 (9.88) 26.90 (9.47) 27.40 (10.30) 0.021 d
Moderate-to-vigorous physical activity [min/day], median (IQR) a 35.14 (35.43) 45.21 (44.32) 47.39 (41.91) 0.029 d
Self-reported moderate-to-vigorous physical activity [min/day], median (IQR) a 90 (139) 115 (120) 120 (120) 0.061
Total MET-min/week/1,000, median (IQR) a 2.19 (3.39) 2.85 (4.28) 2.60 (2.99) 0.067
Abbreviation: SD, standard deviation; IQR, interquartile range, MET, metabolic equivalent total.
a Kruskal–Wallis test; b Analysis of variance (ANOVA); c Chi-squared test
d Dunn’s test, current depressive and/or anxiety disorders versus no depressive and/or anxiety disorders, p<0.05 
e  Dunn’s test, current depressive and/or anxiety disorders versus remitted depressive and/or anxiety disorders, p<0.05
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Table 2: (continued)
correlations for Mid Sleep on Free Days were higher in the control group compared 
to patients with remitted and current depressive and/or anxiety disorders (Supple-
mental material, Table S1). On the other hand, correlations for physical activity 
estimates were no longer significant in people without depressive and/or anxiety dis-
orders compared to the other groups (Supplemental material, Table S1). Our post-
hoc analyses on day-to-day variability in actigraphy estimates showed that  patients 
with current depressive and/or anxiety disorders had significantly lower day-to-day 
variability in moderate-to-vigorous physical activity compared to controls (Supple-
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Sleep duration  c 0.333
< 7 h, % 33.3 27.8 25.6
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Insomnia rating scale, mean (SD) b 8.95 (4.74) 6.87 (4.46) 5.4 (3.52) <0.001 d e
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Self-reported Mid Sleep on Free Days [clock time], mean (SD) b 04:03 (01:10) 03:55 (01:06) 04:00 (00:52) 0.628
Physical activity
Gross motor activity [milli-gravity], median (IQR) a 23.80 (9.88) 26.90 (9.47) 27.40 (10.30) 0.021 d
Moderate-to-vigorous physical activity [min/day], median (IQR) a 35.14 (35.43) 45.21 (44.32) 47.39 (41.91) 0.029 d
Self-reported moderate-to-vigorous physical activity [min/day], median (IQR) a 90 (139) 115 (120) 120 (120) 0.061
Total MET-min/week/1,000, median (IQR) a 2.19 (3.39) 2.85 (4.28) 2.60 (2.99) 0.067
Abbreviation: SD, standard deviation; IQR, interquartile range, MET, metabolic equivalent total.
a Kruskal–Wallis test; b Analysis of variance (ANOVA); c Chi-squared test
d Dunn’s test, current depressive and/or anxiety disorders versus no depressive and/or anxiety disorders, p<0.05 
e  Dunn’s test, current depressive and/or anxiety disorders versus remitted depressive and/or anxiety disorders, p<0.05
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MET a MVPA a
Sleep
Sleep duration 0.076 0.019 -0.017 -0.008 0.005
Sleep efficiency -0.082 -0.043 -0.087 0.031 0.009
Circadian rhythm
Relative amplitude between day-
time and night-time activity level -0.179*** 0.231*** -0.140** 0.235*** 0.146**
Mid Sleep on Free Days -0.078 0.075 0.582*** -0.025 -0.017
Physical activity
Gross motor activity -0.113* 0.105 -0.028 0.286*** 0.203***
MVPA -0.089 0.134 0.009 0.258*** 0.177***
Abbreviations: IPAQ, International Physical Activity Questionnaire – Short Form; IRS, Women’s Health Initiative Insomnia 
Rating Scale; MCTQ, Munich Chronotype Questionnaire; MET, metabolic equivalent total; MVPA, moderate-to-vigorous 
physical activity.
Notes:  *: p < 0.05; **: p < 0.01; ***: p < 0.001.
a Pearson’s correlation
b Polyserial correlation
Table 3: Correlations between self-reported and actigraphy estimates of sleep, circadian rhythm and physical activity (n=359)
Table 4: Associations* between actigraphy-derived sleep, circadian rhythm and physical activity and clinical characteristics
Sleep duration Sleep efficiency Relative amplitude Mid Sleep on Free Days Gross motor activity MVPA
β SE p β SE p β SE p β SE p β SE p β SE p
Psychological scales (n = 359)
IDS 0.162 0.053 0.002 -0.084 0.053 0.115 -0.205 0.052 <0.001 0.132 0.054 0.016 -0.239 0.051 <0.001 -0.185 0.051 <0.001
BAI 0.141 0.053 0.008 -0.033 0.054 0.544 -0.154 0.052 0.003 0.069 0.055 0.206 -0.212 0.051 <0.001 -0.169 0.051 0.001
Clinical characteristics among current cases 
(n = 93)
Number of psychiatric diagnoses 0.309 0.100 0.003 -0.038 0.104 0.714 -0.310 0.102 0.003 0.131 0.108 0.227 -0.383 0.099 <0.001 -0.305 0.100 0.003
Duration of psychiatric diagnoses [waves] 0.129 0.110 0.241 0.060 0.109 0.584 -0.028 0.112 0.803 0.113 0.113 0.323 -0.106 0.112 0.346 -0.037 0.111 0.738
Age of onset -0.172 0.112 0.127 -0.029 0.112 0.798 0.074 0.115 0.519 0.07 0.117 0.548 0.102 0.115 0.375 0.004 0.114 0.970
Antidepressant use 0.169 0.213 0.430 -0.198 0.210 0.348 -0.271 0.215 0.211 0.545 0.212 0.012 -0.344 0.214 0.111 -0.343 0.211 0.108
*Linear regression model adjusted for age, sex and education. Log transformation was applied to gross motor activity and Mid 
Sleep on Free Days. Box-cox transformation was applied to MVPA, sleep efficiency and RA.
Abbreviations: MVPA = moderate-to-vigorous physical activity, RA = relative amplitude between daytime and night-time activity 
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Having higher levels of depressive and anxiety symptoms was significantly asso-
ciated with longer sleep duration, lower relative amplitude between daytime and 
night-time activity level, reduced gross motor activity and moderate-to-vigorous 
physical activity (Table 4). Looking at the smaller sized group of 93 persons with 
current depressive and/or anxiety disorders, number of psychiatric diagnoses was the 
only clinical characteristic significantly associated with longer sleep duration, lower 
relative amplitude between daytime and night-time activity level, lower gross motor 
activity and moderate-to-vigorous physical activity (Table 4). Antidepressant use 
was significantly associated with delayed Mid Sleep on Free Days (Table 4). 
Discussion
In this study we found reduced physical activity level and daily rhythm disturbances 
among those with depressive and anxiety disorders compared to controls using ob-
jective measures, but not using self-reported information. By contrast, self-reported 
but not objective sleep measures differed between persons with depressive and anx-
iety disorders vs controls. Actigraphy estimates gathered in an ecologically-valid 
manner during continuous registration over 2-week time revealed objective differ-
ences in physical activity and circadian rhythm measures between diagnostic groups 
that were not captured with self-reported questionnaires. Moreover, self-reported 
sleep appeared to reflect the sleep misperception commonly presented in persons 
with depressive and anxiety symptoms (Dittoni et al., 2013). This supports the use 
Sleep duration Sleep efficiency Relative amplitude Mid Sleep on Free Days Gross motor activity MVPA
β SE p β SE p β SE p β SE p β SE p β SE p
Psychological scales (n = 359)
IDS 0.162 0.053 0.002 -0.084 0.053 0.115 -0.205 0.052 <0.001 0.132 0.054 0.016 -0.239 0.051 <0.001 -0.185 0.051 <0.001
BAI 0.141 0.053 0.008 -0.033 0.054 0.544 -0.154 0.052 0.003 0.069 0.055 0.206 -0.212 0.051 <0.001 -0.169 0.051 0.001
Clinical characteristics among current cases 
(n = 93)
Number of psychiatric diagnoses 0.309 0.100 0.003 -0.038 0.104 0.714 -0.310 0.102 0.003 0.131 0.108 0.227 -0.383 0.099 <0.001 -0.305 0.100 0.003
Duration of psychiatric diagnoses [waves] 0.129 0.110 0.241 0.060 0.109 0.584 -0.028 0.112 0.803 0.113 0.113 0.323 -0.106 0.112 0.346 -0.037 0.111 0.738
Age of onset -0.172 0.112 0.127 -0.029 0.112 0.798 0.074 0.115 0.519 0.07 0.117 0.548 0.102 0.115 0.375 0.004 0.114 0.970
Antidepressant use 0.169 0.213 0.430 -0.198 0.210 0.348 -0.271 0.215 0.211 0.545 0.212 0.012 -0.344 0.214 0.111 -0.343 0.211 0.108
*Linear regression model adjusted for age, sex and education. Log transformation was applied to gross motor activity and Mid 
Sleep on Free Days. Box-cox transformation was applied to MVPA, sleep efficiency and RA.
Abbreviations: MVPA = moderate-to-vigorous physical activity, RA = relative amplitude between daytime and night-time activity 
level; IDS = Inventory of Depressive Symptomatology score; BAI = Beck Anxiety Inventory score.
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of actigraphy in the assessment of physical activity, sleep and circadian rhythm dis-
turbances in epidemiological studies and clinical practice enhancing subjective data 
from the traditional self-reported questionnaires. The high participation response 
to the study confirms the feasibility and acceptability of monitoring patients with 
depressive and anxiety disorders with actigraphy, which may translate to the clinical 
setting as well.   
We found lower levels of objective physical activity (and lower day−to−day vari-
ability in objective physical activity)  in persons with a current diagnosis, versus 
those with remitted or no diagnosis. Post-hoc analysis (data not shown) confirmed 
that associations for pure anxiety and pure depression cases were similar. Patients 
with current depression and anxiety spent on average 35 minutes per day in mod-
erate-to-vigorous physical activity and a similar effect size has been found in the 
meta-analysis on depression by Schuch (Schuch et al., 2017). In terms of the associ-
ation between circadian rhythm disturbances with psychopathology, we found that 
depressive and anxiety disorders are associated with lower relative amplitude be-
tween daytime and night-time activity level. Similarly, previous studies have shown 
that circadian rhythm appears to be dampened in patients with depression (Hori 
et al., 2016) and mood disorders (Lyall et al., 2018; Shou et al., 2017), suggesting 
that the lower level of daily activity is a core feature of mood disorders (Burton et 
al., 2013). Importantly, less research has been conducted for anxiety, however, our 
results showed similar effects to those in depression. Reduced daily activity lev-
el and circadian rhythm amplitude may be indicative of psychomotor retardation, 
withdrawal from normal activities of daily living (Burton et al., 2013) and circadian 
impairments (Lyall et al., 2018). As improvement in depression with antidepressant 
medications have been linked with greater daytime activity levels (Todder, Caliskan, 
& Baune, 2009) and higher relative amplitude between daytime and night-time 
activity (Todder et al., 2009) when using actigraphy, the continuous measurement 
of daily activity and circadian rhythmicity with wrist-worn actigraphy may help to 
monitor treatment effects (Martin & Hakim, 2011). 
However, first some conditions should be met before actigraphy could play a role in 
monitoring of treatment response. Although it has been suggested that actigraphy 
could be used to follow the progression of depression treatment, it is still unclear 
how sensitive and specific actigraphy is for the characterisation of this change in 
psychological state (Martin & Hakim, 2011). Which actigraphy variables are best 
suited for monitoring purposes and definitions of clinically relevant improvement 
on these variables needs to be examined. Interpretation is also not always immediate 
(e.g., relative amplitude between daytime and night time activity) and clinicians 
may need additional training for the use of devices in the clinical practice. Wearing 
research devices such as a GENEActiv device, may be experienced as stigmatizing as 
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a patient may be asked for its use in public (Scott et al., 2019; Simblett et al., 2019). 
Popular commercial activity trackers are aesthetically pleasing and therefore maybe 
less stigmatizing, but at a cost of lower quality data – whether these devices are 
suitable for monitoring treatment effects is unknown (Scott et al., 2019). Currently, 
the majority of devices used in research settings need to be connected to a computer 
to download data and to extract variables with the use of specific software, resulting 
in a time-consuming procedure. In the future, devices with Bluetooth compatible 
connectivity and consumer devices are likely to become more common, allowing 
the real-time synchronisation of data on the patient’s smartphone app and on a data 
visualisation dashboard. Data may become readily available and interpretable for the 
clinician, while for the patient real-time feedback on activity and sleep may help 
to adopt more healthy habits (Matcham et al., 2019). While actigraphy appeared 
to enhance information obtained from self-reported questionnaires, self-reported 
assessment can also be improved by using a daily electronic diary that is less costly 
and time consuming than actigraphy and it may be more personalised to individuals 
(Martin & Hakim, 2011). Such electronic diaries may also incorporate other ques-
tionnaires on sleep and sleep quality such as the Pittsburgh Sleep Quality Index or 
the Insomnia Severity Index.
Actigraphy indices of sleep were not significantly different across diagnostic groups. 
Moreover, while sleep duration measured with actigraphy was not associated with 
depression and anxiety, self-reported sleep duration was consistently associated with 
psychopathology in the current study and elsewhere (Luik et al., 2015). Self-report-
ed and objectively assessed sleep duration also appeared to be poorly correlated, and 
this possibly indicates that perceived sleep reflects different aspects of sleep than 
the objective estimate. This might be due to sleep misperception, which is more 
common in patients with severe depressive and anxiety symptoms (Dittoni et al., 
2013), and is influenced by their negative perception. It has been argued (Harvey & 
Tang, 2013) that this tendency to misperceive sleep does not preclude the presence 
of a real sleep deficit. Perhaps the increased worry associated with insomnia makes 
it more difficult for patients to move into the deeper stages of sleep and the lighter 
stages of sleep may be more likely to be perceived as wake (Harvey & Tang, 2013). It 
should be also mentioned that the tendency to misperceive sleep may be considered 
as a “prodromic or transitional state” in the development of insomnia that is charac-
terized by a serious objective sleep deficit (Harvey & Tang, 2013). Thus, actigraphy 
may be used to determine whether self-reported sleep problems are not consist-
ent with objective sleep, and the patient would potentially benefit from psychologic 
treatments to reverse misperception, such as cognitive behavioural therapy (Martin 
& Hakim, 2011).   
We also found evidence for dose-response associations as those with more severe de-
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pressive and anxiety symptoms were significantly less active and showed longer sleep 
duration and lower relative amplitude between day and night activity level. Further-
more, in the group with current depression and/or anxiety, we found that psychiatric 
comorbidity was associated with physical inactivity, longer sleep duration and lower 
relative amplitude between day and night activity level. As physical activity and 
circadian rhythm are modifiable factors, exercise, behavioral activation and chro-
notherapy may be offered as adjunctive treatments to usual care in these groups of 
patients (Carek, Laibstain, & Carek, 2011; Chum et al., 2017; Morgenthaler et al., 
2007). The dose-response relationships provide further evidence for the ecological 
validity of actigraphy. Although, recent clinical trials have employed actigraphy to 
monitor activation therapy (Averill et al., 2019) and sleep deprivation (Arnedt et al., 
2017) as adjunctive treatments to usual care, or as a tool to complement behavioral 
activation (Chum et al., 2017), more research is needed to clarify whether actigraphy 
may be used to monitor treatment outcomes of such interventions.  
Sleep duration was found to be longer in persons with a greater number of depres-
sive and anxiety symptoms. This can be explained by the fact that hypersomnia is 
one of the symptoms of depression and it usually characterizes patients with atypical 
features. Another explanation may be antidepressant use. More severe cases are more 
likely to use these medications and, previous research has suggested that long sleep 
duration can be a result of antidepressant use (Robillard et al., 2015), such as sedat-
ing tricyclic antidepressants (Wichniak & Jernajczyk, 2017). While benzodiazepine 
use could also be an explanation, as it is also prescribed for sleep problems, it is a less 
likely explanation here, as only 5 cases used benzodiazepines, and analyses excluding 
these cases did not alter findings (data not shown). Another possible explanation 
of our findings is that the used sleep detection algorithm may misclassify period of 
inactivity as sleep period, which may be possible since patients with depression and 
anxiety exhibit more sedentary behaviour. 
Shifted and delayed rhythm have been previously documented in patients with de-
pression (Hori et al., 2016) and anxiety (Robillard et al., 2015) supporting the ev-
idence for an association between late chronotypes and psychopathology. In our 
sample we noticed later Mid Sleep on Free Days among current cases using antide-
pressant medication after covariate adjustments.. As antidepressant use may result 
in more daytime sleepiness and fatigue (Fava, 2003) and longer sleep duration(Ro-
billard et al., 2015),  this may possibly explain this finding. 
Some limitations should be considered in the current study. Although actigraphy 
provides an estimate of sleep parameters such as sleep duration, sleep efficiency, it 
does not yield estimates of sleep stage, such as REM period that may be associated 
with depression. In addition, it was not possible to extrapolate actigraphy sleep es-
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timates indicative of insomnia such as sleep-onset latency (i.e., time to transit from 
full wakefulness to sleep) and wake after sleep onset (i.e., periods of wakefulness 
occurring after sleep onset). Studies have also shown that actigraphy lacks the preci-
sion of the gold standard polysomnography that provides greater insight into sleep 
problems in people with depression or anxiety (Van Hees et al., 2015). Because sleep 
is inferred from a lack of movement, there may be some misclassification of sleep 
among those who are awake but motionless. Therefore, the technique is biased to-
ward overestimating total sleep duration, which may lead to incorrectly minimizing 
the severity of sleep disturbances. Likewise, assessment of circadian rhythm with 
actigraphy may not reflect the underlying circadian biology and may be influenced 
by unmeasured demographics and other lifestyle factors (Luik, Zuurbier, Hofman, 
Van Someren, & Tiemeier, 2013). We also based our threshold for MVPA on that 
of other studies (Kim et al., 2017), but there is no consensus on these thresholds. We 
also used a less frequently reported measure of chronotype (Sleep midpoint on free 
days). Chronotype is often represented as sleep midpoint on free days corrected for 
sleep-debt accumulated during working days (MSFsc)(Roenneberg et al., 2003). As 
we did not find associations with MSF and MSF and MSFsc were previously found 
to be highly correlated in the NESDA sample (r=0.91, (Antypa et al., 2016)), we 
did not expect to find different results in our analysis and the conclusions would not 
change. Nevertheless, the overall chronotype (early, intermediate, and late chrono-
type) across a sample may influence any correlational associations leading to incon-
sistent associations with psychopathology (Dimitrov et al., 2018). It should also be 
noted that the self-reported questionnaires and the actigraphy measurement did not 
capture the same time period; questionnaires were filled out before actigraphy. We 
also used a limited number of sociodemographic covariates in this study (i.e., age, 
sex, education). Future analyses may take other variables into account (e.g., BMI, 
employment status) to study what factors may explain the association of sleep, cir-
cadian rhythm and physical activity with psychopathology. Correction for multiple 
testing was also not performed and may have led to finding statistical associations 
for chance. Strengths of the study are the inclusion of both depressive and anxiety 
disorder, and the ability to look in-depth at the role of clinical characteristics.
While the measures presented in this paper provide some preliminary insight into 
the objectively-measured physical activity, sleep and circadian rhythms and the 
differences therein between diagnostic groups, these measures are summaries of a 
much richer underlying dataset. Using studies from our collaborative Motor Activ-
ity Research Consortium for Health (m-MARCH) initiative (www.mmarch.org, 
Scott et al., 2017), we plan to employ more sophisticated analytical tools have been 
developed that can improve our understanding of these features, such as functional 
principal component analyses (Gershon, Ram, Johnson, Harvey, & Zeitzer, 2016), 
and functional scalar regression (Goldsmith, Zipunnikov, & Schrack, 2015). These 
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approaches will enhance the power and gain greater insight into these patterns and 
their relationship to depression and anxiety disorders.
To conclude, we found that persons with current depression and/or anxiety exhib-
it reduced physical activity and more circadian rhythm disturbances than controls 
using actigraphy. As the correlations of actigraphy estimates with self-report mea-
sures were generally low, actigraphy monitoring was shown to provide an easy and 
non-invasive approach to capture objective information regarding both night time 
sleep and daytime activity and, sleep and circadian rhythm. In addition, persons 
with greater severity and, among current cases, with more psychiatric comorbidity 
showed lower physical activity and more circadian rhythm disturbances. Therefore, 
adjunctive behavioural and chronotherapy interventions in depression and anxiety 
may especially focus on these individuals. While this study confirms the feasibil-
ity and acceptability of monitoring patients, more research is needed to establish 
whether actigraphy could possibly in the future play a role in monitoring treatment 
response to such interventions. 
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We used the open source R package, GGIR (version 1.5-18), for cleaning the raw 
actigraphy data. According to previously published methods (van Hees et al., 2014), 
the detailed processing pipeline included the following steps: verification of sensor 
calibration error using local gravity as a reference, detection of sustained abnormally 
high values, non-wear detection and, extraction of objective physical activity, sleep 
and circadian rhythm measures. Of those 370 participants with available data, one 
participant (0.3%) had calibration error higher than 0.02 g (1g = 9.81m/s2), one par-
ticipant (0.3%) had sustained abnormally high values, and therefore excluded. The 
processing pipeline implemented by GGIR failed to process data of one participant 
for unknown reasons.    
As participants were found to inconsequently comply to the protocol to press the 
button when going to sleep/getting up (2 participants, 0.5%), a new method was 
used to calculate sleep estimates (i.e., total sleep duration per night and sleep effi-
ciency per night) without the use of a sleep diary (van Hees et al., 2018). Inactivity 
periods were defined as consecutives 5-second epochs in which the arm angle rela-
tive to the horizontal plane did not change of more than 5° over at least 5 minutes 
(Van Hees et al., 2015). With a heuristic algorithm, a Sleep Period Time-window 
was identified as the time window starting at sleep onset and ending when waking 
up after the last sleep episode of the night (van Hees et al., 2018). Inactivity periods 
overlapping the Sleep Period Time-window were labelled as sleep periods. Finally, 
total sleep duration [clock time] was calculated as the sum of estimated sleep periods 
and sleep efficiency [%] was the total sleep duration divided by the time difference 
between sleep onset and wake-up time (i.e., time in bed).
Circadian rhythm was calculated by Mid Sleep on Free Days and the relative am-
plitude between daytime and night-time activity. Assuming that weekend days are 
most likely to be free days of the week, Mid Sleep on Free Days was calculated as 
the middle time point between sleep onset and wake-up time during weekend days. 
Relative amplitude between daytime and night-time activity was calculated accord-
ing to previously published methods (Van Someren et al., 1999). Average weekly es-
timates were derived as [(average value for weekdays × 5 + average value for weekend 
days × 2) / 7], while the average was calculated for Mid Sleep on Free Days. 
Physical activity was assessed as gross motor activity per day and minutes in moder-
ate-to-vigorous physical activity per day. Objective gross motor activity was estimat-
ed by calculating the Euclidian Norm Minus One (ENMO:                                      , 
1g = 9.81m/s2) with any negative values rounded up to zero and by averaging such 
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measure over 5-second epoch (van Hees et al., 2013). Because there is no consensus 
on thresholds to identify moderate-to-vigorous physical activity, objective minutes 
in moderate-to-vigorous physical activity per day were defined as the sum of 1-min 
epochs in which ENMO was larger than 125mg, which has recently been used by 
others (Kim et al., 2017). 
No depressive and/or anxiety disorders 
(n =90)
Remitted depressive and/or anxiety 
disorders (n=176)
Current depressive and/or anxiety 
disorders (n=93)












































MET a MVPA a
Sleep
Sleep duration 0.149 0.198 0.028 0.001 0.013 0.076 0.022 0.039 -0.035 0.033 0.012 -0.038 -0.131 0.030 -0.062
Sleep efficiency -0.063 -0.067 -0.047 0.043 0.061 -0.05 -0.029 -0.077 0.001 -0.001 -0.112 -0.142 -0.119 0.045 -0.059
Circadian rhythm
RA -0.016 0.015 -0.380*** 0.205* 0.156 -0.247*** 0.314*** -0.110 0.261*** 0.186* -0.051 0.082 -0.054 0.180 0.013
Mid Sleep on Free Days 0.087 -0.063 0.638*** 0.021 -0.005 -0.069 0.056 0.604*** 0.019 0.025 -0.220* 0.174 0.508*** -0.163 -0.117
Physical activity
Gross motor activity -0.023 0.070 -0.292** 0.163 0.126 -0.187* 0.113 0.048 0.285*** 0.204** 0.081 -0.005 0.024 0.379*** 0.219*
MVPA 0.029 0.108 -0.278** 0.126 0.092 -0.145 0.093 0.082 0.259*** 0.182* 0.081 0.086 0.106 0.369*** 0.190
Abbreviations: IPAQ, International Physical Activity Questionnaire – Short Form; IRS, Women’s Health Initiative Insomnia 
Rating Scale; MCTQ, Munich Chronotype Questionnaire; MET, metabolic equivalent total; MVPA, moderate-to-vigorous 
physical activity; RA, relative amplitude between daytime and night-time activity level.
Notes:  *: p < 0.05; **: p < 0.01; ***: p < 0.001.
a Pearson’s correlation
b Polyserial correlation
Table S1: Correlations between self-reported and actigraphy estimates of sleep, circadian rhythm and physical activity stratified by 
diagnostic status (n=359)
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No depressive and/or anxiety disorders 
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Remitted depressive and/or anxiety 
disorders (n=176)
Current depressive and/or anxiety 
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MVPA 0.029 0.108 -0.278** 0.126 0.092 -0.145 0.093 0.082 0.259*** 0.182* 0.081 0.086 0.106 0.369*** 0.190
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physical activity; RA, relative amplitude between daytime and night-time activity level.
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Table S2: day-to-day variability in sleep, circadian rhythm and physical activity in persons with current, remitted, no depressive and/



















Sleep duration variability [clock time], 
mean(sd) a 01:05 (00:28) 01:10 (00:37) 00:59 (00:25) 0.045 
b
Sleep efficiency variability [%], mean (sd) a 0.05 (0.03) 0.05 (0.03) 0.05 (0.02) 0.234
Circadian rhythm
Variability in relative amplitude between 
day and night activity, mean (sd) a 0.05 (0.04) 0.05 (0.04) 0.05 (0.03) 0.661
Mid Sleep on Free Daysvariability [clock 
time], mean (sd) a 00:38 (00:34) 00:41 (0:43) 00:37 (00:31) 0.297
Physical activity
Gross motor activity variation [milli-
gravity], mean (sd) a 4.73 (2.45) 5.1 (3.06) 5.51 (3.51) 0.197
Moderate-to-vigorous physical activity 
variability [min], mean (sd) a 18.02 (15.81) 21.46 (18.28) 25.51 (17.56) 0.015 
c
a Kruskal–Wallis test; 
b Dunn’s test, remitted depressive and/or anxiety disorders versus no depressive and/or anxiety disorders, p<0.05
c Dunn’s test, current depressive and/or anxiety disorders versus no depressive and/or anxiety disorders, p<0.05
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Background: Analyzing actigraphy data using standard circadian parametric mod-
els and aggregated nonparametric indices may obscure temporal information that 
may be a hallmark of the circadian impairment in psychiatric disorders. Functional 
data analysis (FDA) may overcome such limitations by fully exploiting the richness 
of actigraphy data and revealing important relationships with mental health out-
comes. To our knowledge, no studies have extensively used FDA to study the rela-
tionship between sociodemographic, health and lifestyle, sampling and psychiatric 
clinical characteristics and daily motor activity patterns assessed with actigraphy in 
a sample of individuals with and without depression/anxiety.
Objective: We aimed to study the association between daily motor activity patterns 
assessed via actigraphy and (1) sociodemographic, health and lifestyle, and sampling 
factors, and (2) psychiatric clinical characteristics (ie, presence and severity of de-
pression/anxiety disorders).
Methods: We obtained 14-day continuous actigraphy data from 359 participants 
from the Netherlands Study of Depression and Anxiety with current (n=93), remit-
ted (n=176), or no (n=90) depression/anxiety diagnosis, based on the criteria of the 
Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Associations 
between patterns of daily motor activity, quantified via functional principal com-
ponent analysis (fPCA), and sociodemographic, health and lifestyle, sampling, and 
psychiatric clinical characteristics were assessed using generalized estimating equa-
tion regressions. For exploratory purposes, function-on-scalar regression (FoSR) 
was applied to quantify the time-varying association of sociodemographic, health 
and lifestyle, sampling, and psychiatric clinical characteristics on daily motor activity.
Results: Four components of daily activity patterns captured 77.4% of the vari-
ability in the data: overall daily activity level (fPCA1, 34.3% variability), early ver-
sus late morning activity (fPCA2, 16.5% variability), biphasic versus monophasic 
activity (fPCA3, 14.8% variability), and early versus late biphasic activity (fPCA4, 
11.8% variability). A low overall daily activity level was associated with a number 
of sociodemographic, health and lifestyle, and psychopathology variables: older age 
(p<.001), higher education level (p=.005), higher BMI (p=.009), greater number of 
chronic diseases (p=.02), greater number of cigarettes smoked per day (p=.02), cur-
rent depressive and/or anxiety disorders (p=.05), and greater severity of depressive 
symptoms (p<.001). A high overall daily activity level was associated with work/
school days (p=.02) and summer (reference: winter; p=.03). Earlier morning activity 
was associated with older age (p=.02), having a partner (p=.009), work/school days 
(p<.001), and autumn and spring (reference: winter; p=.02 and p<.001, respectively). 
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Monophasic activity was associated with older age (p=.005). Biphasic activity was 
associated with work/school days (p<.001) and summer (reference: winter; p<.001). 
Earlier biphasic activity was associated with older age (p=.005), work/school days 
(p<.001), and spring and summer (reference: winter; p<.001 and p=.005, respective-
ly). In FoSR analyses, age, work/school days, and season were the main determinants 
having a time-varying association with daily motor activity (all p<.05).
Conclusions: Features of daily motor activity extracted with fPCA reflect com-
monly studied factors such as the intensity of daily activity and preference for morn-
ingness/eveningness. The presence and severity of depression/anxiety disorders were 
found to be associated mainly with a lower overall activity pattern but not with the 
time of the activity. Age, working and season were the variables most strongly asso-
ciated with patterns and time of activity, and thus future epidemiological studies on 
motor activity in depression/anxiety should take these variables into account.
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Introduction
The near ubiquitous use of accelerometers in electronic devices ranging from “smart-
phones” to wrist-worn accelerometers provides the biomedical community with a 
potential richness of data that is useful to study health outcomes. Wrist-worn ac-
celerometers have been used for more than 20 years by sleep researchers to estimate 
sleep and circadian activity rhythms (Ancoli-Israel et al., 2015; Martin & Hakim, 
2011) and by those studying patterns of physical activity (Matthews et al., 2012). 
Research indicates that disruption in circadian activity rhythms, especially daily mo-
tor activity patters, correlate with poor mental (Lyall et al., 2018) and physical health 
(Farhud & Aryan, 2018). Burton et al., (Burton et al., 2013), and our recent results 
have shown that low level of daily motor activity is associated with depressive(Di-
francesco et al., 2019a; Minaeva, Booij, et al., 2020) and anxiety(Difrancesco et al., 
2019a) disorders. In addition, sociodemographic and lifestyle factors, especially age 
and body mass index (BMI), have been linked to disruptions in daily motor activity 
patterns. Compared to younger persons, older persons have had lower motor activity 
patterns (Banihashemi et al., 2016) and earlier bed and rise times, also known as 
early chronotype (Mitchell et al., 2017). Higher BMI has been associated with lower 
daytime activity level and higher night-time activity level (Cespedes Feliciano et al., 
2017; Shou et al., 2017). Circadian activity rhythms are also controlled externally by 
environmental and social cues. For instance, light is an important synchroniser for 
circadian activity rhythms (Stothard et al., 2017) and has been shown to be effective 
in the treatment of sleep disorders (van Maanen et al., 2016) and affective disorders 
(Penders et al., 2016). 
Despite the great interest in daily motor activity patterns and their association with 
health outcomes and other health factors, commonly used methodology to analyse 
actigraphy data are limited in the description of circadian rhythms. Often used vali-
dated methods aggregate data in daily indices (Klerman et al., 2017) losing import-
ant information that may be a hallmark of circadian impairment. The traditional 
approach to actigraphy data analysis employs cosinor (i.e., based on the mathemat-
ical formula of a cosine wave) or modified cosinor analyses that yield information 
concerning the amplitude of activity, the timing of “peak” activity, and the goodness-
of-fit (how close pattern is to cosine wave) (Klerman et al., 2017). Although this is 
often quite useful in people with robust activity patterns, these analyses assume the 
presence of a particular shape of activity (i.e., a predictable pattern, such as a cosine 
waveform) that may be different in individuals with physical or psychological im-
pairments. Functional data analysis (FDA) can be used to model the complete time 
series of actigraphy data with less restrictive assumptions (Harezlak et al., 2018). 
Recent studies using functional Principal Component Analysis (fPCA), a FDA 
technique, have shown that patterns of daily motor activity with specific shapes 
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are associated with psychiatric clinical characteristics (i.e., apathy (Zeitzer et al., 
2013), depressive and anxiety symptoms (Zeitzer et al., 2018), objectively assessed 
sleep (Zeitzer et al., 2018)) in persons with Alzheimer disease. Another increasingly 
used FDA technique is Function-on-Scalar regression (FoSr) which analyses the 
relative time-varying impact of each variable of interest on the activity patters. In 
addition, this method yields valuable information about the time intervals in which 
the variables of interest have the greatest influence on activity patterns ( J Goldsmith 
et al., 2015; Jeff Goldsmith et al., 2016). Banihashemi et al., (2016)(Minaeva, Boo-
ji, et al., 2020) have suggested that older age and higher BMI are linked to lower 
daytime activity levels and, higher BMI and worse symptom severity are associated 
with nocturnal activity patterns suggestive of sleep disturbances in a population with 
affective disorders. Those findings are based on first attempts using FDA and such 
approaches have not been explored yet in a population with depressive and anxiety 
disorders. In addition, no studies have extensively assessed the association of actig-
raphy functional curves with sociodemographic, lifestyle and sampling factors (i.e., 
season, working days). Functional data analysis may better capture the complexity 
and dynamics of daily motor activity to reveal important behavioural biomarkers. 
This  may help to understand whether intervening on circadian rhythm or sleep (e.g. 
by light therapy or sleep intervention) could be useful regimen in reducing depres-
sive and anxiety disorders.   
In this study, we examine the association of daily activity patterns assessed using 
actigraphy and Functional Data Analysis with (1) sociodemographic (i.e., age, sex, 
partner status, education level), health and lifestyle (i.e., drinking, smoking, chronic 
diseases, BMI) and sampling factors (i.e., season, work or school day/non-work or 
non-school day); (2) psychiatric clinical characteristics (i.e., current/remitted de-
pressive and anxiety disorders, severity of depressive, medication use).  
Methods
Sample
Participants from the Netherlands Study of Depression and Anxiety (NESDA) 
were selected to enrol in the Ecological Momentary Assessment (EMA) & Actigra-
phy sub-study (NESDA-EMAA). NESDA is one of the sites that is member of the 
Motor Activity Research Consortium for Health (m-MARCH)(MMARCH, 2018; 
Scott et al., 2017), a collaborative network on the application of objective assessment 
of motor activity, sleep and mood in population and clinical samples. Details about 
NESDA have been discussed extensively before (Penninx et al., 2008). NESDA was 
designed to investigate the course of depressive and anxiety disorders over a period 
of several years and the factors that influence the development and prognosis of such 
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disorders. NESDA participants were initially recruited for baseline assessment be-
tween 2004-2007 (n = 2981), and seen for the fifth time at the nine-year follow-up 
assessment wave (2014-2017, n = 2069) for a regular follow-up interview, including 
a psychiatric diagnostic interview. In total, 1776 persons participated in  face-to-face 
interviews. A total of 367 siblings of NESDA participants who met diagnostic crite-
ria for a depression or anxiety disorder and had the same biological parents as their 
sibling(s) were added as participants to NESDA’s nine-year follow-up assessment. 
At the nine-year follow-up, we conducted the EMAA substudy among 384 partic-
ipants. The NESDA study, including the EMAA component, was approved by the 
VUmc ethical committee (reference number 2003/183) and all respondents gave in-
formed consent for both the regular interview and the EMAA component. A flow-
chart of the NESDA-EMAA was previously provided in Difrancesco et al., (Minae-
va, Booji, et al., 2020). Eligibility criteria include: 1) they had a smartphone or were 
willing to use a smartphone provided by the study; 2) willing to wear a wrist-worn 
actigraphy device; 3) could be enrolled within one month of the NESDA interview. 
Siblings were invited if they did not have a current or past diagnosis of a depressive 
and/or anxiety disorder or another severe psychiatric disorder (such as psychotic or 
severe addiction disorder). Participants of the EMAA-substudy were provided with 
a wrist-worn GENEActiv device (Activinsights Ltd, Kimbolton, UK) and wore 
them for two weeks on their non-dominant wrist. The devices were initialized and 
set to collect raw activity measures at 30Hz frequency. They also completed ques-
tions on their current mood states using Ecological Momentary Assessment (EMA)
(Schoevers et al., 2020). Here, we only report on the actigraphy component of the 
study. Of the 384 participants included in the NESDA-EMAA study, 14 had no 
available actigraphy data for several reasons, such as technical failure (more details 
in (Difrancesco et al., 2019a)), resulting in 370 (96.4%) participants with available 
data. According to previously published criteria (da Silva et al., 2014), participant’s 
actigraphy data were included in analyses if at least one week day and one weekend 
day of usable data was available, with at least 16 hours recorded per day and per 
night. The final sample consist of 359 (93.5%) participants with 13.68 ± 1.26 valid 
days, of which 90% completed the protocol for 14 days. 
Assessment of sociodemographic, health and lifestyle and, sampling 
factors
Sociodemographic, health and lifestyle factors were assessed at the nine-year fol-
low-up. Sociodemographic factors included age, gender, education level expressed 
in years and partner status. Health and lifestyle factors included body mass index 
(BMI, kg/m2), number of self-reported chronic diseases under treatment (heart 
disease, diabetes, stroke, lung disease, osteoarthritis, cancer, ulcer, intestinal prob-
lems, liver disease, epilepsy, thyroid gland disease), number of cigarettes per day and 
number of alcoholic drinks per day. Sampling factors were assessed at the nine-year 
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follow-up based on EMA and actigraphy assessment. Sampling factors included 
whether the actigraphy assessment was performed on a work/school day and the 
season in which the actigraphy assessment was performed. Work/school day was 
identified with information from EMA assessment. Season was determined based 
on the date of actigraphy assessment (e.g., 25/09/yyyy = autumn) and winter was 
used as reference.
Assessment of depressive and/or anxiety disorders and clinical 
characteristics
As in the previous waves, at the 9-year follow-up, specially trained clinical research 
staff conducted the diagnostic interviews. The Composite International Diagnos-
tic Interview (CIDI, version 2.1)(Wittchen, 1994) was used to establish DSM-IV 
based diagnoses of depressive disorders (dysthymia and major depressive disorder) 
and anxiety (social anxiety disorder, panic disorder with and without agoraphobia, 
agoraphobia and generalized anxiety disorder). For this study, we divided partici-
pants into three groups: 1) no lifetime depressive and/or anxiety disorders, 2) remit-
ted depressive and/or anxiety disorders defined as having a lifetime, but not current 
(6-month) diagnosis, and 3) current depressive or anxiety disorder diagnosed in the 
past 6 months.  
Examined clinical characteristics were: severity of depressive symptoms , and med-
ication use (i.e., antidepressant and benzodiazepines use). Severity of depressive 
symptoms was assessed with the 30-item Inventory of Depressive Symptomatology 
(IDS)(Rush et al., 1996). Antidepressant use and benzodiazepine use was based 
on drug container inspection, and medications were coded according to the World 
Health Organization Anatomical Therapeutic Chemical (ATC) classification. An-
tidepressant and benzodiazepines use was considered present if participants report-
ed using it more than 50% of the time. Antidepressants included were selective 
serotonin reuptake inhibitors (SSRIs, ATC code N06AB), tricyclic antidepressant 
(TCA, ATC code N06AA) and other antidepressants (ATC codes N06AF, N06AG, 




Distributions of all variables were checked on normality with Q-Q plots. For de-
scriptive statistics, participant sociodemographic, health and lifestyle, sampling fac-
tors and clinical characteristics were compared between the three groups (i.e., no, 
remitted and current depressive and/or anxiety disorders). For normally distributed 
continuous data, ANOVA tests were used and for data with a non-normal distribu-
tion Kruskal-Wallis test were used. Chi-squared tests were used to test differences in 
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frequencies across the three groups. All analyses were performed with the statistical 
software R (version 1.0.143), a p value < 0.05 was considered statistically significant.
Assessment of circadian rhythm patterns with FPCA
Raw actigraphy data was processed with open source R package GGIR (version 1.5-
18) (van Hees, 2017) according to published methods (van Hees et al., 2013, 2014). 
Processing of data included autocalibration, non-wear detection, identification of 
potentially corrupted data, collapsing of raw data to epoch level and computation of 
missing data. Collapsing of raw data to epoch level was done by averaging 5-second 
data. Minute-to-minute daily actigraphy data were derived per participant by sum-
ming these 5-second data; day was defined as the 00:00 – 23:59 time interval. As 
days with at least 16 valid hours were included in the analyses, missing data points 
were replaced with participant’s data from the same time of day, averaged across the 
other valid days to provide a person-specific informed approach.  
Daily motor activity patterns were derived from minute-level actigraphy data with 
the R package fda for functional data analysis (version 2.4.8)(Ramsay et al., 2018). 
First, participant minute-to-minute actigraphy data was pre-smoothed as linear 
combinations of a set of nine Fourier basis functions to capture the major trends 
in daily motor activity (the same procedure was applied by Zeitzer (Zeitzer et al., 
2018) and Gershon (Gershon et al., 2016)). After that, functional Principal Com-
ponent Analysis (fPCA) was used for capturing the principal directions of daily 
variation and dimension reduction. FPCA summarized the daily-specific features as 
the coordinates (called principal component scores) of participant curves in the basis 
spanned by the principal components. The first four daily-specific features, in this 
paper referred to as functional principal components, were considered because they 
explained together at least 75% of data variability (a similar cut-off was previously 
used (Gershon et al., 2016)).   
The association between the extracted daily functional principal components for 
each participant and participant sociodemographic, lifestyle, sampling factors and 
clinical characteristics were tested by using multiple Generalized Estimating Equa-
tion (GEE) regressions with each functional principal component as outcome. GEE 
was used to account for correlations between repeated days per person. Separate 
models were run for each clinical characteristic (i.e., current/remitted depressive 
and/or anxiety disorders, IDS, antidepressant use) and each model was adjusted for 
sociodemographic, health and lifestyle and sampling factors; this was done to avoid 
collinearity induced by the high correlation between psychiatric clinical character-
istics. Multiple testing correction was applied by controlling the false discovery rate 
(FDR) (Noble, 2009). 
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Assessment of time-varying associations of the activity with sociodemographic, 
health and lifestyle and mental health determinants with Function-on-Scalar 
Regression
Minute-to-minute daily actigraphy data were aggregated over 10 minutes and av-
eraged over the assessment period for each participant (similar procedure was done 
in ( Jeff Goldsmith et al., 2016)). Function-on-Scalar regression was used to study 
the time-varying association of participant sociodemographic, health and lifestyle, 
sampling and  clinical characteristics with actigraphy data as outcome (i.e., study the 
time-varying impact of several factors on activity patterns). For exploratory purpose, 
function-on-scalar regression analysis was repeated for each clinical characteristic to 
account for the high correlation between psychiatric clinical variables. Each model 
was adjusted for sociodemographic, health and lifestyle and sampling factors. Data 
were analysed with the R script developed by Goldsmith ( Jeff Goldsmith, 2019). 
Results
The sample sociodemographic, health and lifestyle, sampling and clinical charac-
teristics are described in Table 1 (Table 1). Of the total sample (n = 359), 93 had 
current and 176 had remitted depressive and/or anxiety disorders, 90 had no current 
depressive and/or anxiety disorders. The current depressive/anxiety disorder group 
was heterogeneous: in that 38.3% had anxiety disorders only, 33.0% had depressive 
and anxiety disorders and 28.7% had depressive disorders only. As expected, individ-
uals with current depressive and/or anxiety disorders diagnosis scored significantly 
higher on depressive symptoms (p < 0.001) and more frequently used antidepressant 
than both other groups, although no significant differences were found for benzo-
diazepine use. 
Four components describing 77.4% of variability were extracted from the data with 
fPCA (Figure 1) and interpreted as follows. The first component was the overall 
daily activity level. The second component described early versus late morning ac-
tivity, and could be indicative of chronotype. The third component showed a bipha-
sic versus monophasic activity pattern, while the fourth component represented a 
biphasic, early versus a biphasic, late activity pattern. The biphasic pattern showed 
two cycles of increased activity with subsequent decreased activity. A determinant 
associated with a pattern marked with (+) in Figure 1 (Figure 1) has a positive β, 
negative otherwise.
Low overall daily activity level was associated with a number of sociodemographic, 
lifestyle and psychopathology variables (p <0.05, Table 2): older age, higher education 


















N 93 176 90
Demographics
Age, mean (SD) a 50.1 (11.1) 48.2 (13.4) 51.3 (12.5) 0.13
Female, n (%) b 58 (62.4) 120 (68.2) 50 (55.6) 0.12
Education level [years], mean (SD) a 12.5 (3.4) 12.7 (2.8) 13.9 (2.9) <0.001
Having a partner, n (%) b 45 (48.4) 90 (51.1) 51 (56.7) 0.517
Lifestyle factors
BMI, mean (SD) a 27.1 (5.1) 26.6 (5.2) 26 (5.4) 0.369
Chronic diseases [n], mean (SD) a 1.1 (1.2) 1 (1.1) 0.6 (0.8) 0.008
# cigarettes per day, mean (SD) a 3.2 (6.5) 2.9 (6.1) 0.8 (2.7) 0.004
# drinks per day, mean (SD) a 0.5 (0.8) 0.7 (1.2) 0.8 (0.8) 0.158
Actigraphy assessment characteristics
# actigraphy days, mean (SD) 13.7 (1.0) 13.6 (1.5) 13.8 (0.7) 0.48
Measures on work/school days, n (%) b 398 (34.1) 769 (37.2) 467 (42.8) <0.001
Season of actigraphy measurement b <0.001
Winter days, n (%) 277 (21.8) 701 (29.3) 369 (29.7)
Autumn days, n (%) 376 (29.5) 584 (24.4) 362 (29.1)
Spring days, n (%) 432 (33.9) 619 (25.8) 260 (20.9)
Summer days, n (%) 188 (14.8) 492 (20.5) 252 (20.3)
Psychopathology
Only depressive disorders, n (%) 26 (28.7) 46 (26.1) -
Only anxiety disorders, n (%) 36 (38.3) 24 (13.6) -
Depressive & anxiety disorders, n (%) 31 (33.0) 106 (60.2) -
Inventory of Depressive Symptomatology 
(IDS), mean (SD) a 28.6 (11.4) 20.9 (12.5) 6.0 (4.9) < 0.001
Medication use
Antidepressant users, n (%) b 35 (37.2) 34 (19.3) 2 (2.2) < 0.001
Benzodiazepines users, n (%) b 5 (5.3) 8 (4.5) 0 (0.0) 0.10
a Analysis of variance (ANOVA), b Chi-squared test
SD, standard deviation; IQR, interquartile range
Table 1: Demographic, lifestyle factors, actigraphy assessment, psychiatric characteristics and medication use (n = 359).
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Overall daily activity 
intensity
Early vs late morning 
activity
Biphasic vs monophasic 
activity
Early vs late biphasic 
activity
β SE p β SE p β SE p β SE p 
Sociodemographic
Age -0.150 0.039 <0.001 0.082 0.029 0.017 -0.097 0.028 0.005 0.097 0.029 0.005
Sex
Female Ref. Ref. Ref. Ref.
Male -0.054 0.079 0.652 -0.017 0.063 0.828 -0.025 0.055 0.789 -0.071 0.055 0.339
Education level -0.128 0.038 0.005 -0.014 0.034 0.804 0.036 0.026 0.303 -0.026 0.030 0.540
Has a partner 
No Ref. Ref. Ref. Ref.
Yes -0.166 -0.075 0.072 0.183 -0.060 0.009 -0.015 -0.049 0.828 0.051 -0.054 0.496
Lifestyle factors 
BMI -0.118 0.039 0.009 0.048 0.030 0.219 -0.007 0.024 0.828 0.010 0.025 0.804
# chronic diseases -0.109 0.040 0.021 -0.011 0.029 0.818 -0.026 0.026 0.470 -0.047 0.025 0.145
Number of cigarettes per day -0.138 0.050 0.019 0.029 0.034 0.545 -0.046 0.027 0.185 0.016 0.027 0.692
Number of drinks per day 0.079 0.045 0.185 -0.046 0.041 0.396 -0.039 0.031 0.344 -0.009 0.033 0.828
Actigraphy assessment characteristics
Working/ school day
No Ref. Ref. Ref. Ref.
Yes 0.171 0.060 0.019 0.284 0.049 <0.001 0.728 0.052 <0.001 0.190 0.050 <0.001
Season
Winter Ref. Ref. Ref. Ref.
Autumn 0.103 0.089 0.392 0.189 0.070 0.024 0.019 0.067 0.828 0.136 0.060 0.067
Spring 0.147 0.089 0.207 0.331 0.067 <0.001 0.140 0.065 0.083 0.256 0.071 <0.001
Summer 0.285 0.108 0.026 0.178 0.102 0.185 0.327 0.072 <0.001 0.243 0.076 0.005
Psychopathology
Depressive and/or anxiety disorders
No Ref. Ref. Ref. Ref.
Remitted -0.063 0.081 0.596 -0.035 0.076 0.789 -0.046 0.065 0.641 0.077 0.067 0.392
Current -0.236 0.099 0.050 0.019 0.077 0.831 -0.001 0.075 0.991 -0.006 0.074 0.954
IDS -0.143 0.039 <0.001 -0.046 0.035 0.339 -0.015 0.026 0.698 -0.040 0.029 0.303
Antidepressant use
No Ref. Ref. Ref. Ref.
Yes -0.168 0.105 0.220 -0.124 0.064 0.138 -0.078 0.065 0.382 -0.106 0.079 0.325
Note: * multivariable GEE model, multiple testing correction using false discovery rate (FDR) estimation.
Table 2: Multivariable association* of daily motor activity patterns with sociodemographic, lifestyle, actigraphy assessment character-
istics and psychopathology (n=359)
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Overall daily activity 
intensity
Early vs late morning 
activity
Biphasic vs monophasic 
activity
Early vs late biphasic 
activity
β SE p β SE p β SE p β SE p 
Sociodemographic
Age -0.150 0.039 <0.001 0.082 0.029 0.017 -0.097 0.028 0.005 0.097 0.029 0.005
Sex
Female Ref. Ref. Ref. Ref.
Male -0.054 0.079 0.652 -0.017 0.063 0.828 -0.025 0.055 0.789 -0.071 0.055 0.339
Education level -0.128 0.038 0.005 -0.014 0.034 0.804 0.036 0.026 0.303 -0.026 0.030 0.540
Has a partner 
No Ref. Ref. Ref. Ref.
Yes -0.166 -0.075 0.072 0.183 -0.060 0.009 -0.015 -0.049 0.828 0.051 -0.054 0.496
Lifestyle factors 
BMI -0.118 0.039 0.009 0.048 0.030 0.219 -0.007 0.024 0.828 0.010 0.025 0.804
# chronic diseases -0.109 0.040 0.021 -0.011 0.029 0.818 -0.026 0.026 0.470 -0.047 0.025 0.145
Number of cigarettes per day -0.138 0.050 0.019 0.029 0.034 0.545 -0.046 0.027 0.185 0.016 0.027 0.692
Number of drinks per day 0.079 0.045 0.185 -0.046 0.041 0.396 -0.039 0.031 0.344 -0.009 0.033 0.828
Actigraphy assessment characteristics
Working/ school day
No Ref. Ref. Ref. Ref.
Yes 0.171 0.060 0.019 0.284 0.049 <0.001 0.728 0.052 <0.001 0.190 0.050 <0.001
Season
Winter Ref. Ref. Ref. Ref.
Autumn 0.103 0.089 0.392 0.189 0.070 0.024 0.019 0.067 0.828 0.136 0.060 0.067
Spring 0.147 0.089 0.207 0.331 0.067 <0.001 0.140 0.065 0.083 0.256 0.071 <0.001
Summer 0.285 0.108 0.026 0.178 0.102 0.185 0.327 0.072 <0.001 0.243 0.076 0.005
Psychopathology
Depressive and/or anxiety disorders
No Ref. Ref. Ref. Ref.
Remitted -0.063 0.081 0.596 -0.035 0.076 0.789 -0.046 0.065 0.641 0.077 0.067 0.392
Current -0.236 0.099 0.050 0.019 0.077 0.831 -0.001 0.075 0.991 -0.006 0.074 0.954
IDS -0.143 0.039 <0.001 -0.046 0.035 0.339 -0.015 0.026 0.698 -0.040 0.029 0.303
Antidepressant use
No Ref. Ref. Ref. Ref.
Yes -0.168 0.105 0.220 -0.124 0.064 0.138 -0.078 0.065 0.382 -0.106 0.079 0.325
Note: * multivariable GEE model, multiple testing correction using false discovery rate (FDR) estimation.
Table 2: (continued)
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Figure 1: Patterns of daily activity explaining 77.4% of variability in the data (n=359).
The black line represents the average daily activity, the red line represents the average daily activity + one standard deviation of PC 
score, the purple line represents the average daily activity – one standard deviation of PC score.  A) the first component (on the upper 
left) represents high (+) versus low (-) daily activity intensity; B) the second component (on the upper right) shows early (+) versus 
late (-) morning activity; C) the third component (on the bottom left) shows biphasic (+) versus monophasic (-) activity; D) the fourth 
component (on the bottom right) represents biphasic early (+) versus late (-) activity. A determinant associated with a pattern marked 
with (+) has a positive β, negative otherwise.
per day, having current depressive/anxiety disorders, higher severity of depressive 
symptoms. Higher overall daily activity level was associated with working/school 
days, and summer (ref. winter) (all p <0.05, Table 2). Earlier morning activity was 
associated with older age, having a partner, work/school days, autumn and spring 
(ref. winter) (all p <0.05, Table 2). Monophasic activity was associated with older age 
(p <0.01, Table 2). Biphasic activity was associated with work/school days, summer 
(ref. winter) (all p <0.01, Table 2). Earlier biphasic activity was associated with older 
age, work/school days, spring and summer (ref. winter) (all p <0.01, Table 2).
Age, working status and season were significantly associated with motor activity in 
the function-on-scalar regression analyses (Figure 2, p <0.05). Older age was espe-
cially related to lower activity in the late afternoon (around 18:00hrs). Working or 
going to school was associated with higher activity level with a dip in activity level 






























































C) Biphasic vs monophasic activity
(14.8% Variability)
B) Early vs late morning activity
(16.5% Variability)
D) Biphasic early vs late activity
(11.8% Variability)
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Figure 2: Effect of sociodemographic, lifestyle factors, actigraphy characteristics and clinical characteristics on time of the activity from 
multivariable Functional on Scalar regression. Note:  *: p < 0.05; **: p < 0.01.
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around noon compared to not working/going to school (Figure 2). Compared to 
those assessed in winter, those assessed in summer, spring and autumn had higher 
activity in the morning and those assessed in the summer had higher activity late in 
the afternoon (Figure 2). Average daily motor activity curves by age, working status 
and seasons are shown in Figure 3.
Discussion
This is the first study to study the associations of sociodemographic, lifestyle, sam-
pling factors and psychiatric clinical characteristics with patterns of daily motor ac-
tivity in a sample of people with and without depressive and anxiety disorders using 
functional data analysis. Patterns of daily motor activity extracted with fPCA seem 
to reflect commonly studied circadian activity rhythm features such as the daily ac-
tivity level and the time-of-day preference for morningness or eveningness(Kivelä et 
al., 2018). Presence and severity of depressive and anxiety disorders were associated 
with overall lower activity pattern, but had no impact on time of activity. Sociode-
mographic, lifestyle and sampling factors were independently associated with daily 
motor activity patterns. Function on scalar regression analyses indicated that age, 
working status and season of assessment were associated with time of the activity. 
Comparison with previous literature
The majority of variability (77.4 %) was explained by four principal components that 
reflect the complexity of activity patterns. In line with previous studies employing 
fPCA, the first two components indicated commonly studied actigraphy features 
related to circadian rhythms: overall level of physical activity (Gershon et al., 2016; 
Zeitzer et al., 2013, 2018)and the time-of-day preference for morningness or eve-
ningness (Gershon et al., 2016). Interpretation of the third and fourth components 
was less clear. We found a monophasic versus a biphasic activity pattern, as previous-
ly reported in other studies (Gershon et al., 2016; Zeitzer et al., 2018), who  suggest-
ed that a biphasic rhythm may reflect napping behavior. This monophasic pattern 
could also be related to the temporary drop in alertness and performance that often 
occurs during the early afternoon, referred to as the post-lunch dip, that reflects the 
12-hour harmonic of the circadian clock (Monk, 2005). Therefore, the level of daily 
activity and chronotype seem to be consistent components across studies applying 
fPCA, demonstrating the generalizability of the extracted components and confirm-
ing that these are important features of daily activity patterns.  
Sociodemographic factors, especially age, were associated with daily motor activ-
ity patterns with lower activity level. This is in line with the study byTakagi et al. 
(Takagi et al., 2015). This may be due to the age-related decline in physical activity 
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(Sallis, 2000). Aging causes changes in the organism, which leads to gradual loss of 
function, frailty, disease and disability (Paterson & Warburton, 2010) and therefore 
results in decreased physical activity and physical functioning. The sleep-wake cycle 
also appears to change in the aging process. Our findings showing the association 
between shifted earlier rhythms and increasing age are consistent with previous re-
search that shows that aging is associated with advanced sleep timing (as reviewed 
by Duffy et al.( Jeanne F. Duffy et al., 2015)) and preference for morningness (as re-
viewed by Hood et al.(Hood et al., 2017)). The circadian phase of melatonin has also 
been reported to become earlier with age, as has the timing of the cortisol rhythm 
( Jeanne F. Duffy et al., 2015). The suprachiasmatic nucleus (SCN), which represents 
the biological clock of the brain, shows functional changes with age (Peters, 2007) 
that may be related to disturbances in circadian rhythms. 
Work status and season, not surprisingly, were also very important for daily activity 
patterns and circadian rhythms. Circadian rhythms are controlled centrally by the 
SCN and influenced externally by behavioral/social cues and by the light exposure 
as reviewed by Duffy & Czeisler ( Jean F. Duffy & Czeisler, 2009). Our findings that 
assessments during autumn, spring and summer days showed significantly higher 
level of activity and earlier morning activity compared to winter days seem to be 
consistent with, the systematic review of Tucker & Gilliland (Tucker & Gilliland, 
2007)has shown that level of activity varies with seasonality and it is the lowest 
during winter. Also, other factors related to seasons can impact on daily activity such 
as  weather conditions, which can also explain different circadian patterns across 
seasons. Also, on working/school days there appeared to be higher and longer daily 
activity and earlier morning activity compared to non-working/non-school days. 
Indeed, it is well known in the literature that modern life habits including night 
work, shift work ( James et al., 2017)), jet lag (Vosko et al., 2010)), and social jet lag 
(Wittmann et al., 2006)), are associated with circadian rhythms disruptions. 
We also found that health and lifestyle factors are linked to daily activity patterns. 
Our results are in line with previous research reporting the association of lower 
activity level with higher BMI in the NIMH Family study (Shou et al., 2017), and 
higher number of chronic diseases. (Durstine et al., 2013). These results may be  sug-
gestive of sedentary behavior, a factor known to relate to weight gain and disabilities. 
Early morning activity was associated with higher BMI. This might be due to respi-
ration-related diseases such as apnea, which is known to be more prevalent in per-
sons with a high BMI and can disturb sleep severely (Romero-Corral et al., 2007). 
An important question of this research was to study timing of daily motor activity 
and psychopathology. However, we have found no association with disrupted timing 
of the activity. Our functional data driven-models have instead shown similar asso-
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ciations to our previous analyses on NESDA data (Difrancesco et al., 2019a; Minae-
va, Booji, et al., 2020) indicating that current depressive and/or anxiety disorders and 
more severe symptoms were associated with lower physical activity level but not with 
preference for eveningness. These results may suggest that perhaps the use of daily 
indices of motor activity is enough when studying the association with psychopa-
thology. On the other hand, we have only evaluated group level differences; studying 
differences at the individual level may be important to explore. For instance, by using 
a idiographic approach (i.e., study associations that differ between time points or 
between individuals), it may be possible to study the dynamics between daily motor 
activity and depression/anxiety (Rosmalen et al., 2012), and help identify patients 
in whom activity is strongly predictive of mood. Collecting more empirical data 
in clinical practice is necessary to establish whether this is a promising approach. 
Strengths 
An important  strength of this paper is the use of functional data analysis, which is a 
useful statistical tool for data exploration and visualization. By providing a graphical 
representation of motor activity and circadian rhythms, functional data analysis can 
help to identify specific patterns. This could help to generate new hypotheses which 
could in turn contribute to the improvement of treatment of circadian disturbances. 
Functional data analysis could also be used to predict future outcomes of treatment. 
For instance, the previous study of Zeitzer et al., (Zeitzer et al., 2018) has shown that 
low daytime activity and having a late afternoon peak extracted with fPCA are predic-
tive of higher mortality rate in community-dwelling older men, although it remains 
to be investigated whether fPCA components add to the prediction over traditional 
actigraphy measures. Daily curves of motor activity could be potentially used also in 
predictive models to pick up early signs of recovery or non-response, and if predictive, 
could inform clinicians in monitoring treatment response or treatment planning. 
Limitations
The current study was limited by several factors. Data is observational and cross 
sectional, and so the associations cannot be inferred to be causal. As this study is 
formed of individuals participating in the fifth wave of a prospective cohort, there 
may  be a selection bias towards highly motivated individuals. Future studies may 
investigate whether our results may be replicated in a wider population with and 
without depression and anxiety. Actigraphy provides only an indirect assessment 
of circadian rhythm, however, has the advantage of continuously monitoring over a 
relatively long period of time. Not all functional components were easily interpreta-
ble. While the first two components are (possibly) indicative of the overall level of 
activity and the time-of-day preference for morningness or eveningness, the third 
and fourth components need to be replicated in order to provide a better interpre-
tation and validity. 
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Conclusions
Our study showed that features of daily motor activity extracted with functional 
Principal Component Analysis reflect commonly studied factors such as the daily 
activity level and the time-of-day preference for morningness or eveningness . Age, 
work status and seasons were the most strongly associated with patterns of daily 
activity and had time-varying impact on daily motor activity. Presence and severity 
of depressive and anxiety disorders were associated with an overall lower activity 
pattern but no differences in the timing of activity. Beside psychopathology, sociode-
mographic, health and lifestyle, and sampling factors were independently associated 
with overall lower activity pattern.
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Background: Considering the heterogeneity of depression, distinct depressive 
symptom dimensions may be differentially associated with more objective actigra-
phy-based estimates of physical activity (PA), sleep and circadian rhythm (CR). We 
examined the association between PA, sleep, and CR assessed with actigraphy and 
symptom dimensions (i.e., mood/cognition, somatic/vegetative, sleep).   
Methods: 14-day actigraphy data of 359 participants were obtained from the Neth-
erlands Study of Depression and Anxiety. PA, sleep, and CR estimates included 
gross motor activity (GMA), sleep duration (SD), sleep efficiency (SE), relative 
amplitude between daytime and night-time activity (RA) and sleep midpoint. The 
30-item Inventory of Depressive Symptomatology was used to assess depressive 
symptoms, which were categorised in three depression dimensions: mood/cognition, 
somatic/vegetative and sleep. 
Results: GMA and RA were negatively associated with higher score on all three 
symptom dimensions: mood/cognition (GMA: β= -0.155, p<0.001; RA: β= -0.116, 
p=0.002), somatic/vegetative (GMA: β= -0.165, p<0.001; RA: β= -0.133, p<0.001), 
sleep (GMA: β= -0.169, p<0.001; RA: β= -0.190, p<0.001). The association with 
sleep was more pronounced for two depression dimensions: longer SD was linked to 
somatic/vegetative (β=0.115, p=0.015) dimension, and lower SE was linked to sleep 
(β= -0.101, p=0.011) dimension. 
Conclusion: As the three symptom dimensions were associated with actigra-
phy-based low PA and dampened CR, these seem to be general indicators of depres-
sion. Sleep disturbances appeared more linked to the somatic/vegetative and sleep 
dimensions; the effectiveness of sleep interventions in patients reporting somatic/
vegetative symptoms may be explored, as well as the potential of actigraphy to mon-
itor treatment response to such interventions.
Keywords: Actigraphy; Major Depressive Disorder, symptom dimensions
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Introduction
Major depressive disorder (MDD) is a highly prevalent disorder, associated with 
high disability (Murray et al., 2012). It often has a chronic course (Verduijn et al., 
2017) and a third of the patients experience poor treatment outcomes (Gaynes et 
al., 2009). Despite the challenges in finding consensus regarding classification, di-
agnosis and treatment, there has been a recent and significant increase in research 
to identify novel methods to measure, unravel etiology, and treat depressive disor-
ders. Actigraphy, an ecologically valid method to objectively measure disturbances in 
sleep, circadian rhythm and physical activity, has become widely used in depression 
research.
Several studies, including the systematic review of Burton et al. (2013) and our 
previous work (Difrancesco et al., 2019; Minaeva et al., 2020), have shown that 
depressive disorders and symptoms are associated with lower daily activity (Hel-
gadóttir et al., 2015; Hori et al., 2016; Stubbs et al., 2016) and circadian rhythm 
amplitude (Lyall et al., 2018). The association between actigraphy measures of sleep 
and depression is less clear. Although night-time activity level appears to be higher 
in patients with depression (Burton et al., 2013), this is not always reflected in actig-
raphy measures of sleep duration and sleep efficiency. Despite studies assessing sleep 
with self-reported questionnaires have shown that both insomnia and hypersomnia 
are associated with depression (Nutt et al., 2008; van Mill et al., 2010), our previous 
results with actigraphy have found that higher severity of depressive symptom is 
associated with longer (but not shorter) sleep duration (Difrancesco et al., 2019). 
Depression is however heterogeneous in its presentation and these results may not 
be generalizable to all patients. 
Symptoms vary substantially in patients with depression and opposite clinical pres-
entations occur. For instance, both insomnia and hypersomnia (Nutt et al., 2008) 
and  psychomotor retardation and agitation (Avery & Silverman, 1984) are symp-
toms of depression. Considering that 1030 unique DSM-5 symptom profiles have 
been found among 3703 patients with MDD (Fried & Nesse, 2015), substantial 
symptom variation occurs among individuals who all qualify for the same DSM-
5 diagnosis. Thus, as the ‘depression’ label provides limited information about the 
particular problems experienced by a patient, some researchers have moved away 
from traditional methods of diagnosis such as the DSM-5 and have focused on 
symptom dimensions (Fried, 2017). Although approaches to identify symptom di-
mensions vary, empirical methods such as factor analyses have been employed to 
identify symptoms dimensions or factor structures underlying self-reported ques-
tionnaires on depressive symptoms in a population based sample, such as the often 
used Inventory of Depressive Symptomatology (IDS) (Hegeman et al., 2012; Rush 
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et al., 1996; Wardenaar et al., 2010). Most studies illustrate the existence of three 
major symptom dimensions: mood/cognition, somatic and sleep symptom dimen-
sions (Hegeman et al., 2012; Rush et al., 1996; Wardenaar et al., 2010). 
Although it is clear that depression is heterogeneous, little research has focused on 
the role of symptoms dimensions assessed with severity measures in sleep and cir-
cadian rhythm disturbances and physical inactivity as assessed objectively with ac-
tigraphy. As cognitive impairments have been linked to sleep problems (Mantua & 
Simonelli, 2019) and physical inactivity has been related to somatic/energy related 
symptoms (Puetz, 2006), a differential association with symptom dimensions may 
be expected. However, this has not properly been investigated so far. A better un-
derstanding would be of benefit for the diagnosis and treatment of depression. For 
instance, pharmacological treatment, psychotherapy and chronotherapies to treat 
sleep and circadian rhythm problems can be especially administered to patients with 
specific symptom dimensions.       
The aim of this study was to examine the association between actigraphy-based 
physical activity, sleep and circadian rhythm with symptom dimensions (i.e., cog-
nition/mood, somatic, sleep). The association with individual depressive symptoms 
was also explored to further check on the consistency of findings for symptoms 
within dimensions. To address these questions, we used data from the Netherlands 
Study of Depression and Anxiety (NESDA) which includes persons without and 
with current or remitted depressive and/or anxiety disorders. As depression and anx-
iety are highly comorbid disorders (Lamers et al., 2011; Rodney et al., 1997) and 
we previously mentioned limitations in traditional diagnosis method, using the full 




Participants from the Netherlands Study of Depression and Anxiety (NESDA) 
were selected to participate in the Ecological Momentary Assessment (EMA) & 
Actigraphy sub-study (NESDA-EMAA). Details about NESDA have been pro-
vided extensively before (Penninx et al., 2008). NESDA was designed to investi-
gate the course of depressive and anxiety disorders over a period of several years 
and the factors that influence the development and prognosis of such disorders. 
NESDA participants were initially included at the baseline assessment in 2004-
2007 (n=2981), and seen for the fifth time at the nine-year follow-up assessment 
wave (2014-2017, n=1776) for a follow-up interview. At that time, also 367 sib-
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lings of NESDA participants were added, bringing the 9-year follow-up sample to 
2143 subjects. At this wave, 384 participants enrolled for the EMAA sub-study. The 
NESDA study, including NESDA -EMAA, was approved by the VUmc ethical 
committee (reference number 2003/183) and all respondents gave informed consent 
for both the regular interview and the EMAA sub-study. See for a flowchart of the 
NESDA-EMAA in our previous work (Difrancesco et al., 2019). Participants were 
eligible if they had a smartphone or were willing to use a smartphone provided by 
the study, and were willing to wear a wrist-worn actigraphy device. Participants to 
the EMAA-sub-study were provided with a GENEActiv device (Activinsights Ltd, 
Kimbolton, UK). Participants wore the wrist-worn GENEActiv actigraphy device 
for 14 days on their non-dominant wrist. Of the 384 participants included in the 
NESDA-EMAA study, 14 had no available actigraphy data for several reasons, such 
as technical failure, resulting in 370 (96.4%) participants with available data. Ac-
cording to previously published criteria (da Silva et al., 2014), participant’s actigra-
phy data were included in analyses if at least one week day and one weekend day of 
usable data was available, with at least 16 hours recorded per day and per night. The 
final sample was composed of 359 (93.5%) participants with on average 13.68 ± SE 
1.26 valid days, of whom 90% completed the protocol for 14 days. 
Depressive symptoms and symptom dimensions
The Dutch version of the 30-item Inventory of Depressive Symptomatology, 
self-report (IDS) (Rush et al., 1996) was used to assess depressive symptoms (0 = 
no problems to 3 = severe problems) in the previous 7 days. A total sum score can 
be calculated (range, 0–84), with higher scores indicating higher levels of depressive 
symptomatology. Validity and reliability have been shown before, with Cronbach’s 
alpha ranging from 0.92 to 0.94 (Rush et al., 1996). We used three dimensional 
depression symptom sum scores based in a prior factor analyses in NESDA (War-
denaar et al., 2010): mood/cognition, somatic/vegetative and sleep. The mood/cog-
nition dimension consisted of the 16 items: feeling irritable, interpersonal sensitivity, 
feeling sad, diminished quality of mood, feeling anxious or tense, diminished ca-
pacity of pleasure/enjoyment, diminished reactivity of mood, diminished interest in 
people/activities, suicidal thoughts, future pessimism, concentration/decision mak-
ing problems, self-criticism and blame, psychomotor retardation, reduced interest 
in sex, low energy level/fatigability, leaden paralysis. The somatic/vegetative domain 
included 9 items: panic/phobic symptoms, psychomotor agitation, decreased weight, 
increase in appetite, other bodily symptoms, decrease in appetite, increased weight, 
constipation/diarrhoea, aches and pains. Finally, the sleep domain included 4 items: 
early morning awakening, problems sleeping during the night, problems falling 
asleep, sleeping too much. The item ‘diurnal variation (worse in the morning)’ did 
not belong to any domain in the factor analyses and was therefore used only in our 
exploratory analyses with individual symptoms.
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Actigraphy estimates of sleep, circadian rhythm and physical activity
In this study, the accelerometer was set to sample at 30 Hz and raw actigraphy data 
was analysed using an open source R package, GGIR (version 1.5-18). Actigraphy 
data were gathered after the depressive symptoms assessment with a median number 
of 23 days between the two assessments. As described before (Difrancesco et al., 
2019), we used objective indicators of sleep, circadian rhythm and physical activity. 
Sleep was assessed as total sleep duration per night [in hh:mm] and sleep efficiency 
per night [%]. Circadian rhythm was assessed by the relative amplitude (RA) be-
tween daytime and night-time activity per day and sleep midpoint [clock time]. RA 
describes the amplitude between the activity during the day and the night; lower RA 
means a dampened circadian rhythm amplitude suggesting lower activity during the 
day and higher activity during the night. Sleep midpoint is a proxy of chronotype 
or preference for morningness/eveningness; later sleep midpoint means a prefer-
ence for evening chronotype. Exploratory analyses showed that RA and sleep mid-
point have low correlation and therefore they describe different aspects of circadian 
rhythm (Supplemental material Table S1). Physical activity is indexed/expressed 
given as gross motor activity (GMA) per day [milli-gravity (mg), 1g = 9.81m/s2]. 
Daily estimates of each variable were used in the current study.
Covariates and descriptive variables
Covariates were age, sex and education level expressed in years at the time of the 
NESDA EMAA sub-study. These covariates were selected as they have an estab-
lished theoretical association with depression and with sleep, circadian rhythm and 
physical activity levels, and have been regularly used in similar studies (Droomers et 
al., 2001; Stamatakis et al., 2007).
DSM-IV based diagnoses of depressive disorders (dysthymia and major depres-
sive disorder) and anxiety (social anxiety disorder, panic disorder with and without 
agoraphobia, agoraphobia and generalized anxiety disorder) were established with 
the Composite International Diagnostic Interview (CIDI, version 2.1)(Wittchen, 
1994). The interviews were conducted at the regular interview by specially trained 
clinical research staff. Participants were divided into three groups for descriptive 
purposes only: 1) a group with no lifetime depressive and/or anxiety disorders, 2) 
a group with remitted depressive and/or anxiety disorders (having a lifetime, but 
not current (6-month) diagnosis), and 3) a group with current depressive or anxiety 
disorder in the past 6 months. 
Antidepressant use was based on drug container inspection, and medications were 
coded according to the World Health Organization Anatomical Therapeutic Chem-
ical (ATC) classification. Antidepressant use was considered present if participants 
reported using it more than 50% of the time. Antidepressants included were selec-
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tive serotonin reuptake inhibitors (SSRIs, ATC code N06AB), tricyclic antidepres-
sant (TCA, ATC code N06AA) and other antidepressants (ATC codes N06AF, 
N06AG, N06AX).
Statistical analyses
Distributions of all variables were checked on normality with QQ plots. Non-nor-
mally distributed outcomes were transformed with Log-transformation (gross mo-
tor activity) or with Box-Cox transformation (sleep duration, sleep efficiency, relative 
amplitude between daytime and night-time activity level and sleep midpoint). Cor-
relation of symptom dimensions were explored using Pearson correlation coefficient 
to assess the degree of intercorrelation of symptom dimensions. The association of 
actigraphy estimates with symptom dimensions and individual symptoms was tested 
in separate models using Generalized Estimating Equations (GEE) corrected for 
covariates and with each actigraphy estimate as outcome. GEE was used to account 
for correlations between repeated days per person. Separate models were ran for 
each symptoms dimension and each individual symptoms; each model was adjusted 
for age, sex and education level. As having a current/remitted diagnosis of depres-
sion and/or anxiety is highly correlated with severity of symptoms, adjustment for 
diagnostic groups was not performed.
All analyses were performed with the statistical software R (version 1.0.143). A 
p-value < 0.05 was considered statistically significant. Correction for multiple test-
ing by using false discovery rate (FDR) was applied when testing the association 
with symptom dimensions adjusting for the number of outcomes (n=5) and symp-
tom dimensions (n=3). This was not done for individual symptoms, as our aim was 
to visually explore overall patterns to help understand whether symptoms follow the 
same patterns as the dimension they belong to or not. Specifically, we visually as-
sessed the univariate associations of individual symptoms with actigraphy measures 
by using a forest plot presenting the standardised coefficients and the 95% confi-
dence intervals. In this way, it was possible to visualise whether the associations with 
individual symptoms followed the same direction as the dimension they belong to 
and whether some symptoms were outliers. 
Results
Demographics and descriptive
Table 1 shows demographics and descriptive in our sample. The average age of the 
sample was 49.5 ± 12.6  years, of whom 63.7% was female and with a duration of ed-
ucation of 12.9 ± 3.1 years. Most of the persons included had a lifetime diagnosis of 
depressive and/or anxiety disorders: 93 (26.0%) persons had current depressive and/
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or anxiety disorders, 176 (49.0%) persons had remitted depressive and/or anxiety 
disorders and only 90 (25.0%) persons had no depressive and/or anxiety disorders. 
The average severity of depressive symptoms in the sample was 14.2 ± 11.7 on the 
IDS total score.  
Symptoms dimensions were moderately to strongly correlated (correlation ranged 
from 0.41 for the somatic/vegetative and sleep dimensions, to 0.75 for mood/cogni-
tion and somatic/vegetative dimensions, not tabulated and available upon request). 
Association of sleep, circadian rhythm and physical activity with 
dimensions
14-day lower gross motor activity and relative amplitude between daytime and 
nighttime activity level were significantly associated with all three symptom dimen-
sions (Table 2, all p<0.05). The associations with actigraphy-based sleep were more 
pronounced for two dimensions. Longer sleep duration was significantly associat-
ed with higher somatic/vegetative symptom dimension score (Table 2; β= 0.113, 
p=0.021) but not with mood/cognition and sleep symptom dimension scores. Lower 
sleep efficiency was associated with higher sleep symptom dimension score (Table 2; 
β= -0.101,  p=0.011) but not with mood/cognition and somatic/vegetative symptom 
dimension scores.
Table 1: Demographics and psychopathology in the NESDA sample 
All subjects (n = 359)
Demographics
Age, mean (SD) 49.5 (12.6)
Female, n (%) 228 (63.7 %)
Education [year], mean (SD) 12.9 (3.1)
Psychopathology
Depressive and/or anxiety disorders
No lifetime disorders, n (%) 90 (25.0 %)
Remitted disorder, n (%) 176 (49.0 %)
Current disorder, n (%) 93 (26. %)
IDS Score, mean (SD) 14.2 (11.7)
Mood/Cognition symptom score  (IDS), mean (SD) 8.4 (7.9)
Somatic/vegetative symptom score (IDS), mean (SD) 5.1 (3.6)
Sleep symptom score  (IDS), mean (SD) 3.0 (2.0)
Antidepressant use, n (%) 71 (19.7%)
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Physical activity Sleep Circadian rhythm
Gross motor 






Symptom dimensions β SE p β SE p β SE p β SE p β SE p
Mood/Cognition -0.163 0.043 <0.001 0.081 0.042 0.066 -0.048 0.036 0.200 -0.122 0.036 0.003 0.091 0.047 0.066
Somatic/vegetative -0.146 0.038 <0.001 0.113 0.044 0.021 -0.043 0.038 0.263 -0.116 0.039 0.008 0.090 0.046 0.066
Sleep -0.169 0.038 <0.001 0.078 0.039 0.066 -0.101 0.036 0.011 -0.190 0.039 <0.001 0.069 0.043 0.132
*GEE model (outcomes = sleep, circadian rhythm and physical activity) adjusted for age, sex and education level. 
  Correction for multiple testing by using false discovery rate (FDR).
Table 2: Univariate association* between symptom dimensions and sleep, circadian rhythm and physical activity (n = 359)
Figure 1: Univariate association between individual IDS symptoms and the actigraphy measures: physical activity (i.e., gross motor 
activity), sleep (i.e., sleep duration, sleep efficiency) and circadian rhythm (i.e., relative amplitude, sleep midpoint) in all sample (n = 
359). Error bars represent 95% confidence intervals. Adjusted for age, sex, and education. Note: ● = mood/cognition, ▲= somatic/
vegetative, ■ = sleep, І = no dimension; black = p0<.05, grey = p>0.05.  
Gross motor activity Sleep duration
-0.2 -0.20.0 0.00.2 0.2
6. Feeling irritable
7. Feeling anxious or tense




15. Concentration/decision making problems
5. Feeling sad
10. Diminished quality of mood
8. Diminished reactivity of mood
21. Diminished capacity for pleasure
22. Reduced interest in sex
19. Diminished interest in people/activity
23. Psychomotor retardation








26. Other bodily symptoms
28. Constipation/diarrhoea
25. Aches and pains
3. Early morning awakenings
2. Problems sleeping during the night
1. Problems falling asleep
4. Sleeping too much













Physical activity Sleep Circadian rhythm
Gross motor 






Symptom dimensions β SE p β SE p β SE p β SE p β SE p
Mood/Cognition -0.163 0.043 <0.001 0.081 0.042 0.066 -0.048 0.036 0.200 -0.122 0.036 0.003 0.091 0.047 0.066
Somatic/vegetative -0.146 0.038 <0.001 0.113 0.044 0.021 -0.043 0.038 0.263 -0.116 0.039 0.008 0.090 0.046 0.066
Sleep -0.169 0.038 <0.001 0.078 0.039 0.066 -0.101 0.036 0.011 -0.190 0.039 <0.001 0.069 0.043 0.132
*GEE model (outcomes = sleep, circadian rhythm and physical activity) adjusted for age, sex and education level. 
  Correction for multiple testing by using false discovery rate (FDR).
Table 2: (continued)
Figure 1: (continued)
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Patterns of sleep, circadian rhythm and physical activity in individual 
symptoms
Figure 1 shows the association of individual symptoms with 14-day physical activity, 
sleep and circadian rhythm patterns. Associations of gross motor activity and rela-
tive amplitude between daytime and night-time activity level showed more signifi-
cant associations with individual symptoms compared to other actigraphy variables. 
For GMA and RA 63% (n=19) and 53% (n=16) of all individual symptoms – spread 
across different dimensions - were significantly associated with lower GMA and 
lower RA between daytime and night-time activity level. Other symptoms – al-
though not significantly associated -  followed a similar, expected negative direction 
in their associations with GMA and RA. By inspecting the forest plots, no differ-
ential association of GMA and RA with symptom dimensions can be confirmed. 
When considering actigraphy-based sleep duration, eight of the in total thirty indi-
vidual symptoms were significantly associated with longer sleep duration. Although 
most of somatic/vegetative symptoms followed the same direction in the association 
with sleep duration, ‘increased weight’ deviated from the overall pattern. Also, as 
expected ‘early morning awakenings’ in the sleep dimension was associated with 
objective shorter sleep duration.
Although not captured in the analyses using symptom dimensions, 30% (n=9) of 
all symptoms were associated with later sleep midpoint. Of these seven symptoms, 
four belong to the mood/cognition dimension and three belong to the sleep dimen-
sion. Most individual symptoms were following the same positive direction in the 
association with sleep midpoint, with the exception of ‘early morning awakenings’ 
that showed an – expected – negative direction. This may possibly show that there is 
more heterogeneity in terms of effect estimates for individual symptoms. 
Only two symptoms were associated with lower sleep efficiency. As expected, all 
sleep symptoms were following the same negative direction in the association with 
sleep efficiency as shown by the sleep dimension. 
Discussion
This is the first study to examine 14-day actigraphy estimates of sleep, circadian 
rhythm and physical activity and their relationship with symptoms and symptom di-
mensions of depression. As all three symptom dimensions were associated with lower 
and dampened 14-day physical activity and circadian patterns, it could be concluded 
that physical inactivity and low circadian amplitude are general indicators of depres-
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sive symptom severity. However, sleep disturbances may be more specifically linked 
to somatic/vegetative and sleep symptom dimensions, as associations with longer 
sleep duration and lower sleep efficiency were more pronounced for these symptom 
dimensions. While exercise and behavioural activation may be used as adjunctive 
treatments in all patients with depression, sleep interventions may be especially ef-
fective in people with more self-reported somatic/vegetative and sleep symptoms. 
While few studies have suggested that actigraphy may serve as an objective meas-
ure of psychomotor retardation in patients with depression (Krane-Gartiser et al., 
2015), our results seem to support that physical inactivity is a general feature of de-
pression (Burton et al., 2013) and symptom severity (Minaeva et al., 2020). This was 
also reflected in our analyses with individual symptoms, as over 60% of depressive 
symptoms – across different symptom dimensions - were associated with low gross 
motor activity with moderate effect sizes. The association between physical activity 
and depression has been studied before and appears to be bidirectional. Patients 
with depression are typically less active, and they experience a range of barriers to 
engaging in physical activity such as depressive symptoms, higher body mass index, 
physical co-morbidity, and lower self-efficacy (Vancampfort et al., 2015). Low levels 
of physical activity increase the risk of depression (Mammen & Faulkner, 2013) and, 
physical activity and exercise (i.e. structured physical activity) can improve depres-
sive symptoms (Schuch et al., 2016). A large meta-analysis in the general population 
(Biswas et al., 2015) demonstrated that sedentary behaviour is associated with an 
increased risk of developing cardiovascular disease, type 2 diabetes, cardiovascular 
and all-cause mortality. As persons with depression are less active than the general 
population, they encounter additional risks in developing cardiovascular and chronic 
diseases and mortality. Physical activity and behavioural activation, predominantly 
through exercise, may produce an antidepressant effect through multiple biological 
and psychosocial pathways (Kandola et al., 2019). Neuroplasticity, neuroendocrine 
responses, inflammation and oxidative stress have been suggested to play a role at 
a biological level. Several psychosocial factors accompany, and potentially interact 
with, these biological changes to influence depression, such as self-esteem (Kandola 
et al., 2019). While there is less research into the psychosocial benefits of exercise 
on depression, they are likely to be of parallel importance. As we observed lower 
physical activity across all symptom dimensions, physical activity and behavioral 
activation may be of help to all patients with depression as it may produce an anti-
depressant effects through multiple biological and psychosocial pathways. 
Similarly, dampened circadian amplitude was generally associated with all symptom 
dimensions, supporting previous findings on the association between dampened 
rhythms and mood disorders (Lyall et al., 2018). As reviewed by Vadnie and Mc-
Clung (2017), multiple mechanisms can explain the association between circadian 
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rhythm disruptions and mood disorders including depression. One of the main the-
ories is that disrupted circadian rhythms in the master pacemaker, or suprachias-
matic nucleus (SCN) may be the cause of mood disturbances. However, also other 
environmental factors, such as light, or genetic perturbations may influence mood 
independently from the central clock. Additionally, other studies have suggested 
that sleep and circadian rhythm disturbances may be symptoms of mood disorders. 
As dampened circadian amplitude was associated with all symptom dimensions, 
circadian rhythm interventions such as behavioural activation may be administered 
as adjunctive treatment to all patients with depression.  
When studying sleep, it is important to make a clear distinction between subjective 
and objective sleep measures. The first provides information about a person’s per-
ception about his/her sleep quantity and quality. The latter refers to the objective 
measure of sleep duration and sleep efficiency with actigraphy. When assessing sub-
jective sleep, persons diagnosed with depression often report sleep disturbances such 
as insomnia and hypersomnia (Nutt et al., 2008; van Mill et al., 2010). While in our 
previous work using actigraphy (Difrancesco et al., 2019) we have shown that de-
pressive symptom severity is associated with longer objective sleep duration, in these 
follow-up analyses the association appeared to be more pronounced in patients with 
somatic/vegetative symptoms. We found a possible explanation for these findings. 
Persons with more somatic/vegetative symptoms experience more physical com-
plains, such as aches and pains, bodily symptoms, than may directly impact on their 
ability to be physically active and resulting in more sleep disturbances. The sleep 
dimension itself may be problematic as it combines opposite clinical presentations 
(i.e., insomnia and hypersomnia) for which the associations with objective sleep is 
expected in opposite directions. However, as could be expected, lower sleep efficien-
cy assessed objectively with actigraphy was associated with sleep symptoms assessed 
with self-ratings. Although in our previous work we did not find an association 
between objective sleep efficiency and subjective sleep assessed with the Women’s 
Health Initiative Insomnia Rating Scale (Difrancesco et al., 2019), objective mea-
sure of sleep efficiency seems indicative of self-reported sleep disturbances assessed 
with the IDS. Sleep interventions may focus not only on patients reporting sleep 
problems, but also on those reporting somatic/vegetative symptoms. Actigraphy may 
be used to assess the effectiveness of such interventions. 
This study has several limitations. First, although we adjusted for multiple testing, 
we explored several associations when looking at individual symptoms and that may 
lead to chance findings. However, we aimed to look more at broader patterns than 
to focus on specific symptoms. Second, the assessment of depression symptoms and 
actigraphy were not done at the same time, although there was a median number of 
23 days between the two assessments. Another limitation is that sleep and circadian 
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rhythms are complicated concepts and actigraphy may provide only an indirect and 
rough estimate of them based on wrist movement, whereas polysomnography is the 
gold standard. In addition, sleep midpoint was evaluated during the entire period 
and it can be argued that chronotype is often assessed with sleep midpoint on free 
days corrected for the sleep debit accumulated during the working days. However, 
sleep midpoint measured with actigraphy provides a valid approximation of chrono-
type and it is moderately correlated with it as shown by Santisteban et al. (2018). 
Although not assessed in our study, shift work may affect sleep schedules and there-
fore it may influence the results on the association with sleep and circadian rhythms 
( James et al., 2017). While data did not show reversed activity/sleep patterns as 
would be expected with night shifts, early and late day shifts could have occurred 
and may also have an impact. Individual symptoms may fit in different symptoms 
dimensions, and classifications are not always consistent across studies. We based 
our classification on those of Wardenaar et al. (2010), in which classification, psy-
chomotor retardation and low energy level/fatigability for instance were part of the 
mood/cognition dimension, but they could also be fit in the somatic/vegetative di-
mension. However, by looking at individual symptom patterns we found consistency 
as most of symptoms follow the same direction in the associations as the dimension 
they belong to. Although we did not investigated the role of anxiety, as Wardenaar 
et al. (2010) have shown that symptom dimensions were consistent across diagnostic 
groups (i.e., remitted depression, lifetime anxiety, healthy controls), comorbid anx-
iety does not seem to confound the studied associations. Important strength of the 
study is the attempt to investigate the heterogeneity of depressive symptoms with 
actigraphy in a relatively large sample. Another important strength is that on average 
14 days of actigraphy data per participant were available. 
To conclude, this is the first study to examine the different symptom dimensions of 
depression and their association with several objective indicators of physical activ-
ity, sleep, circadian rhythm gathered with wrist-worn actigraphy devices. As low-
er physical activity level and dampened circadian amplitude were associated with 
higher scores on all three dimensions, lower physical activity level and dampened 
circadian rhythms appeared to be general indicators of depression and depression 
severity. Disturbances in objective sleep were more pronounced for somatic/vegeta-
tive symptoms, suggesting that longer sleep duration may be more closely linked to 
this dimension. Sleep interventions may focus not only on patients reporting sleep 
problems, but also on those reporting somatic/vegetative symptoms. Physical activ-
ity, behavioural activation, and circadian rhythm interventions may be not limited 
to groups of patients based on their symptoms, but may be promoted in all patients 
with depression. However, clinical implementation awaits further evidence based on 
empirical data if indeed actigraphy may be used to monitor treatment response of 
such interventions.  
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Depressive and anxiety disorders are highly prevalent psychiatric disorders (Zorn et 
al., 2017), associated with high disability (Vos et al., 2016), with at least a third of 
patients experiencing poor treatment outcomes (Gaynes et al., 2009). Disturbances 
in mood and sleep are core symptoms of affective disorders and are therefore intri-
cately linked to each other (Kahn et al., 2013). 
Persons with affective disorders typically report low levels of positive affect (i.e., 
anhedonia) and high levels of negative affect (i.e., sad mood, guilt) on question-
naire and interview measures (American Psychiatric Association, 2013; Peeters et 
al., 2006). Sleep disturbances in affective disorders can entail difficulty initiating or 
maintaining sleep, or early morning awakening (insomnia), but also sleeping too 
much (hypersomnia), or both (Staner et al., 2006). As affect and sleep can fluctuate 
on a daily basis (Fung et al., 2014; Peeters et al., 2006), ambulatory assessments 
using mobile technologies (i.e., actigraphy devices and smartphones) may offer new 
opportunities to study the longitudinal day-to-day bidirectional associations be-
tween sleep and momentary affective states (i.e., positive and negative affect). With 
repeated measures throughout the day or even continuous data collection, high reso-
lution data can be obtained that allows us to study associations within much smaller 
time-scales (within day or across days). Determining the extent to which sleep and 
affect interact on a daily level will provide additional insight and can inform on the 
usefulness of daily monitoring using mobile technologies and on target areas for 
(and timing of ) user-feedback & micro-interventions.
Ecological Momentary Assessment (EMA) can provide detailed and frequent in-
formation on self-reported sleep quality and quantity, and on variations in mood 
and affect (Ebner-Priemer & Trull, 2009) assessed via a smartphone. This allows 
the examination of day-to-day bidirectional associations between self-reported sleep 
quality and affect. Better sleep quality has been found to predict improved affect in 
healthy controls as well as persons with depressive (Bouwmans et al., 2017; Bower et 
al., 2010; Triantafillou et al., 2019) and anxiety disorders (Triantafillou et al., 2019). 
Better affect has been found to be predictive of better self-reported sleep quality in 
both healthy controls as well as persons with depressive and anxiety disorders (Tri-
antafillou et al., 2019). 
Besides EMA, another ambulatory assessment, actigraphy, provides objective and 
daily measurements of a person’s sleep quality and quantity in their living environ-
ments (Martin & Hakim, 2011). To date, less studies have examined the relationship 
between objectively assessed sleep and affect. Two studies found no bidirectional 
association between actigraphy-assessed sleep quality and mood in elderly (Parsey & 
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Schmitter-Edgecombe, 2019) and between sleep duration and mood in a sample of 
persons with lifetime diagnosis of unipolar and bipolar depression and healthy con-
trols (Merikangas et al., 2019). As in our previous study using the current sample we 
found that self-reported sleep and actigraphy-based sleep are often poorly correlated 
(Difrancesco et al., 2019), passive monitoring of sleep with wrist-worn actigraphy 
may provide new opportunities for sleep monitoring in patients with depression and 
anxiety.
The aim of this study was to investigate the (1) day-to-day bidirectional longitudinal 
association between  sleep measures and positive and negative momentary affect 
from ambulatory assessments using mobile technologies, and (2) whether these as-




Participants from the Netherlands Study of Depression and Anxiety (NESDA) 
were selected to participate in the Ecological Momentary Assessment (EMA) & 
Actigraphy sub-study (NESDA-EMAA). Details about NESDA have been provid-
ed extensively before (Penninx et al., 2008). NESDA was designed to investigate the 
course of depressive and anxiety disorders over a period of several years and the fac-
tors that influence the development and prognosis of such disorders. NESDA par-
ticipants were initially included at the baseline assessment in 2004-2007 (n=2981), 
and seen for the fifth time at the nine-year follow-up assessment wave (2014-2017, 
n=1776) for a follow-up interview. At that time, also 367 siblings of NESDA par-
ticipants were added, bringing the 9-year follow-up sample to 2143 subjects. At this 
wave, 384 participants enrolled for the EMAA sub-study. The NESDA study, in-
cluding NESDA -EMAA, was approved by the VUmc ethical committee (reference 
number 2003/183) and all respondents gave informed consent for both the regular 
interview and the EMAA sub-study. See for a flowchart and details of the NES-
DA-EMAA in our previous work (Difrancesco et al., 2019)(Schoevers et al., 2020). 
Participants of the NESDA-EMAA study were asked to fill out the EMA assess-
ments, an electronic diary on their smartphone, and to wear a wrist-worn actigraphy 
device (GENEActiv, Activinsights Ltd, Kimbolton, UK) for 14 days. In case partici-
pants did not possess a smartphone, or their phone was not suitable for participation 
(e.g. no internet bundle), a smartphone was provided for the duration of the study 
(n = 107, 27.9%). Participants of the EMA assessment completed a set of items 5 
times a day (i.e. every 3 hours; fixed design). Of all sent EMA assessment invites 
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to 384 participants, only 8.72% were missing. EMA data of 19 participants were 
excluded due to various reasons such as low response rate (response rate below 50%; 
in line with Servaas et al. (2017)) or technical failure, resulting in 365 participants 
with available data. Participants wore the wrist-worn GENEActiv actigraphy device 
on their non-dominant wrist, day and night. Of the 384 participants included in 
the NESDA-EMAA study, 14 had no available actigraphy data for several reasons, 
such as technical failure, resulting in 370 (96.4%) participants with available data. 
According to previously published criteria (da Silva et al., 2014), participant’s actig-
raphy data were included in analyses if at least one week day and one weekend day 
of usable data was available, with at least 16 hours recorded per day and per night. 
The final sample was composed of 359 (93.5%) participants with on average 13.68 
± SE 1.26 valid days, of whom 90% of participants had complete 24-h actigraphy 
data for 14 days.
Assessment of depressive and/or anxiety disorders
As in the previous waves, at the 9-year follow-up, DSM-IV based diagnoses of 
depressive disorders (dysthymia and major depressive disorder) and anxiety (social 
anxiety disorder, panic disorder with and without agoraphobia, agoraphobia and 
generalized anxiety disorder) were established with the Composite International 
Diagnostic Interview (CIDI, version 2.1)(Wittchen, 1994). The interviews were 
conducted by specially trained clinical research staff. Participants were divided into 
three groups: 1) a group with no lifetime depressive and/or anxiety disorders, 2) a 
group with remitted depressive and/or anxiety disorders (having a lifetime, but not 
current (6-month) diagnosis), and 3) a group with current depressive or anxiety 
disorder in the past 6 months. 
Ambulatory assessment variables
Positive and negative momentary affect states 
EMA questionnaires were assessed five times a day and had up to 31 items per time 
point. They contained both momentary affect state items and other items on activ-
ities, context and lifestyle. To assess momentary affect states, items covering high 
and low arousal, positive and negative momentary affect states were used from the 
Uncovering the Positive Potential of Emotional Reactivity study (Bennik, 2015). 
Included items were: I feel satisfied, relaxed, upset, cheerful, irritated, listless, down, 
energetic, enthusiastic, nervous, bored, calm, and anxious. All items were rated on a 
7-point Likert scale ranging from ‘1 = not at all’ to ‘7 = very much’. As used previ-
ously (Schoevers et al., 2020), a positive affect (PA) subscale was calculated by taking 
the average of PA items (at this moment I feel satisfied, relaxed, cheerful, energetic, 
enthusiastic, and calm). Similarly, a negative affect (NA) subscale was calculated by 
averaging all NA items (at this moment I feel upset, irritated, listless/apathic, down, 
nervous, bored, anxious) (Schoevers et al., 2020).
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Sleep variables
Actigraphy-assessed sleep
In this study, the accelerometer was set to sample at 30 Hz and raw actigraphy 
data was analysed using an open source R package, GGIR (van Hees, 2017). As 
described before (Difrancesco et al., 2019), we used objective indicators of sleep: 
sleep efficiency per night [in %] and total sleep duration per night [in hh:mm]. The 
daily estimates were used in the current study. In short, objective sleep estimates 
were obtained using the GGIR package (van Hees, 2017) that uses an algorithm 
described extensively before (van Hees et al., 2018). This algorithm can distinguish 
whether inactivity periods are sleep periods without the use of sleep diaries; the 
algorithm has been validated on a large sample of the UK Biobank. 
EMA-based sleep
Besides objectively assessed sleep duration, we also considered sleep variables collected 
in the EMA assessments, to get a full picture on how objective and self-reported 
measures relate. Self-reported sleep was assessed in each EMA questionnaire but for 
the purpose of this study were based on the first assessment of the day only. Included 
items were sleep duration (“How long did you sleep?” [in hh:mm]) and sleep quality. 
Sleep quality (“Did you sleep well?”) was rated on a 7-point Likert scale ranging 
from ‘1 = not good’ to ‘7 = very good’.     
Covariates: age, sex and work/school days 
Covariates were age, sex and work/school days at the time of the NESDA EMAA 
substudy. These covariates were selected as they have an established theoretical as-
sociation with psychopathology and with sleep, circadian rhythm and physical ac-
tivity levels, and have been regularly used in similar studies (Droomers et al., 2001; 
Stamatakis et al., 2007). Work/school days were identified with information from 
daily EMA assessment as participants were asked to document their location; if they 
reported their location to be at school/work at least once during a day it was counted 
as a work/school day.
Statistical analyses
For descriptive purpose, correlations between sleep variables were tested with Pear-
son’s correlation. 
Generalized estimating equation models (GEE) were used to test the bidirectional 
longitudinal association between momentary affect states assessed every three hours 
and self-reported/objective sleep adjusting for age, sex and work days (a summary 
of the performed analyses is given in Figure 1). Therefore, separate analyses were 
performed by first using momentary affect states (i.e., PA or NA) as outcome (Mod-
el 1) and then by using sleep variables (i.e., EMA-based sleep quality or EMA-
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based sleep duration or objective sleep duration) as outcome (Model 2). Although 
both short and long sleep duration (defined as ≤6 hours and ≥10 hours, respectively, 
(Levine et al., 2003)) are often reported in persons with depression/anxiety (Nutt 
et al., 2008; Zhai et al., 2015), a potential relationship between short and long sleep 
versus normal sleep (7 ≤ hours ≤ 9) and affect was not tested. This was not done as 
less than 10% of our participants slept ≥10 hours in our sample (Difrancesco et al., 
2019), making it impossible to have enough power to detect such effect. We there-
fore only used sleep duration as continuous variable in our analyses.
Data centring of momentary affect states and sleep variables was performed by 
within-person mean; therefore, estimates in the models indicate the effect of de-
viations of affect and sleep from the diurnal person-specific mean. The first-order 
autoregressive working correlation structure was chosen to take into account the 
within-person correlation over the 2-week observation period.  
The same analyses were repeated to test for the moderating effect of current or 
remitted depressive and/or anxiety disorders. When moderation terms were signifi-
cant, stratified analyses by diagnostic group were conducted to interpret and visual-
ise the group effect.
Post-hoc analyses were performed to test the main effect and moderating effect of 
time of the day on the associations.
All analyses were performed with the statistical software R Studio (R Studio ver-
sion 1.2.5033, R version 3.5) and the ‘gee’ library. A p-value < 0.05 was considered 
statistically significant.  
Results
Demographics, ambulatory assessment variables and psychopathology 
Table 1 and Figure 2 show demographics, ambulatory assessment variables and psy-
chopathology in the NESDA EMAA subsample. The average age was 49.5 ± 12.6 
years, and 63.7% were females. Of the 16920 total EMA assessments, 32.7% were 
on work/school days. The median momentary affect states were 5 (IQR 1.5) and 
1.3 (IQR 0.9) for positive and negative affect respectively. The median sleep qual-
ity was 5 (IQR 2), while the median sleep duration was 7.5 h (IQR 1.5 h) when 
assessed with EMA and 7.04 h (IQR 1.7 h) when assessed with actigraphy. The 
median actigraphy-assessed sleep efficiency was 90% (IQR 10%). Moderate signif-
icant correlations were found between EMA-based sleep quality and EMA-based 
sleep duration (r = 0.41, p<0.001), and between self-reported sleep duration and 
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Figure 1: summary of the bidirectional longitudinal association between momentary affect states assessed every three hours and 
(objective and self-reported) sleep. The filled boxes indicate the outcomes. Note Model 1: as we included the previous mood rating 
of the same day in the model, this variable is not present for the first assessment of the day and therefore not depicted as an arrow. 
Table 1: Demographics, ambulatory assessment variables  and psychopathology in the NESDA sample  
Sample
N 359
Demographic and health variables
Age, mean (SD) 49.5 (12.6)
Female, n (%) 228 (63.7 %)
Psychopathology
Depressive and/or anxiety disorders
No, n (%) 90 (25.0 %)
Remitted, n (%) 176 (49.0 %)
Current, n (%) 93 (25.1 %)























Model 1: Predicting mood
Model 2: Predicting activity
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Figure 2: distribution of mood and sleep duration in the NESDA sample (n = 359): positive (A) and negative (B) affect by daily as-
sessment and by diagnosis, actigraphy assessed sleep by diagnosis (C = sleep efficiency, D = sleep duration), self-reported sleep by 
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actigraphy-assessed sleep duration (r = 0.50, p<0.001). Weak correlation was found 
between EMA-based sleep quality and actigraphy-assessed sleep duration (r = 0.09, 
p<0.001). 
Most of the persons included had a lifetime diagnosis of depressive and/or anxi-
ety disorders: 93 (26.0%) persons had current depressive and/or anxiety disorders, 
176 (49.0%) persons had remitted depressive and/or anxiety disorders and only 90 
(25.0%) persons had no lifetime depressive and/or anxiety disorders. 
Day-to-day longitudinal association between sleep and subsequent 
momentary affect states
Better sleep quality was predictive of subsequent higher positive affect scores and 
lower negative affect scores the same day (Table 2, both p<0.001). When testing the 
moderating effect of current or remitted depressive and/or anxiety disorders: having 
a current depressive and/or anxiety disorder moderated the relationship between 
better sleep quality and lower negative affect score, as the interaction term was sta-
tistically significant (p=0.003, Supplemental Material, Table S1). As the interaction 
term was significant, we visualise group effects (Figure 3): a more pronounced neg-
ative association was observed between better sleep quality and subsequent negative 
affect for the groups with current and remitted depressive and/or anxiety disorders. 
Self-reported and objective sleep duration were not predictive of subsequent affect 
the same day (Table 2), nor did current/remitted depressive and/or anxiety disorders 
have a moderating effect (Supplemental Material, Table S1 and Table S2). When 
adjusting for time of the day, results did not change. Time of the day did not mod-
erate the associations (results not shown).
     
Day-to-day longitudinal association between momentary affect states and 
subsequent sleep
Higher score on positive affect and lower score in negative affect predicted better 
sleep quality the next day (Table 3, both p<0.01). No interaction with current/remit-
ted depressive and/or anxiety disorders was observed, suggesting that such associa-
tions do not depend on diagnostic group (Supplemental Material, Table S3). Affect 
states neither predicted self-reported and actigraphy assessed sleep duration (Table 
3), nor did current/remitted depressive and/or anxiety disorders have a moderating 
effect (Supplemental Material, Table S3 and Table S4). When adjusting for time of 
the day, results did not change. Time of the day did not moderate the associations 
(results not shown).
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Positive affect Negative affect
β SE p β SE p
Predictor = EMA assessed sleep quality
Sleep quality (t-1) 0.035 0.006 <0.001 -0.022 0.005 <0.001
Mood (t-1)
Positive affect (t-1) 0.327 0.014 <0.001
Negative affect (t-1) 0.350 0.020 <0.001
Predictor = EMA assessed sleep duration
Sleep duration (t-1) 0.011 0.008 0.147 -0.008 0.005 0.161
Mood (t-1)
Positive affect (t-1) 0.334 0.014 <0.001
Negative affect (t-1) 0.356 0.020 <0.001
Predictor = Actigraphy assessed sleep efficiency
Sleep efficiency (t-1) 0.198 0.120 0.099 -0.078 0.071 0.273
Mood (t-1)
Positive affect (t-1) 0.335 0.014 <0.001
Negative affect (t-1) 0.357 0.021 <0.001
Predictor = Actigraphy assessed sleep duration
Sleep duration (t-1) -0.002 0.006 0.785 0.004 0.004 0.256
Mood (t-1)
Positive affect (t-1) 0.335 0.014 <0.001
Negative affect (t-1) 0.357 0.021 <0.001
Table 2: Association between sleep and momentary affect states of the following day (n = 359)








Figure 3: longitudinal association between EMA-based sleep quality and subsequent momentary assessment states stratified by di-
agnostic group. 
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Sleep Sleep
β SE p β SE p
Outcome = EMA assessed sleep quality
Mood (t-1)
Positive affect (t-1) 0.031 0.02 0.128
Negative affect (t-1) -0.102 0.031 0.001
Sleep quality (day-1) -0.063 0.024 0.010 -0.066 0.024 0.006
Outcome = EMA assessed sleep duration
Mood (t-1)
Positive affect (t-1) -0.003 0.019 0.870
Negative affect (t-1) -0.047 0.026 0.078
Sleep duration (day-1) -0.085 0.021 <0.001 -0.086 0.021 <0.001
Outcome = Actigraphy assessed sleep efficiency
Mood (t-1)
Positive affect (t-1) 0.001 0.001 0.434 -0.001 0.002 0.523
Negative affect (t-1)
Sleep efficiency (day-1) -0.106 0.029 <0.001 -0.106 0.029 <0.001
Outcome = Actigraphy assessed sleep duration
Mood (t-1)
Positive affect (t-1) -0.015 0.016 0.348
Negative affect (t-1) 0.005 0.025 0.833
Sleep duration (day-1) -0.111 0.028 <0.001 -0.111 0.028 <0.001
Table 3: Association between momentary affect states and sleep of the following night (n = 359)
Discussion
This study examined the day-to-day bidirectional longitudinal association between 
self-reported and actigraphy-based sleep measures and momentary affect in a pop-
ulation with and without remitted or current depressive and/or anxiety disorders. 
Better self-reported sleep quality was predictive of improved affect the same day 
especially in persons with current depressive and/or anxiety disorders. On the other 
hand, better affect on the preceding day was predictive of higher self-reported sleep 
quality. No bidirectional longitudinal association was found between self-reported 
and actigraphy-based sleep duration and affect. Thus, the bidirectional associations 
between sleep quality and affect may highlight the potential of improving sleep 
quality as a target for affect improvement and regulation in patients with depression 
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and anxiety by breaking the vicious circle.   
 This study supports previous findings on the bidirectional longitudinal relationship 
between sleep quality and affect. Similarly to our results, better self-reported sleep 
quality has been linked to subsequent increased positive affect and decreased neg-
ative affect (Bouwmans et al., 2017; Triantafillou et al., 2019), and better affect has 
been linked to improved sleep quality (Triantafillou et al., 2019) in individuals with-
out and with depressive and anxiety disorders when using daily (electronic) diaries 
and EMA. Both cognitive and biological mechanisms may explain the relationship 
between poor sleep quality and affect. Sleep deprivation may impact on emotions 
with alterations in especially the limbic system. Rapid eye movement (REM) sleep 
has been suggested as a modulator of affective brain processes, offering a regulatory 
function which restructures experiences in an emotionally adaptive manner (Kahn et 
al., 2013). Emotional information and memory processing may also be relevant, as a 
negative remembering bias has been shown, by which individuals tend to remember 
negative but not positive experiences following loss of sleep (Kahn et al., 2013). 
Finally, the cognitive-energy model (Zohar et al., 2005) suggests that sleep loss 
depletes energy levels, thus disrupting adaptive affective responses to stress. On the 
other hand, there is also data to suggest that an individual’s coping style and emotion 
regulation strategy (e.g., avoidant emotion regulation, rumination) may moderate 
the relationship between low mood and sleep loss (Kahn et al., 2013)
Interestingly, in our study better sleep quality was found to improve subsequent 
affect especially in persons with current depression and/or anxiety. Although some 
studies have found that history of depression and anxiety did not mediate the rela-
tionship (Bouwmans et al., 2017; Triantafillou et al., 2019), a possible explanation of 
our results is that individuals with an already vulnerable emotion-regulation system 
may experience even more adverse effects from poor sleep quality (Harvey, 2011). 
In contrast, no association was found between self-reported or actigraphy-based 
sleep duration and affect. These results seem to be consistent with other research 
which found no bidirectional association between affect and actigraphy-based sleep 
quality in an elderly population (Parsey & Schmitter-Edgecombe, 2019) and ac-
tigraphy-based sleep duration in a population with lifetime diagnosis of unipolar 
and bipolar depression (Merikangas et al., 2019). In line with our previous findings 
(Difrancesco et al., 2019), this study showed that the correlation between objective 
sleep duration and self-reported sleep quality was low and therefore objective and 
self-reported measures capture different aspects, enhancing the assessment of sleep. 
While the current study looking at day-to-day associations did not observe associa-
tions between sleep duration and affect, sleep duration may nevertheless impact on 
Sleep Sleep
β SE p β SE p
Outcome = EMA assessed sleep quality
Mood (t-1)
Positive affect (t-1) 0.031 0.02 0.128
Negative affect (t-1) -0.102 0.031 0.001
Sleep quality (day-1) -0.063 0.024 0.010 -0.066 0.024 0.006
Outcome = EMA assessed sleep duration
Mood (t-1)
Positive affect (t-1) -0.003 0.019 0.870
Negative affect (t-1) -0.047 0.026 0.078
Sleep duration (day-1) -0.085 0.021 <0.001 -0.086 0.021 <0.001
Outcome = Actigraphy assessed sleep efficiency
Mood (t-1)
Positive affect (t-1) 0.001 0.001 0.434 -0.001 0.002 0.523
Negative affect (t-1)
Sleep efficiency (day-1) -0.106 0.029 <0.001 -0.106 0.029 <0.001
Outcome = Actigraphy assessed sleep duration
Mood (t-1)
Positive affect (t-1) -0.015 0.016 0.348
Negative affect (t-1) 0.005 0.025 0.833
Sleep duration (day-1) -0.111 0.028 <0.001 -0.111 0.028 <0.001
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affect. Results from meta-analyses on prospective longitudinal studies, have shown 
that insomnia (Baglioni et al., 2011) and, both short and long vs normal sleep du-
ration (Zhai et al., 2015), assessed with self-reported retrospective ratings, are lon-
gitudinally associated with increased risk of depression 6 months later. Therefore, 
self-reported sleep disturbances may have important long-term effects resulting in 
depression and worsening of depressive symptoms. More research is needed to un-
derstand the underlying biological mechanisms.  
We observed bidirectional day-to-day effects between sleep quality and affect, pos-
sibly pointing to a vicious circle. A question for future studies is whether improving 
sleep quality may have positive outcomes on daily affect, especially in patients with 
depression and anxiety. As online psychological interventions have been shown to be 
effective for psychiatric disorders (Carlbring et al., 2018) and EMA can provide day-
to-day assessments, EMA may be an add-on monitoring tool to (online) psycho-
therapy and Ecological Momentary Interventions (EMI). Specifically for insomnia, 
digital cognitive behavioral therapy (CBT-I) can be administered to patients with 
depression and anxiety; self-reported sleep quality may be an indicator of treatment 
response. Mobile technologies may also be used to monitor patients more broad-
ly. Similarly to the biofeedback-based treatments for insomnia, integrating mobile 
technologies with apps summarizing affect and sleep may provide feedback to pa-
tients. This may help raise patients’ awareness, and may help them to gain control. 
This study has limitations. First, the observational study design can only point to 
areas of interest for monitoring and interventions, but does not allow us to make 
definitive recommendations on such interventions. Future clinical trials may further 
investigate the application of mobile technologies to monitor and measure treatment 
response. While actigraphy is feasible, it only detects sleep based on wrist movement 
and therefore may not be optimal to measure sleep. As restless REM sleep has been 
identified as a potential target for treatment of mental disorders (Wassing et al., 
2019), REM sleep may be a better indicator of objective sleep disruptions. Although 
antidepressant use can be seen as a confounder, it is also closely associated with se-
verity of depression and anxiety (the most severe cases use it), therefore, using it as a 
covariate may be seen as an overcorrection. In addition, as we have previously shown, 
antidepressant use is not associated with sleep duration (Difrancesco et al., 2019). 
Important strength of the study is the use of mobile technology to study the bidi-
rectional day-to-day relationships between objective and self-reported indicators of 
sleep and affect on a relatively large sample with CIDI-based depression and anx-
iety diagnoses. Another strength of this study is that it strongly supports previous 
research on the longitudinal association between sleep quality and affect.  
To conclude, this 2-week intensive ambulatory assessment study using mobile tech-
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nology has shown a bidirectional association between better self-reported sleep 
quality and better affect, while no bidirectional association was found between 
self-reported and actigraphy-based sleep duration and affect. Mobile technologies 
may be insightful tools to provide feedback to patients about their sleep and affect. 
Improving sleep quality may be an important target of treatment to enhance affect in 
patients with depression and anxiety. Future studies may investigate whether EMA 
technology measuring sleep quality can be used to monitor treatment outcomes in 
depression and anxiety. 
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Positive affect Negative affect
β SE p β SE p
Predictor = EMA assessed sleep quality
Sleep quality (t-1) 0.013 0.011 0.236 0.002 0.006 0.681
Mood (t-1)
Positive affect (t-1) 0.326 0.014 <0.001
Negative affect (t-1) 0.348 0.020 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.003 0.004 0.488 -0.002 0.002 0.365
Current -0.004 0.005 0.393 0.001 0.003 0.873
Interactions
Sleep quality (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Sleep quality (t-1) * Remitted depressive and/or 
anxiety disorders 0.023 0.014 0.107 -0.029 0.009 0.001
Sleep quality (t-1) * Current depressive and/or 
anxiety disorders 0.034 0.018 0.052 -0.031 0.010 0.003
Predictor = EMA assessed sleep duration
Sleep duration (t-1) 0.01 0.019 0.611 0.005 0.01 0.587
Mood (t-1)
Positive affect (t-1) 0.334 0.014 <0.001
Negative affect (t-1) 0.355 0.02 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.003 0.004 0.459 -0.002 0.002 0.41
Current -0.005 0.005 0.358 0.001 0.003 0.815
Interactions
Sleep duration (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Sleep duration (t-1) * Remitted depressive and/or 
anxiety disorders -0.007 0.021 0.734 -0.014 0.013 0.253
Sleep duration (t-1) * Current depressive and/or 
anxiety disorders 0.017 0.024 0.487 -0.017 0.014 0.207
Table S1: Longitudinal association between EMA-based sleep and subsequent affect and moderation effect of current/remitted depres-
sive and/or anxiety disorders compared to controls (n = 359) 
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Positive affect Negative affect
β SE p β SE p
Predictor = actigraphy assessed sleep efficiency
Sleep efficiency (t-1) -0.076 0.221 0.731 -0.103 0.085 0.223
Mood (t-1)
Positive affect (t-1) 0.335 0.014 <0.001 0.357 0.021 <0.001
Negative affect (t-1)
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.003 0.004 0.434 -0.001 0.002 0.442
Current -0.005 0.005 0.319 0.001 0.003 0.779
Interactions
Sleep efficiency (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Sleep efficiency (t-1) * Remitted depressive and/or 
anxiety disorders 0.389 0.287 0.175 0.062 0.147 0.674
Sleep efficiency (t-1) * Current depressive and/or 
anxiety disorders 0.332 0.312 0.287 -0.006 0.165 0.973
Predictor = actigraphy assessed sleep duration
Sleep duration (t-1) -0.009 0.012 0.462 0.009 0.006 0.165
Mood (t-1)
Positive affect (t-1) 0.335 0.014 <0.001
Negative affect (t-1) 0.357 0.021 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.004 0.004 0.397 -0.001 0.002 0.534
Current -0.005 0.005 0.335 0.001 0.003 0.765
Interactions
Sleep duration (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Sleep duration (t-1) * Remitted depressive and/or 
anxiety disorders -0.005 0.014 0.709 0.002 0.008 0.791
Sleep duration (t-1) * Current depressive and/or 
anxiety disorders 0.032 0.018 0.076 -0.018 0.011 0.094
Table S2: Longitudinal association between actigraphy assessed sleep and subsequent affect and moderation effect of current/remit-
ted depressive and/or anxiety disorders compared to controls (n = 359) 
Positive affect Negative affect
β SE p β SE p
Predictor = EMA assessed sleep quality
Sleep quality (t-1) 0.013 0.011 0.236 0.002 0.006 0.681
Mood (t-1)
Positive affect (t-1) 0.326 0.014 <0.001
Negative affect (t-1) 0.348 0.020 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.003 0.004 0.488 -0.002 0.002 0.365
Current -0.004 0.005 0.393 0.001 0.003 0.873
Interactions
Sleep quality (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Sleep quality (t-1) * Remitted depressive and/or 
anxiety disorders 0.023 0.014 0.107 -0.029 0.009 0.001
Sleep quality (t-1) * Current depressive and/or 
anxiety disorders 0.034 0.018 0.052 -0.031 0.010 0.003
Predictor = EMA assessed sleep duration
Sleep duration (t-1) 0.01 0.019 0.611 0.005 0.01 0.587
Mood (t-1)
Positive affect (t-1) 0.334 0.014 <0.001
Negative affect (t-1) 0.355 0.02 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.003 0.004 0.459 -0.002 0.002 0.41
Current -0.005 0.005 0.358 0.001 0.003 0.815
Interactions
Sleep duration (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Sleep duration (t-1) * Remitted depressive and/or 
anxiety disorders -0.007 0.021 0.734 -0.014 0.013 0.253
Sleep duration (t-1) * Current depressive and/or 
anxiety disorders 0.017 0.024 0.487 -0.017 0.014 0.207
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Sleep Sleep
β SE p β SE p
Outcome = EMA assessed sleep quality
Mood (t-1)
Positive affect (t-1) 0.046 0.036 0.204
Negative affect (t-1) -0.106 0.101 0.293
Sleep quality (t-1) -0.063 0.024 0.010 -0.066 0.024 0.006
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted 0.031 0.013 0.018 0.031 0.013 0.019
Current 0.021 0.014 0.135 0.021 0.014 0.133
Interactions
Mood (t-1) * No depressive and/or anxiety disor-
ders Ref. Ref.
Mood (t-1) * Remitted depressive and/or anxiety 
disorders 0.008 0.046 0.860 -0.012 0.11 0.916
Mood (t-1) * Current depressive and/or anxiety 
disorders -0.053 0.052 0.302 0.021 0.111 0.853
Outcome = EMA assessed sleep duration
Mood (t-1)
Positive affect (t-1) -0.040 0.043 0.350
Negative affect (t-1) 0.020 0.137 0.883
Sleep duration (t-1) -0.085 0.021 <0.001 -0.087 0.021 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.007 0.013 0.604 -0.007 0.013 0.593
Current 0.001 0.016 0.991 0.001 0.016 0.987
Interactions
Mood (t-1) * No depressive and/or anxiety disor-
ders Ref. Ref.
Mood (t-1) * Remitted depressive and/or anxiety 
disorders 0.042 0.051 0.404 -0.088 0.142 0.533
Mood (t-1) * Current depressive and/or anxiety 
disorders 0.046 0.052 0.370 -0.057 0.14 0.684
Table S3: Longitudinal association between affect and subsequent EMA-based sleep and moderation effect of current/remitted depres-
sive and/or anxiety disorders compared to controls (n = 359) 
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Sleep Sleep
β SE p β SE p
Outcome = EMA assessed sleep quality
Mood (t-1)
Positive affect (t-1) 0.046 0.036 0.204
Negative affect (t-1) -0.106 0.101 0.293
Sleep quality (t-1) -0.063 0.024 0.010 -0.066 0.024 0.006
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted 0.031 0.013 0.018 0.031 0.013 0.019
Current 0.021 0.014 0.135 0.021 0.014 0.133
Interactions
Mood (t-1) * No depressive and/or anxiety disor-
ders Ref. Ref.
Mood (t-1) * Remitted depressive and/or anxiety 
disorders 0.008 0.046 0.860 -0.012 0.11 0.916
Mood (t-1) * Current depressive and/or anxiety 
disorders -0.053 0.052 0.302 0.021 0.111 0.853
Outcome = EMA assessed sleep duration
Mood (t-1)
Positive affect (t-1) -0.040 0.043 0.350
Negative affect (t-1) 0.020 0.137 0.883
Sleep duration (t-1) -0.085 0.021 <0.001 -0.087 0.021 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.007 0.013 0.604 -0.007 0.013 0.593
Current 0.001 0.016 0.991 0.001 0.016 0.987
Interactions
Mood (t-1) * No depressive and/or anxiety disor-
ders Ref. Ref.
Mood (t-1) * Remitted depressive and/or anxiety 
disorders 0.042 0.051 0.404 -0.088 0.142 0.533
Mood (t-1) * Current depressive and/or anxiety 
disorders 0.046 0.052 0.370 -0.057 0.14 0.684
Positive affect Negative affect
β SE p β SE p
Predictor = actigraphy assessed sleep efficiency
Mood (t-1)
Positive affect (t-1) 0.001 0.003 0.830
Negative affect (t-1) -0.002 0.005 0.729
Sleep efficiency (t-1) -0.106 0.029 <0.001 -0.106 0.029 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted 0.001 0.001 0.460 0.001 0.001 0.464
Current 0.001 0.001 0.587 0.001 0.001 0.588
Interactions
Mood (t-1) * No depressive and/or anxiety disorders Ref. Ref.
Mood (t-1) * Remitted depressive and/or anxiety 
disorders 0.001 0.003 0.819 0.001 0.005 0.964
Mood (t-1) * Current depressive and/or anxiety 
disorders 0.001 0.003 0.880 0.001 0.005 0.830
Outcome = actigraphy assessed sleep duration
Mood (t-1)
Positive affect (t-1) -0.077 0.041 0.058
Negative affect (t-1) 0.052 0.11 0.638
Sleep duration (t-1) -0.111 0.028 <0.001 -0.111 0.028 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.005 0.014 0.729 -0.005 0.014 0.717
Current 0.005 0.018 0.766 0.005 0.018 0.774
Interactions
Mood (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Mood (t-1) * Remitted depressive and/or anxiety 
disorders 0.068 0.046 0.141 -0.049 0.115 0.671
Mood (t-1) * Current depressive and/or anxiety 
disorders 0.080 0.050 0.111 -0.052 0.117 0.657
Table S4: Longitudinal association between affect and subsequent actigraphy assessed sleep and moderation effect of current/remit-
ted depressive and/or anxiety disorders compared to controls (n = 359) 
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Within-day bidirectional associations between 
physical activity and affect: 
A real-time ambulatory study in persons with and 
without depressive and anxiety disorders
Sonia Difrancesco, Brenda W.J.H. Penninx, Kathleen R Merikangas, Albert 
M. van Hemert, Harriëtte Riese, Femke Lamers






Background: Ambulatory assessments offer opportunities to evaluate dynamics of 
physical activity and affect using mobile technologies. This study examines – at the 
group and at the person level - bidirectional associations between activity level and 
affect in a 3-hour timeframe using mobile monitoring, and evaluates whether these 
associations differ between people with and without current or remitted depression/
anxiety.
Methods: Two-week ecological momentary assessment (EMA) and actigraphy data 
of 359 participants with current (n = 93), remitted (n = 176), or no (n = 90) CIDI 
depression/anxiety diagnoses were obtained from the Netherlands Study of Depres-
sion and Anxiety. Positive affect (PA) and negative affect (NA) were calculated from 
affect states assessed by EMA 5 times per day. Average activity levels between EMA 
assessments were calculated from actigraphy data.
Outcomes: At the group level, a bidirectional longitudinal association was found 
between activity level and affect. Higher activity level predicted affect 3 hours later 
(higher PA: b=0.109, p<0.001; lower NA: b= -0.043, p<0.001), while affect predict-
ed higher activity level 3 hours later (higher PA: b=0.066, p<0.001; lower NA: b= 
-0.053, p<0.001). Current depression/anxiety disorders moderated the association 
between higher activity level and subsequent lower NA; it was stronger for patients 
than controls (p=0.01). At the person level, analyses revealed heterogeneity in with-
in-person associations. 
Interpretation: Higher physical activity may improve affect, especially among pa-
tients with current depression/anxiety. However, the relationships vary largely from 
person to person. Mobile technologies may help identify who would benefit from 
behavioural interventions.  
Funding: IMI 2 Joint Undertaking (No 115902).
Keywords: Actigraphy; Ecological Momentary Assessment; Depressive disorders, 
Anxiety disorders
120 Sleep, circadian rhythms and physical activity in depression and anxiety: The role of ambulatory assessment tools
Introduction
Physical activity has gained importance in the management of affective disorders 
(Zschucke et al., 2013), as an effective (add-on) treatment (Schuch et al., 2016) 
and preventive factor for a new onset (Hu et al., 2020). Physical activity may also 
play a role in maintaining mood homeostasis. A potential mechanism is that mood 
homeostasis, e.g. stabilization of one’s mood through engaging in mood-modifying 
activities such as physical activity or exercise, is thought to be impaired in depression 
(Taquet et al., 2020). Mobile technologies such as actigraphy devices and smart-
phones offer new opportunities to study the bidirectional longitudinal association 
between momentary assessed physical activity and mood states (i.e., positive and 
negative affect) on a fine-grained time scale in patients’ daily environment. This may 
increase our understanding of the role physical activity in mood homeostasis, espe-
cially relevant in persons with affective disorders. 
Actigraphy, which measures physical activity using a wrist-worn device, provides 
objective and high-density measurements of a person’s physical movement in their 
living environments (Martin & Hakim, 2011). Studies have shown that low phys-
ical activity level assessed with actigraphy is linked to affective disorders (Burton 
et al., 2013), including depression and anxiety (Difrancesco et al., 2019). Ecologi-
cal Momentary Assessment (EMA) provides detailed and frequent information on 
daily variations in mood and affect (Aan het Rot et al., 2012) that could influence 
systems that regulate physical activity. Studies employing EMA have shown that 
persons with a current depression disorder diagnosis have higher instability of neg-
ative and positive affect than persons without a diagnosed disorder (Aan het Rot et 
al., 2012; Schoevers et al., 2020). However, the association between physical activity 
and positive and negative affect with mobile technology has not often been inves-
tigated. Merikangas et al., 2019 (Merikangas et al., 2019) have found a negative 
unidirectional association between physical activity and subsequent sad mood and 
the association was stronger in persons with lifetime diagnosis of bipolar I disorder 
versus healthy controls. The study was, however, limited by a relatively small sample 
size of 91 persons with depressive disorders who were lifetime rather than current 
cases, making it impossible to distinguish trait vs state effects.
Another advantage of mobile technologies is that they allow to study the with-
in-person association between physical activity and affect and their relationships at 
the individual level (also known as idiographic approach). Studies using ambulatory 
assessment tools and idiographic methods have shown that patterns in the asso-
ciation between physical activity and affect (Rosmalen et al., 2012) and between 
physical activity and stress (Burg et al., 2017) may differ widely across persons. As a 
consequence, not all persons may benefit of physical activity to improve their mood 
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and to lower their stress level. As recent personalised approaches in psychiatry have 
shown that smartphone-based micro-interventions can elicit short-term mood 
changes (Meinlschmidt et al., 2016), the use of mobile technologies can play a role 
in personalising treatment via direct feedback of actigraphy devices and apps assess-
ing positive and negative affect.
The aim of this study was to investigate the bidirectional longitudinal association – 
at the group and individual level - between physical activity and affect assessed using 
mobile technologies, and whether these associations differ in persons without and 
with current or remitted depression and/or anxiety disorder diagnoses.  
Method 
Enrolment, intake and ambulatory assessment   
Participants from the Netherlands Study of Depression and Anxiety (NESDA) 
were selected to participate in the Ecological Momentary Assessment (EMA) & 
Actigraphy sub-study (NESDA-EMAA). Details about NESDA have been provid-
ed extensively before (Penninx et al., 2008). NESDA was designed to investigate the 
course of depressive and anxiety disorders over a period of several years and the fac-
tors that influence the development and prognosis of such disorders. NESDA par-
ticipants were initially included at the baseline assessment in 2004-2007 (n=2981), 
and seen for the fifth time at the nine-year follow-up assessment wave (2014-2017, 
n=1776) for a follow-up interview. At that time, also 367 siblings of NESDA par-
ticipants were added, bringing the 9-year follow-up sample to 2143 subjects. At 
this wave, 384 participants enrolled for the EMAA sub-study. The NESDA study, 
including NESDA -EMAA, was approved by the VUmc ethical committee (ref-
erence number 2003/183) and all respondents gave informed consent for both the 
regular interview and the EMAA sub-study. See for a flowchart and details of the 
NESDA-EMAA in our previous work (Difrancesco et al., 2019; Schoevers et al., 
2020). NESDA is also one of the sites that is member of the Motor Activity Re-
search Consortium for Health (m-MARCH)(Scott et al., 2017). Participants of 
the NESDA-EMAA study were asked to fill out the EMA assessment, which is an 
electronic diary, on their smartphone and wore a wrist-worn actigraphy device (GE-
NEActiv, Activinsights Ltd, Kimbolton, UK) for 14 days. In case participants did 
not possess a smartphone, or their phone was not suitable for participation (e.g. no 
internet bundle), a smartphone was provided for the duration of the study (n=107, 
27.9%). Participants of the EMA assessment completed a set of items 5 times a day 
(i.e. every 3 hours; fixed design). Participants wore the wrist-worn GENEActiv ac-
tigraphy device on their non-dominant wrist, day and night. 
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Assessment of depressive and/or anxiety disorders and antidepressant use
As in the previous waves, at the 9-year follow-up, DSM-IV based diagnoses of 
depressive disorders (dysthymia and major depressive disorder) and anxiety (social 
anxiety disorder, panic disorder with and without agoraphobia, agoraphobia and 
generalized anxiety disorder) were established with the Composite International 
Diagnostic Interview (CIDI, version 2.1)(Wittchen, 1994), a highly reliable
and valid instrument for assessing depressive and anxiety disorders.. Participants 
were categorized into three groups: 1) a group with no lifetime depressive and/
or anxiety disorders, 2) a group with remitted depressive and/or anxiety disorders 
(having a lifetime, but not current (6-month) diagnosis), and 3) a group with current 
depressive or anxiety disorder in the past 6 months. 
Antidepressant use was based on drug container inspection, and medications were 
coded according to the World Health Organization Anatomical Therapeutic Chem-
ical (ATC) classification. Antidepressant use was considered present if participants 
reported using it more than 50% of the time. Antidepressants included were selec-
tive serotonin reuptake inhibitors (SSRIs, ATC code N06AB), tricyclic antidepres-
sant (TCA, ATC code N06AA) and other antidepressants (ATC codes N06AF, 
N06AG, N06AX).
Ambulatory assessment variables
Positive and negative momentary affect states 
EMA questionnaires were assessed five times a day and had up to 31 items per time 
point. They contained both momentary affect state items and other items on activ-
ities, context and lifestyle. To assess momentary affect states, items covering high 
and low arousal, positive and negative momentary affect states were used from the 
Uncovering the Positive Potential of Emotional Reactivity study (Bennik, 2015). 
Included items were: I feel satisfied, relaxed, upset, cheerful, irritated, listless, down, 
energetic, enthusiastic, nervous, bored, calm, and anxious. All items were rated on a 
7-point Likert scale ranging from ‘1 = not at all’ to ‘7 = very much’. A positive affect 
(PA) subscale was calculated by taking the average of PA items (at this moment I 
feel satisfied, relaxed, cheerful, energetic, enthusiastic, and calm). Similarly, a nega-
tive affect (NA) subscale was calculated by averaging all NA items (at this moment 
I feel upset, irritated, listless/apathic, down, nervous, bored, anxious).
Physical activity
Raw actigraphy data was processed with open source R package GGIR (version 
1.5-18) (van Hees, 2017). Minute-to-minute daily actigraphy data were derived per 
participant by summing 5-second data. The average physical activity (in milli-gravity 
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units) between EMA assessments was calculated for each day and for each partici-
pant. 
Minutes spent in sedentary behaviour (physical activity level < 30 milli-gravity 
(Rowlands et al., 2014)), light physical activity (physical activity level between 30 
and 125 milli-gravity) and moderate-to-vigorous physical activity (physical activity 
level > 125 milli-gravity (Kim et al., 2017)) between EMA assessments were also 
calculated for each day and for each participant. 
Covariates: age, sex and work/school days 
Covariates were age, sex and work/school days at the time of the NESDA EMAA 
substudy. These covariates were selected as they have an established theoretical as-
sociation with psychopathology and with physical activity levels. Work/school days 
were identified with information from daily EMA assessment as participants were 
asked to document their location; if they reported their location to be at school/
work at least once during a day it was counted as work/school day.
Statistical analyses
Data cleaning and missing data
Data cleaning steps including handling of missing data were previously described 
for both EMA (Schoevers et al., 2020) and actigraphy (Difrancesco et al., 2019) 
data and are further reported in the Supplemental Material. The final sample was 
composed of 359 (93.5%) participants with on average 64.5 ± SD 6.7 valid EMA 
observations and 13.68 ± SD 1.26 valid actigraphy days. 
 Statistical testing
The distribution of physical activity and momentary affect states observations strat-
ified by diagnostic groups were visualised with a box plot. As the distribution of 
observations were skewed, Kruskall-Wallis test was used to test differences between 
diagnostic groups.
Generalized estimating equation models (GEE) were used to test – at group level - 
the bidirectional longitudinal association between momentary affect states assessed 
every three hours and the between assessments average physical activity adjusting 
for age, sex and work days (A summary of the analyses is shown in Figure 1). There-
fore, analyses were performed by first using momentary affect states as outcome 
(Model 1) and then by using physical activity as outcome (Model 2). Physical activ-
ity was log transformed to take account of the skewed distribution. Data centring 
of momentary affect states and physical activity was performed by within-person 
mean; therefore, estimates in the models indicate the effect of changes in affect and 
physical activity from the diurnal person-specific mean. The first-order autoregres-
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sive working correlation structure was chosen to take into account the within-person 
correlation over the 2-week observation period. 
The same analyses were repeated to test for the moderating effect of current or 
remitted depressive and/or anxiety disorders. When moderation terms were sig-
nificant, stratified analyses by diagnostic group were conducted to interpret and 
visualise the group effect. Specifically, for each diagnostic group, the longitudinal 
associations between minutes spent in sedentary behaviour, light physical activity 
and moderate-to-vigorous physical activity and momentary assessment states were 
tested with GEE adjusting for age, sex and work days. The longitudinal associations 
were then  graphically displayed with a forest plot for interpretation of the results. In 
addition, the moderating effect of antidepressant use on the longitudinal association 
between physical activity and subsequent momentary affect states in patients with 
current depressive and/or anxiety disorders was explored.
For this analyses the moderating effect of time of the day on the bidirectional lon-
gitudinal association between momentary affect states and physical activity was also 
explored. 
At the individual level, an analysis was performed to visually explore the heteroge-
neity in the within-person bidirectional longitudinal associations between physical 
activity and momentary affect states. A linear regression model was run for each 
participant and within-person slopes were graphically represented in a forest plot as 
done before by Burg et al (Burg et al., 2017). 
All analyses were performed with the statistical software R Studio (R Studio ver-
sion 1.2.5033, R version 3.5) and the ‘gee’ library, a p-value < 0.05 was considered 
statistically significant.  
Results
Demographics, psychopathology and ambulatory assessment variables
The total sample of 359 individuals had an average age of 49.5 ± SD 12.6 years 
and 63.7% were women. Of the total sample, 93 had current and 176 had remitted 
depressive and/or anxiety disorders, 90 had no current depressive and/or anxiety 
disorders. Seventy-one individuals of the total sample (19.7%) used antidepressants. 
Of the 16920 total EMA assessments, 32.7% were on work/school days. Figure 1 
shows the distribution of the affect and physical activity observations; statistically 
significant differences were found between diagnostic groups (p <0.001). 
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Within-day longitudinal association between physical activity and subse-
quent momentary affect states
Higher activity level was longitudinally associated with higher positive affect and 
lower negative affect scores in the following 3 hours within the same day (Table 1, 
Model 1, both p’s<0.001). When testing the moderating effect of current or remitted 
depressive and/or anxiety disorders, the main effect of activity remained statisti-
cally significant. However, having a current depressive and/or anxiety disorder ap-
peared to moderate the relationship between higher physical activity level and lower 
negative affect score, as the interaction term was statistically significant (p=0.010; 
Supplemental Material, Table S1). Having a remitted depressive and/or anxiety dis-
order appeared to moderate the relationship between higher physical activity level 
and higher positive affect score, as the interaction term was statistically significant 
(p=0.033; Supplemental Material, Table S1); a similar direction in the association 
was found in individuals with a current depressive and/or anxiety disorder (p=0.052; 
Supplemental Material, Table S1). As interaction terms were significant, we visu-
alise group effects (Figure 3): a more pronounced positive association was observed 
between more time spent in light and moderate-to-vigorous activity level, less time 
spent in in sedentary behaviour and subsequent positive affect for the groups with 
Figure 1: Summary of the bidirectional longitudinal association between momentary affect states assessed every three hours and the 
average physical activity between assessments. The filled boxes indicate the outcomes.
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current and remitted depressive and anxiety disorders. A compatible pattern was 
observed for negative affect in individuals with current depressive and/or anxiety 
disorders: less time in sedentary behaviour and more time spent in light and mod-
erate-to-vigorous physical activity were associated with subsequent lower negative 
affect score. Time of the day did not moderate the relationship between physical 
activity level and subsequent momentary affect states (results not shown, available 
upon request). In the current cases, antidepressant use moderated the relationship 
between physical activity level and subsequent momentary affect states (Supple-
mental Material, Table S3, p=0.025). Higher physical activity level enhanced subse-
quent positive affect especially in persons taking antidepressants. 
Although higher physical activity was associated with subsequent improved affect 
at the group level, analyses at the person level showed substantial heterogeneity 
in within-person associations (Figure 4). In some individuals, physical activity de-
creased positive affect score (within-person slope b < -0.20; 14.6% of the total sam-
ple) and increased negative affect score (within-person slope b > 0.20; 11.6% of the 
total sample) or had no clear effect. 
Positive affect Negative affect
β SE p β SE p
 Model 1
Activity (t-1) 0.109 0.014 <0.001 -0.043 0.009 <0.001
Affect (t-1)
Positive affect (t-1) 0.336 0.014 <0.001
Negative affect (t-1) 0.360 0.020 <0.001
Activity Activity
β Se p β Se p
Model 2
Affect (t-1)
Positive affect (t-1) 0.066 0.008 <0.001
Negative affect (t-1) -0.053 0.011 <0.001
Activity (t-1) 0.068 0.013 <0.001 0.075 0.013 <0.001
Note: Model adjusted for age, sex and work/school day (details given in the method section)
Table 1: Bidirectional longitudinal associations between physical activity and momentary affect states (n = 359)
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Positive affect Negative affect
β SE p β SE p
 Model 1
Activity (t-1) 0.109 0.014 <0.001 -0.043 0.009 <0.001
Affect (t-1)
Positive affect (t-1) 0.336 0.014 <0.001
Negative affect (t-1) 0.360 0.020 <0.001
Activity Activity
β Se p β Se p
Model 2
Affect (t-1)
Positive affect (t-1) 0.066 0.008 <0.001
Negative affect (t-1) -0.053 0.011 <0.001
Activity (t-1) 0.068 0.013 <0.001 0.075 0.013 <0.001
Note: Model adjusted for age, sex and work/school day (details given in the method section)
Figure 2: Distribution of affect and physical activity observations in the NESDA sample (n = 359): positive (A) and negative (B) affect by 
daily assessment and by diagnosis, activity level between assessments by diagnosis (C) and minutes spent in different activity levels 
(i.e., sedentary, light and moderate-to-vigorous) by diagnosis (D). 
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Figure 3: Longitudinal association between physical activity and subsequent affect (i.e., positive affect, negative affect) stratified by 
























































































































































































































































Figure 4: Within-person slopes of bidirectional longitudinal associations between physical activity and affect. 
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Within-day longitudinal association between momentary affect states 
and subsequent physical activity
Higher score in positive affect and lower score in negative affect were longitudinally 
associated with higher activity level in the following 3 hours (Table 1, Model 2, both 
p<0.01). Additionally, when testing  the moderating effect of current or remitted 
depressive and/or anxiety disorders, the main effect remained significant and no 
interaction (all p>0.05; Supplemental Material, Table S2) with current or depres-
sive and/or anxiety disorders was observed. Time of the day did not moderate the 
relationship between momentary affect states and subsequent physical activity level 
(results not shown). 
Again, analyses at the person level revealed heterogeneity in within-person associa-
tions (Figure 4). In some individuals, a negative association between better positive 
(within-person slope b < -0.20; 8.5% of the total sample) and negative (within-per-
son slope b > 0.20; 18.5% of the total sample) affect scores and subsequent physical 
activity were present or no association could be observed.    
Discussion
This is one of the first studies to investigate the bidirectional within-day associations 
between momentary assessed daily activity and affect using mobile technology on a 
fine-grained time scale in a population with diagnosed current and remitted depres-
sion/anxiety disorders and controls. Higher physical activity level was longitudinally 
associated with improved subsequent affect with enhanced positive affect and re-
duced negative affect, especially in the group with current depression and/or anxiety. 
Better mood (i.e., higher positive and lower negative affect) was also associated with 
subsequent higher activity level. Thus, bidirectional associations between physical 
activity and affect was confirmed and, highlight the potential of physical activity 
as a target for mood improvement and regulation in patients with depression and 
anxiety by breaking the vicious circle. As variability in the within-person association 
between physical activity and subsequent affect was observed, physical activity may 
not be effective in enhancing affect in all individual. Ambulatory assessment tools 
may be useful to personalise physical activity interventions in patients who would 
benefit most from such interventions.  
This study supports and extends previous findings on the bidirectional relationship 
between physical activity and mood. In line with our results, exercise has been linked 
to subsequent increased positive affect and decreased negative affect as summarised 
in the literature review by Chan et al., 2019 (Chan et al., 2019). Lower activity level 
has been linked to more sad mood in a sample with lifetime history of bipolar and 
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unipolar depression (Merikangas et al., 2019) using mobile technologies. However, 
the latter study did not find that mood was related to changes in motor activity, 
perhaps because of person-level differences in the study sample (Zuidersma et al., 
2020). Both psychosocial and neurophysiological mechanisms have been suggested 
to explain such association such as self-efficacy and the distraction hypothesis, the 
thermogenic effects and the endorphin theory. Physical activity may lead to im-
proved self-efficacy (i.e., an individual’s belief in his or her ability to successfully 
carry out the necessary action required to satisfy situational demands) and psycho-
logical well-being (Barnett, 2013). According to the distraction hypothesis, exercise 
distracts us from stressful stimuli or offers us a break from daily routine, emancipat-
ing us from negative moods (Leith, 1994). The endorphin hypothesis suggests that 
exercise has a positive effect on mood due to an increased release of β-endorphins 
following exercise (Bender et al., 2007). The thermogenic hypothesis says that a 
rise in core body temperature following exercise is responsible for the reduction in 
symptoms of depression (de Vries, 1981).
Importantly, higher physical activity level was found to be longitudinally associated 
with subsequent affect improvement especially in individuals diagnosed with a cur-
rent depression and/or anxiety disorder. In line with our findings, previous studies 
have shown that lifetime history of affective disorders moderates the association 
between physical activity level (Merikangas et al., 2019), daily activities (Taquet et 
al., 2020) and affect. Possible explanations of why current depression and/or anxiety 
patients have a stronger coupling of physical activity and subsequent mood than 
controls could be the following. Persons with depression and/or anxiety may be 
more sensitive to their daily context (Schoevers et al., 2020) and therefore exter-
nal changes, such as in their physical activity level or daily activities (e.g., social 
activities), may impact their mood more strongly. In addition, it has been recently 
suggested that individuals with a history of depression have impaired mood ho-
meostasis compared to controls, as they have difficulties in stabilise their mood via 
mood-modifying activities (Taquet et al., 2020). Physical activity and exercise may 
therefore be important to target affect in an effort to break a downwards spiral and 
thus improve mood. 
However, physical activity may not be beneficial for all individuals with depression 
and anxiety as shown by the heterogeneity of within-person associations between 
physical activity and affect. While some individuals experienced a significant bene-
ficial effect of physical activity on affect, others experienced a negative effect or no 
clear effect. These results may also explain why research on physical activity interven-
tions to treat mental health disorders is often inconsistent and meta-analyses have 
demonstrated a range of effect sizes and large heterogeneity (Stubbs et al., 2016), 
and translation of research finding into clinical practice is hampered (Zuidersma et 
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al., 2020). Our results highlight the advantage of using ambulatory assessment tools 
and idiographic approaches for future research to hopefully improve on effectiveness 
of physical activity interventions in patients with depression and anxiety. 
A question that remains for future studies is the extent to which mobile technol-
ogies may assist behavioural interventions to increase physical activity in patients 
with depression and anxiety. As online psychological interventions have been shown 
to be effective for psychiatric disorders (Carlbring et al., 2018) and mobile technol-
ogies can in real-time monitor patients, mobile technologies may be an add-on tool 
to online (personalized) psychotherapy. Behavioural activation may be automatically 
recommended by intelligent algorithms based on physical activity data collected 
by the wrist-worn actigraphy device of a specific individual. From a broader pro-
spective, when proven effective, mobile technologies may be better integrated into 
mental health care, given their good social acceptance (Bos et al., 2019) and with 
relatively lower costs compared to traditional interventions (Olff, 2015). Also, feed-
back on affect and activity level alone may already help patients by increasing their 
awareness on how their physical activity and mood are related, as a first step in 
behavioural change. 
This study has limitations. First, the observational study design does not allow to 
make definitive causal interpretations and to make recommendations for interven-
tions in clinical practice. Second, implementation in clinical practice may be not 
as straight forward as individual differences in the associations between affect and 
physical activity are large. Future clinical trials may further investigate the use of 
idiographic approaches (i.e., individual models) and mobile technologies to pro-
vide personalised treatments. Important strength of the study is the use of mobile 
technology to study the bidirectional relationship between physical activity and mo-
mentary assessed affect on a relatively large sample with CIDI-based depression and 
anxiety diagnoses.
To conclude, this study has shown a bidirectional association between higher phys-
ical activity level and better mood. Increasing physical activity level may be an im-
portant target of treatment to improve mood by breaking the downward spiral in 
patients with depression and anxiety. These findings highlight the importance of 
mobile technologies which capture salient information about subjective experience 
affect and objective physical activity level in real-time. The bidirectional association 
between physical activity and affect can however vary from person to person. We 
therefore also pointed out the urge of future idiographic research to make mobile 
technologies useful for clinical practice. Mobile technologies may be used for re-
al-time personalised monitoring of affect and physical activity and to provide feed-
back to patients. This may increase their awareness on how mood and activity are 
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interlinked, and perhaps increasing patient’s self-management skills and support be-
havioural changes. As mobile technologies are widely used and accepted in patient’s 
daily life, future online psychological interventions such as behavioural activation 
may integrate in such technologies to provide personalised interventions in patients 
with depression and anxiety. 
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Supplemental material 
Data cleaning and missing data
Data cleaning steps including handling of missing data were previously described 
for both EMA (Schoevers et al., 2020) and actigraphy (Difrancesco et al., 2019). 
Of all sent EMA assessments to 384 participants, only 8.72% were missing. EMA 
data of 19 participants were excluded due to various reasons such as low response 
rate (response rate below 50%; in line with Servaas et al. (2017)) or technical failure, 
resulting in 365 participants with available data. Of the 384 participants, 14 had 
no available actigraphy data for several reasons, such as technical failure, resulting 
in 370 (96.4%) participants with available data. According to previously published 
criteria (da Silva et al., 2014), participant’s actigraphy data were included in analyses 
if at least one week day and one weekend day of usable data was available, with at 
least 16 hours recorded per day and per night. Missing actigraphy data points were 
replaced with participant’s data from the same time of day, averaged across the other 
valid days to provide a person-specific informed approach. The final sample was 
composed of 359 (93.5%) participants with on average 64.5 ± SD 6.7 valid EMA 
observations and 13.68 ± SD 1.26 valid actigraphy days. 
Positive affect Negative affect
β SE p β SE p
Activity (t-1) 0.059 0.021 0.005 -0.023 0.013 0.074
Mood (t-1)
Positive affect (t-1) 0.336 0.014 <0.001
Negative affect (t-1) 0.359 0.020 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted -0.001 0.005 0.788 -0.002 0.002 0.322
Current -0.005 0.006 0.359 0.004 0.004 0.318
Interactions
Activity (t-1) * No depressive and/or anxiety 
disorders Ref. Ref.
Activity (t-1) * Remitted depressive and/or anxiety 
disorders 0.064 0.030 0.033 -0.004 0.018 0.836
Activity (t-1) * Current depressive and/or anxiety 
disorders 0.073 0.038 0.052 -0.065 0.025 0.010
Note: Model adjusted for age, sex and work/school day
Table S1: Longitudinal association between physical activity and subsequent momentary affect states and moderating effect of cur-
rent/remitted depressive and/or anxiety disorders compared to controls (n = 359)
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Physical activity Physical activity
β SE p β SE p
Mood (t-1)
Positive affect (t-1) 0.086 0.021 0.036
Negative affect (t-1) -0.125 0.057 0.029
Activity (t-1) 0.068 0.013 <0.001 0.075 0.013 <0.001
Depressive and/or anxiety disorders
No Ref. Ref.
Remitted 0.003 0.006 0.619 0.003 0.006 0.592
Current 0.001 0.007 0.832 0.002 0.007 0.817
Interactions
Positive affect (t-1) * No depressive and/or anxiety 
disorders Ref.
Positive affect (t-1) * Remitted depressive and/or 
anxiety disorders -0.021 0.024 0.379
Positive affect (t-1) * Current depressive and/or 
anxiety disorders -0.028 0.025 0.262
Negative affect (t-1) * No depressive and/or anxiety 
disorders Ref.
Negative affect (t-1) * Remitted depressive and/or 
anxiety disorders 0.088 0.059 0.138
Negative affect (t-1) * Current depressive and/or 
anxiety disorders 0.069 0.059 0.245
Note: Model adjusted for age, sex and work/school day
Table S2: Longitudinal association between momentary affect states and subsequent physical activity and moderating effect of cur-
rent/remitted depressive and/or anxiety disorders compared to controls (n = 359)
Table S3: Longitudinal association between physical activity and subsequent momentary affect states and moderating effect of anti-
depressant use within persons with current depression/anxiety (n = 93)
Positive affect Negative affect
β SE p β SE p
Activity (t-1) 0.074 0.039 0.060 -0.056 0.023 0.014
Mood (t-1)
Positive affect (t-1) 0.383 0.024 <0.001
Negative affect (t-1) 0.399 0.027 <0.001
Antidepressant use
No Ref. Ref.
Yes  -0.010 0.010 0.340 0.007 0.008 0.385
Interactions
Activity (t-1) * No antidepressant use Ref. Ref.
Activity (t-1) * Yes antidepressant use 0.133 0.059 0.025 -0.076 0.046 0.103
Note: Model adjusted for age, sex and work/school day
Chapter Six: Real-time bidirectional longitudinal association between physical activity and affect - Supplemental material
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This thesis extensively examined the relationships between sleep, circadian rhythms, 
physical activity and psychopathology using ambulatory assessment tools. Specifi-
cally, it emphasizes the role of actigraphy and Ecological Momentary Assessment 
(EMA) to assess sleep, circadian rhythms and physical activity in persons with de-
pression and anxiety. The sample used in the analyses was composed of 359 partici-
pants with current (n=93), remitted (n=176) or no (n=90) CIDI depression/anxiety 
diagnoses; a subsample of the NESDA study. To better explain results of this thesis, 
Table 1 summarises the main findings.   
In Chapter 2, we studied the relationships between sleep, circadian rhythms and 
physical activity with depression and anxiety by using actigraphy and self-report-
ed questionnaires. Specifically, we found reduced physical activity level and daily 
rhythm disturbances among those with depressive and anxiety disorders compared 
to controls using actigraphy-assessed measures, but not using self-reported infor-
mation. By contrast, self-reported but not actigraphy-assessed sleep measures dif-
fered between persons with depressive and anxiety disorders vs controls. In addition, 
we studied the associations of sleep, circadian rhythms and physical activity with 
clinical characteristics (i.e., severity of depressive and anxiety symptoms, number of 
psychiatric diagnoses, duration of depressive and/or anxiety disorders and antide-
pressant use). We found evidence for dose-response associations as those with more 
severe depressive and anxiety symptoms were significantly less active and showed 
longer sleep duration and lower relative amplitude between day and night activity 
level assessed with actigraphy.
In Chapter 3, we studied the associations between sociodemographic, health and 
lifestyle, sampling, and mental health determinants and physical activity patterns. 
We also explored the use of two more advanced statistical techniques also known as 
Functional Data Analysis methods: (a) Functional Principal Component Analysis 
(fPCA) was used to extract motor activity patterns assessed with actigraphy; (b) 
function-on-scalar regression was used to assess the association of psychopathol-
ogy and other determinants with timing of activity. Specifically, we showed that 
data-driven features of daily motor activity extracted with fPCA reflect commonly 
studied factors such as the intensity of daily activity and preference for morningness/
eveningness. Presence and severity of depression/anxiety disorders were found to be 
mainly associated with intensity of daily activity but not with timing of activity. Age, 
working and season were most strongly associated with overall daily activity patterns 
and timing of activity.
In Chapter 4, we explored the heterogeneity of depression in the association with 
sleep, circadian rhythm and physical activity assessed with actigraphy. To examine 
the heterogeneity of depression, individual depressive symptoms were clustered 
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in three symptom dimensions: mood/cognition, somatic/vegetative and sleep. We 
found that all three symptom dimensions were associated with actigraphy-based 
low physical activity and dampened circadian rhythms. Therefore, these seem to be 
general indicators of depression. However, sleep disturbances appeared more linked 
to the somatic/vegetative and sleep dimensions.
In Chapter 5, we studied the bidirectional longitudinal associations between ac-
tigraphy and EMA-based sleep and affect the same day. Better EMA-based sleep 
quality was longitudinally associated with improved affect the same day especially in 
persons with current depressive and/or anxiety disorders. On the other hand, better 
affect on the preceding day was longitudinally associated with higher EMA-based 
sleep quality. No bidirectional longitudinal association was found between EMA-
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Table 1: Summary of results of this thesis. + = linear positive association, - = linear negative association, U = U-shape 
association, x = non-significant association, empty cell = not tested association. 
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In Chapter 6, we examined the bidirectional longitudinal associations between ac-
tigraphy-assessed physical activity and affect in a 3-hour time frame. Higher physi-
cal activity level was longitudinally associated with improved subsequent affect with 
enhanced positive affect and reduced negative affect, especially in persons with cur-
rent depression and/or anxiety. Better mood (i.e., higher positive and lower negative 
affect scores) was also associated with subsequent higher activity level. In addition 
to group-level analyses, we also explored the associations at the individual level. 
Heterogeneity was found in the within-person bidirectional association between 
physical activity and affect, indicating that the associations may differ from person 
to person. For instance, a positive effect of physical activity on subsequent affect 
was found  for some people, while no clear effect or a negative effect were found for 
others. 
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Discussion of the main findings
Are disturbances in sleep and circadian rhythms and altered 
physical activity assessed with ambulatory assessment tools associated 
with psychopathology?
Answer: Yes, this thesis demonstrates that disturbances in sleep and circadian rhythms 
and altered physical activity assessed with ambulatory assessment tools are associat-
ed with psychopathology. 
Association of sleep disturbances with psychopathology
Actigraphy-based sleep measures
Although actigraphy-based sleep duration and efficiency are not associated with 
depressive and anxiety disorders (Chapter 2) and affect (Chapter 5), we found a 
dose-response association between longer sleep duration and more severe symptoms 
(Chapter 2). Lower actigraphy assessed sleep efficiency was also associated with the 
sleep dimension and longer actigraphy-based sleep duration was more specifically 
linked to the somatic/vegetative symptom dimension (Chapter 4). As depression 
and anxiety are heterogeneous conditions, objective sleep disturbances may be more 
linked to specific clinical characteristics and symptom dimensions. 
Sleep duration was found to be longer in persons with a greater number of depres-
sive and anxiety symptoms.  As hypersomnia is one of the symptoms of depression 
(1), persons with more depressive symptoms may also experience more frequently 
longer sleep time. Another explanation may be antidepressant use. More severe cases 
are more likely to use these medications and previous research has suggested that 
long sleep duration can be a result of antidepressant use (2), such as sedating tricyclic 
antidepressants (3). While benzodiazepine use could also be an explanation, as it is 
also prescribed for sleep problems, it is a less likely explanation here, as only 5 cases 
used benzodiazepines. 
Longer sleep duration was also found to be associated with the somatic/vegetative 
symptom dimension. A possible explanation is that persons with more somatic com-
plaints, such as aches and pains and other bodily symptoms, may have more chronic 
or somatic diseases resulting in fatigue and increased sleepiness (4). As it could be 
expected, lower sleep efficiency assessed objectively with actigraphy was associat-
ed with the sleep symptom dimension. Although we did not find an association 
between objective sleep efficiency and subjective sleep assessed with the Women’s 
Health Initiative Insomnia Rating Scale (Chapter 2), the objective measure of sleep 
efficiency seems indicative of self-reported sleep disturbances assessed with the In-
ventory of Depressive Symptomatology. 
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Ecological Momentary assessment of sleep
A bidirectional longitudinal association was found between sleep quality assessed 
with Ecological Momentary Assessment and affect (Chapter 5). Better self-report-
ed sleep quality was predictive of improved affect the same day, especially in persons 
with current depressive and/or anxiety disorders. On the other hand, better affect on 
the preceding day was predictive of higher self-reported sleep quality.
Both cognitive and biological mechanisms may explain the relationship between 
sleep quality and affect. Sleep deprivation may impact on emotions with altera-
tions in especially the limbic system. Rapid eye movement (REM) sleep has been 
suggested as a modulator of affective brain processes, offering a regulatory function 
which restructures experiences in an emotionally adaptive manner (5). Emotional 
information and memory processing may also be relevant, as a negative remember-
ing bias has been shown, by which individuals tend to remember negative but not 
positive experiences following loss of sleep (5). Finally, the cognitive-energy model 
(Zohar et al., 2005) suggests that sleep loss depletes energy levels, thus disrupting 
adaptive affective responses to stress. On the other hand, there is also data to sug-
gest that an individual’s coping style and emotion regulation strategy (e.g., avoidant 
emotion regulation, rumination) may moderate the relationship between low mood 
and sleep loss (5). Interestingly, in our study, better sleep quality was found to im-
prove subsequent affect, especially in persons with current depression and/or anxiety. 
A possible explanation for our results is that individuals with an already vulnera-
ble emotion-regulation system may experience even more adverse effects from poor 
sleep quality (6). 
Association of low circadian rhythm amplitude and physical activity 
with psychopathology
Associations at the group level
Low physical activity level and dampened circadian rhythm amplitude are consis-
tently associated with psychopathology in both cross-sectional (Chapter 2, 3, 4) 
and longitudinal analyses at the group-level (Chapter 6). In addition, those asso-
ciations were independent from several sociodemographic, lifestyle and sampling 
factors (Chapter 3). Low physical activity level and dampened circadian rhythms 
appeared to be general indicators of depression and anxiety and depression severity. 
A dose-response association was found (Chapter 2), as those persons with higher 
depressive and anxiety symptoms were less active and had reduced circadian rhythm 
amplitude. Therefore, it could be concluded that physical inactivity and low circadi-
an amplitude are general indicators of depression and anxiety.
Reduced daily activity level and circadian rhythm amplitude may be indicative of 
psychomotor retardation, withdrawal from normal activities of daily living (7) and 
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circadian impairments (8). The association between physical activity and depression 
has been studied before and appears to be bidirectional. Patients with depression are 
typically less active, and they experience a range of barriers to engaging in physical 
activity such as depressive symptoms, higher body mass index, physical co-morbid-
ity, and lower self-efficacy (9). Low levels of physical activity increase the risk of 
depression (10) and, physical activity and exercise (i.e. structured physical activity) 
can improve depressive symptoms (11). A large meta-analysis in the general pop-
ulation (12) demonstrated that sedentary behaviour is associated with an increased 
risk of developing cardiovascular disease, type 2 diabetes, cardiovascular and all-
cause mortality. As persons with depression are less active than the general popula-
tion, they thus encounter additional risks in developing cardiovascular and chronic 
diseases and mortality. Physical activity and behavioural activation, predominantly 
through exercise, may produce an antidepressant effect through multiple biological 
and psychosocial pathways (13). Neuroplasticity, neuroendocrine responses, inflam-
mation and oxidative stress have been suggested to play a role at a biological level. 
Several psychosocial factors accompany, and potentially interact with, these biolog-
ical changes to influence depression, such as self-esteem (13). While there is less 
research into the psychosocial benefits of exercise on depression, they are likely to 
be of parallel importance. As we observed lower physical activity across all symptom 
dimensions, physical activity and behavioral activation may be of help to all patients 
with depression as it may produce an antidepressant effects through multiple biolog-
ical and psychosocial pathways. 
As reviewed by Vadnie and McClung (2017), multiple mechanisms can explain the 
association between circadian rhythm disruptions and mood disorders. One of the 
main theories is that disrupted circadian rhythms in the master pacemaker, or su-
prachiasmatic nucleus (SCN) may be the cause of mood disturbances. However, 
also other environmental factors, such as light, or genetic perturbations may influ-
ence mood independently from the central clock. Additionally, other studies have 
suggested that sleep and circadian rhythm disturbances may be symptoms of mood 
disorders. As dampened circadian amplitude was associated with all symptom di-
mensions, circadian rhythm interventions such as behavioural activation may be ad-
ministered as adjunctive treatment to all patients with depression.  
Associations at the individual-level 
As most of our analyses are performed at the group-level, these associations may 
be not the same for all individuals. Indeed, as we have shown in Chapter 6, the 
longitudinal association between physical activity and affect may differ from per-
son to person. Although some people experienced enhanced affect in response to 
higher levels of physical activity, other people experienced the opposite or no clear 
effect. Physical activity and exercise may therefore be not be beneficial for all per-
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sons with depression and anxiety. These results may also explain why research on 
physical activity interventions to treat mental health disorders is often inconsistent 
and meta-analyses have demonstrated a range of effect sizes and large heterogeneity 
(15), and translation of research finding into clinical practice is hampered (16). Our 
results highlight the advantage of using ambulatory assessment tools and idiograph-
ic approaches for future research to hopefully improve on effectiveness of physical 
activity interventions in patients with depression and anxiety. 
Are ambulatory assessment estimates better than traditional self-reported 
or subjective measures of sleep, circadian rhythm and physical activity?
Answer: not always, it depends on what you want to measure. Actigraphy enhances the 
assessment of sleep, circadian rhythms and physical activity but it may also measure 
different aspects compared to self-reported questionnaires. Self-reported sleep re-
mains an important indicator of psychopathology.
In this thesis, we often found differential associations between sleep, circadian 
rhythm, physical activity patterns and psychopathology when using subjective mea-
sures and actigraphy estimates. Specifically, we found reduced physical activity level 
and daily rhythm disturbances among those with depressive and anxiety disorders 
compared to controls using objective measures, but not using self-reported informa-
tion (Chapter 2). In addition, while persons with current depression/anxiety report-
ed more insomnia and both shorter and longer sleep duration compared to controls, 
actigraphy-based measures were not different across diagnostic groups (Chapter 2). 
We also found a bidirectional longitudinal association between EMA-based sleep 
quality and affect. Better EMA-based sleep quality was longitudinally associated 
with higher affect scores the following day and higher affect scores are longitudinally 
associated with better sleep quality the following night. However, no bidirectional 
association was found between actigraphy-assessed sleep and affect (Chapter 5). 
The low correlations between objective/actigraphy-based measures and self-report-
ed estimates (Chapter 2 and Chapter 5) suggest that objective and self-reported 
measures capture different aspects. For instance, it is well known in the literature 
that self-reported sleep and objective sleep are two very different concepts (17). The 
first provides information about a person’s perception about his/her sleep quantity 
and quality. The latter refers to the objective measure of sleep with actigraphy or 
other tools such as polysomnography, the gold standard for the assessment of sleep. 
Self-reported sleep often reflects the sleep misperception which is more common 
in patients with severe depressive and anxiety symptoms (18), and is influenced by 
their negative perception. This tendency to misperceive sleep does not preclude the 
presence of a real sleep deficit (17). Perhaps the increased worry associated with 
insomnia makes it more difficult for patients to move into the deeper stages of 
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sleep and the lighter stages of sleep may be more likely to be perceived as wake 
(17). It should be also mentioned that the tendency to misperceive sleep may be 
considered as a “prodromic or transitional state” in the development of insomnia 
that is characterized by a serious objective sleep deficit (17). Thus, actigraphy may 
be used to determine whether self-reported sleep problems are not consistent with 
objective sleep, and whether the patient would potentially benefit from psychologic 
treatments to reverse misperception, such as cognitive behavioural therapy (19). It 
is also important to mention that the objective estimation of sleep with actigraphy 
may be limited and it will be discussed further in the Methodological Consideration 
section.
Actigraphy may therefore enhance the assessment of sleep, circadian rhythm and 
physical activity compared to more traditional tools. However, self-reported sleep 
may an important indicator of psychopathology and therefore target of psychologic 
treatments to reverse misperception, such as cognitive behavioural therapy. 
Methodological considerations
Assessment of sleep with wrist-worn actigraphy devices
Although actigraphy provides an estimate of sleep parameters such as sleep dura-
tion, sleep efficiency, it does not yield estimates of sleep stage, such as REM period 
that may be associated with depression. In addition, it was not possible to extrap-
olate actigraphy sleep estimates indicative of insomnia such as sleep-onset latency 
(i.e., time to transit from full wakefulness to sleep) and wake after sleep onset (i.e., 
periods of wakefulness occurring after sleep onset). Studies have also shown that 
actigraphy lacks the precision of the gold standard polysomnography that provides 
greater insight into sleep problems in people with depression or anxiety (20). Be-
cause in actigraphy, sleep is inferred from a lack of movement, there may be some 
misclassification of sleep among those who are awake but motionless. Therefore, the 
technique is biased toward overestimating total sleep duration, which may lead to 
incorrectly minimizing the severity of sleep disturbances.
Ecological Momentary Assessment limitations
As summarized in the systematic review of Colombo et al (21), Ecological Mo-
mentary Assessment has several advantages but also has some limitations. Although 
studies using Ecological Momentary Assessment has shown a quite high compli-
ance, some patients may perceive this tool as time-consuming. Patients are required 
to complete multiple assessments throughout a day, and protocols often last 2 or 
more weeks. Frequent momentary questionnaires of mental well-being may also 
be perceived as slightly more burdensome to the persons with affective disorders 
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(22) compared to persons with not disorders. In addition, although research has 
shown that Ecological Momentary Assessment is feasible in the short term, research 
assessing Ecological Momentary Assessment for prolonged time periods (e.g., 12 
months) is limited and therefore compliance in the long term is still unclear. For 
instance, patients may engage less with Ecological Momentary Assessment after 
long time periods. Another important consideration is that patients taking part to 
this study may be highly motivated and therefore the high adherence may not be 
generalizable to real world settings. 
Study design
Th e observational study design can only point to areas of interest for monitoring and 
interventions, but does not allow us to make definitive recommendations on such 
interventions. Clinical trials should be implemented to further investigate mobile 
technologies with their intended clinical application.
Statistical analysis
The currently used methodology in this thesis may be limited when studying longi-
tudinal associations between sleep, physical activity and affect. As shown in Chap-
ter 6, unique associations may be present at the individual level and new statistical 
methods may take that into account. For instance, Group Iterative Multiple Model 
Estimation (GIMME) can be used to study associations at the group-level and at 
the individual level from time-series. At the same time, it can be used to visualise 
and describe individual and personalised models of psychopathology. 
Clinical implications 
Can ambulatory assessment tools be used in clinical practice?
Answer: Yes, they might be used in clinical practice as complementary tools to provide 
more personalized psychological treatments, and monitor patients with depression 
and anxiety. However, they still can’t be used routinely in clinical practice or as sole 
tool to measure sleep, circadian rhythms and physical activity. Although ambulatory 
assessment tools are very promising tools in psychiatry, systematic reviews (21) re-
veal the need of high quality clinical trials to bridge the gap between research and 
clinical practice. 
As actigraphy and Ecological Momentary Assessment were able to capture several 
associations with psychopathology, this thesis confirmed the ecological validity of 
ambulatory assessment tools in measuring (self-reported and objective) sleep, cir-
cadian rhythms, physical activity and affect. Ambulatory assessment tools may be 
complementary tools to treatment that may help personalize psychological inter-
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ventions and more broadly they may be used monitor patients with depression and 
anxiety. 
Sleep interventions may be given not only to patients with sleep problems but also 
to patients with somatic/vegetative symptoms. Behavioral activation and physical 
activity interventions may be promoted in all patients with depression and anxiety. 
However, individual differences may play a role in the effectiveness of these inter-
ventions. As mobile technologies can in real-time monitor patients, mobile tech-
nologies may be an add-on tool to psychotherapy. Behavioural interventions, such 
as behavioural activation and cognitive-behavioural therapy, may be automatical-
ly recommended by intelligent algorithms based on physical activity or sleep data 
collected by ambulatory assessment tools. An example of this are Ecological Mo-
mentary Interventions (23), in which psychological and behavioural interventions 
are delivered through smartphones and personal mobile devices to elicit short-term 
mood changes. 
Actigraphy-based physical activity level and Ecological Momentary Assess-
ment-based sleep may be indicators of treatment response. For instance, as improve-
ment in depression with antidepressant medications have been linked with greater 
daytime activity levels (24) when using actigraphy, the continuous measurement of 
daily activity with wrist-worn actigraphy may help to monitor treatment effects (19). 
Although, recent clinical trials have employed actigraphy to monitor behavioral ac-
tivation therapy (25) and sleep deprivation (26) as adjunctive treatments to usual 
care, or as a tool to complement behavioral activation (27), more research is needed 
to clarify whether actigraphy may be used to monitor treatment outcomes of such 
interventions.  
Actigraphy-based physical activity level and Ecological Momentary Assess-
ment-based sleep may be also used to predict short-term and long-term mood 
changes, detect worsening of depressive and anxiety symptoms and perhaps predict-
ing relapse. Detecting early signs of future deterioration is very important as it may 
help delivering timely preventive interventions. The Remote Assessment of Disease 
and Relapse – Central Nervous System (RADAR-CNS) study (28) is an example 
of the use of mobile technologies to predict early signs of depressive relapse in pa-
tients with lifetime diagnosis of depression. Future findings will tell whether mobile 
technologies may play a role in preventing depressive relapse.    
Ambulatory assessment tools may also be very useful for patients to improve their 
communication with clinicians, provide educational material on psychiatric disor-
ders as well as to provide feedback on their affect, sleep and physical activity patterns 
(29).  Similarly to the biofeedback-based treatments for insomnia (30), integrat-
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ing mobile technologies with apps summarizing affect, physical activity and sleep 
may provide feedback to patients. This may help raise patients’ awareness, and may 
help them to gain control. An example of providing feedback to patients is through 
dashboards summarizing their sleep and physical activity patterns over a period of 
time. From a broader prospective, mobile technologies may be better integrated into 
mental health care, given their good social acceptance and with relatively lower costs 
compared to traditional interventions. 
Barriers to clinical implementation 
However, first some conditions should be met before ambulatory assessment tools 
could play a role in clinical practice. Although it has been suggested that actigraphy 
could be used to follow the progression of depression treatment, it is still unclear 
how sensitive and specific actigraphy is for the characterization of this change in 
psychological state (19). Which actigraphy variables are best suited for monitoring 
purposes and definitions of clinically relevant improvement on these variables needs 
to be examined. Interpretation is also not always immediate (e.g., relative amplitude 
between daytime and night time activity) and clinicians may need additional train-
ing for the use of devices in the clinical practice. Wearing research devices such as a 
GENEActiv device, may be experienced as stigmatizing as a patient may be asked 
for its use in public (31,32). Popular commercial activity trackers are aesthetically 
pleasing and therefore maybe less stigmatizing, but at a cost of lower quality data – 
whether these devices are suitable for monitoring treatment effects is unknown (31). 
Currently, the majority of devices used in research settings need to be connected to 
a computer to download data and to extract variables with the use of specific soft-
ware, resulting in a time-consuming procedure. In the future, devices with Bluetooth 
compatible connectivity and consumer devices are likely to become more common, 
allowing the real-time synchronisation of data on the patient’s smartphone app and 
on a data visualisation dashboard. Data may become readily available and interpret-
able for the clinician. Platforms and servers that send encrypted data only and meet 
all GDPR requirements are needed to ensure safe handling of the data. 
Recommendations for future research
Mobile technologies appear promising ambulatory tools to monitor patients with 
depression and anxiety. Although the low cost and scalability of wrist-worn actigra-
phy devices and smartphone facilitate a potential wealth of behavioral and psycho-
logical data, clinical implementation awaits further evidence based on epidemiolog-
ical and empirical data. 
First, as the relationship between sleep, circadian rhythms and physical activity and 
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psychopathology has not been extensively studied before, more research is needed 
to replicate our findings in other samples. Replication may be very important to 
further validate our results on other samples with depression and anxiety and, un-
derstanding which variables are more consistently associated with psychopathology. 
This may help, for instance, to identify possible digital biomarkers of depression and 
anxiety (33) and to choose clinical trial outcomes (34) when assessing the effective-
ness of a treatment.
Second, as this thesis has assessed the relationships over a 2-week period, several 
questions are still open on the association between sleep, circadian rhythms and 
physical activity with psychopathology. Future research using a long-term longitudi-
nal study design (e.g., 1 or 2 years) may specifically assess the value of actigraphy and 
Ecological Momentary Assessment variables to predict long-term outcomes such as 
relapse or response to treatment. For instance, the RADAR-CNS study (28) is as-
sessing whether data collected with mobile technologies may be a composite digital 
signature of depression relapse in order to early intervene and prevent worsening of 
symptoms. 
Third, as associations at the individual-level may be different than associations at 
the group level, idiographic approaches may also be promoted in future research to 
unravel the relationships between sleep, circadian rhythm and physical activity and 
psychopathology at the individual level. Observational studies at the individual level 
may provide new insights on personalized diagnostic information about potential 
risk and protective factors, yielding person-tailored treatment advice and detecting 
psychological changes during a therapeutic process (16). Idiographic analyses may 
enrich and complement analyses at the group level .
Finally, future research should focus on implementing high quality clinical trials 
(21) to assess the use of mobile technologies to provide personalize treatments. Per-
sonalized cognitive and behavioral interventions to improve symptoms and affect 
in patients with depression and anxiety should be explored in future clinical trials 
with the use of mobile technologies. For instance, a recent randomized controlled 
trial has been set-up to support psychological treatment in depressed patients with 
personalized Ecological Momentary Assessment and actigraphy monitoring and 




This thesis extensively examined and demonstrated that disturbances in sleep and 
circadian rhythms and altered physical activity assessed with ambulatory assessment 
tools are associated with psychopathology. Although actigraphy-assessed sleep dis-
turbances are not associated with depression and anxiety diagnoses, longer sleep 
duration assessed with actigraphy is more frequent among people with higher de-
pressive symptoms and somatic/vegetative symptoms. In addition, higher subjective 
sleep quality assessed with Ecological Momentary Assessment is longitudinally as-
sociated with better affect. Low physical activity levels and dampened circadian am-
plitude are consistently associated with psychopathology and therefore are general 
indicators of depression and anxiety. However, individual differences exist and may 
be taken into account when providing cognitive and behavioral interventions. While 
more research is needed on validity, form and content of ambulatory assessments for 
psychiatric populations, mobile technologies are a promising to aid personalization 
of treatment and monitoring of treatment response. Such applications should be 
explored in future epidemiological and clinical studies.   
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Summary
Background
Depression and anxiety are highly prevalent psychiatric disorders. More than 300 
million people are affected by depression and nearly the same number of people 
suffer from a range of anxiety disorders. Depression is ranked by the World Health 
Organization (WHO) as the single largest contributor to global disability, and anx-
iety disorders are ranked 6th. 
Disturbances in sleep and circadian rhythm and altered physical activity have long 
been recognized as core features of depression and anxiety. Sleep problems, such as 
experiencing insomnia or hypersomnia nearly every day is also one of the DSM‐V di-
agnostic criteria of depressive disorders. Disturbances in sleep and circadian rhythm 
and altered physical activity are traditionally assessed using self-reported question-
naires and have been extensively studied in epidemiological studies. Several studies 
reported that depression and anxiety are consistently associated with sleep difficul-
ties. Sleep disturbances are characterized most frequently by insomnia, but also by 
hypersomnia in some individuals. Overall, sleep disturbances include reduced sleep 
duration, longer time to fall asleep and more awakenings during the night and lower 
sleep quality. Circadian rhythm disturbances often occur in patients with depression 
and anxiety. Chronotype or the individual’s time-of-day preference for morningness 
or eveningness is especially studied in persons with depression and anxiety and it is 
related to circadian rhythms. Evening chronotype has been linked to depression and 
anxiety. Depression and anxiety have also been found to be associated with altered 
physical activity. Altered forms of physical activity are not only limited to sedentary 
behaviour and low daily activity levels, but psychomotor retardation, agitation, and 
withdrawal from normal activities of daily living as well. 
Although traditional self-reported questionnaires have high validity and reliability, 
they are often limited in detecting sudden changes in patient’s symptoms. Addi-
tionally, most patients have negative and recall bias while completing assessment 
questionnaires and may recall their symptoms as worse than they present. As most 
symptoms are not continuously tracked outside the clinical setting or between treat-
ment sessions, there has been a recent and significant increase in research to identify 
novel methods to measure depressive and anxiety disorders.
Ambulatory assessment tools including wrist-worn actigraphy devices and smart-
phones may provide new opportunities for diagnosis, treatment and monitoring of 
depression and anxiety. As ambulatory assessment tools can provide a real-time and 
real-world measurements, they may be used to refine the diagnostic process, tailor 
treatment, improve the monitoring for actionable outcomes, such as identify early 
164 Sleep, circadian rhythms and physical activity in depression and anxiety: The role of ambulatory assessment tools
signs of relapse and give feedback to patients about their condition. Ambulatory 
assessment tools have become widely used in psychiatric research to measure dis-
turbances in sleep and circadian rhythm and, physical activity alterations. However, 
more research is needed to understand the added value of these tools in psychiatric 
clinical practice.  
Sample
This thesis is mainly using data from the Netherlands Study of Depression and 
Anxiety (NESDA). NESDA was designed to investigate the course of depressive 
and anxiety disorders over a period of several years and the factors that influence 
the development and prognosis of such disorders. 2981 Participants were initially 
included at the baseline assessment in 2004-2007, and seen for the fifth time at the 
nine-year follow-up assessment wave (2014-2017) for a regular follow-up interview, 
including a psychiatric diagnostic interview. Three hundred sixty-seven siblings of 
a subsample of NESDA participants were (also) included by asking NESDA par-
ticipants at the regular nine-year follow-up interview for their consent to approach 
their siblings. A sub sample from NESDA, consisting of 384 people, was selected 
to participate in the Ecological Momentary Assessment & Actigraphy sub-study 
(NESDA-EMAA). Among demographic, psychiatric and lifestyle characteristics, 
data from ambulatory assessment tools measuring negative and positive affect as 
well as actigraphy simultaneously during 2 weeks were collected at the nine-year 
follow-up assessment.
Thesis aim
This thesis focuses on examining sleep, circadian rhythm and physical activity as-
sessed with ambulatory assessment tools in depressive and anxiety disorders.
Important findings of this thesis
This thesis extensively examined the relationships between sleep, circadian rhythms, 
physical activity and psychopathology using ambulatory assessment tools. Specifi-
cally, it emphasizes the role of actigraphy and Ecological Momentary Assessment 
(EMA) to assess sleep, circadian rhythms and physical activity in persons with de-
pression and anxiety. 
In Chapter 2, we studied the relationships between sleep, circadian rhythms and 
physical activity with depression and anxiety by using actigraphy and self-report-
ed questionnaires. Specifically, we found reduced physical activity level and daily 
rhythm disturbances among those with depressive and anxiety disorders compared 
to controls using actigraphy-assessed measures, but not using self-reported infor-
mation. By contrast, self-reported but not actigraphy-assessed sleep measures dif-
fered between persons with depressive and anxiety disorders vs controls. In addition, 
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we studied the associations of sleep, circadian rhythms and physical activity with 
clinical characteristics (i.e., severity of depressive and anxiety symptoms, number of 
psychiatric diagnoses, duration of depressive and/or anxiety disorders and antide-
pressant use). We found evidence for dose-response associations as those with more 
severe depressive and anxiety symptoms were significantly less active and showed 
longer sleep duration and lower relative amplitude between day and night activity 
level assessed with actigraphy.
In Chapter 3, we studied the associations between sociodemographic, health and 
lifestyle, sampling, and mental health determinants and physical activity patterns. 
We also explored the use of two more advanced statistical techniques also known as 
Functional Data Analysis methods: (a) Functional Principal Component Analysis 
(fPCA) was used to extract motor activity patterns assessed with actigraphy; (b) 
function-on-scalar regression was used to assess the association of psychopathol-
ogy and other determinants with timing of activity. Specifically, we showed that 
data-driven features of daily motor activity extracted with fPCA reflect commonly 
studied factors such as the intensity of daily activity and preference for morningness/
eveningness. Presence and severity of depression/anxiety disorders were found to be 
mainly associated with intensity of daily activity but not with timing of activity. Age, 
working and season were most strongly associated with overall daily activity patterns 
and timing of activity.
In Chapter 4, we explored the heterogeneity of depression in the association with 
sleep, circadian rhythm and physical activity assessed with actigraphy. To examine 
the heterogeneity of depression, individual depressive symptoms were clustered 
in three symptom dimensions: mood/cognition, somatic/vegetative and sleep. We 
found that all three symptom dimensions were associated with actigraphy-based 
low physical activity and dampened circadian rhythms. Therefore, these seem to be 
general indicators of depression. However, sleep disturbances appeared more linked 
to the somatic/vegetative and sleep dimensions.
In Chapter 5, we studied the bidirectional longitudinal associations between ac-
tigraphy and EMA-based sleep and affect the same day. Better EMA-based sleep 
quality was longitudinally associated with improved affect the same day especially in 
persons with current depressive and/or anxiety disorders. On the other hand, better 
affect on the preceding day was longitudinally associated with higher EMA-based 
sleep quality. No bidirectional longitudinal association was found between EMA-
based and actigraphy-based sleep duration and affect.
In Chapter 6, we examined the bidirectional longitudinal associations between ac-
tigraphy-assessed physical activity and affect in a 3-hour time frame. Higher physi-
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cal activity level was longitudinally associated with improved subsequent affect with 
enhanced positive affect and reduced negative affect, especially in persons with cur-
rent depression and/or anxiety. Better mood (i.e., higher positive and lower negative 
affect scores) was also associated with subsequent higher activity level. In addition to 
group-level analyses, we also explored the associations at the individual level. Heter-
ogeneity was found in the within-person bidirectional association between physical 
activity and affect, indicating that the associations may differ from person to person. 
For instance, a positive effect of physical activity on subsequent affect was found 
for some people, while no clear effect or a negative effect were found for others. 
Conclusion
This thesis extensively examined and demonstrated that disturbances in sleep and 
circadian rhythms and altered physical activity assessed with ambulatory assessment 
tools are associated with psychopathology. Although actigraphy-assessed sleep dis-
turbances are not associated with depression and anxiety diagnoses, longer sleep 
duration assessed with actigraphy is more frequent among people with higher de-
pressive symptoms and somatic/vegetative symptoms. In addition, higher subjec-
tive sleep quality assessed with Ecological Momentary Assessment is longitudinally 
associated with better affect. Low physical activity levels and dampened circadian 
amplitude are consistently associated with psychopathology and therefore are gen-
eral indicators of depression and anxiety. However, individual differences exist and 
may be taken into account when providing cognitive and behavioural interventions. 
While more research is needed on validity, form and content of ambulatory assess-
ments for psychiatric populations, mobile technologies are a promising to aid per-
sonalization of treatment and monitoring of treatment response. Such applications 
should be explored in future epidemiological and clinical studies.  
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